Chief Minister's Comprehensive Health Insurance Scheme

Back

NAME OF THE HOSPITAL	Dhanalakshmi Srinivas Hospital,Perambalur TN.
ADDRESS	NH-45, Trichy Chennai Highway,Siruvachur,PERAMBALUR-621113
CONTACT NUMBER	8489923800
AVAILABLE SPECIALITIES	CARDIOLOGY
	CARDIOTHORACIC SURGERIES
	E N T
	MEDICAL GASTROENTEROLOGY
	GENERAL MEDICINE
	GENERAL SURGERY
	GENITOURINARY SURGERY
	GYNAECOLOGY OBSTETRIC SURGERY
	HEPATOLOGY
	INFECTIOUS DISEASES - GENERAL MEDICINE
	INTERVENTIONAL CARDIOLOGY
	MEDICAL ONCOLOGY
	NEONATOLOGY
	NEUROLOGY
	NEUROSURGERY
	OFMS
	OPHTHALMOLOGY SURGERIES
	ORTHOPEDIC TRAUMA
	REPLACEMENT
	PAEDIATRIC INTENSIVE CARE
	PAEDIATRIC SURGERIES
	PAEDIATRICS
	PLASTIC SURGERY
	PULMONLOGY
	RHEUMATOLOGY
	SPINE
	SURGICAL GASTRO ENTEROLOGY
	SURGICAL ONCOLOGY
	THORACIC MEDICINE
	VASCULAR SURGERIES

Packages	Rate
CM0001 : CORONARY BALLOON ANGIOPLASTY (PPCI)	48000
CM0002 : PTCA WITH STENT	63000
CM0003 : ADDITIONAL STENT	19800
CM0004 : ASD DEVICE CLOSURE	71100
CM0005 : VSD DEVICE CLOSURE	71100
CM0006 : PDA STENTING	54000
CM0007 : DEVICE CLOSURE	47700
CM0008 : SINGLE COIL	22500
CM0009 : MULTIPLE COILS	36000
CM0010 : BALLOON VALVOTOMY(ALL VALVE)	35100
CM0011-A : PERMANENT PACEMAKER IMPLANTATION (SINGLE)	72000
CM0011-B : PERMANENT PACEMAKER IMPLANTATION (DUAL CHAMBER)	90000
CM0012 : TEMPORARY PACEMAKER IMPLANTATION	7200
CM0013 : COARCTATION OF AORTA - WITH STENT	56700
CM0014 : COARCTATION OF AORTA - WITHOUT STENT	29700
CM0015 : COARCTATION OF AORTA - ADDITIONAL STENT ONLY	36000
CM0016 : PRIMARY ANGIOPLASTY FOR ACUTE MI +DRUG ELUTING STENT	56700
CM0017 : PRIMARY ANGIOPLASTY - ADDITIONAL STENT ONLY	19800
CM0018 : ENHANCED EXTERNAL COUNTER PULSATION THERAPY (EECP)	22500
CM0019 : CORONARY BYPASS SURGERY	90000
CM0020 : CORONARY BYPASS SURGERY-POST ANGIOPLASTY	108000
CM0021 : CABG WITH IABP PUMP	120600
CM0022 : CORONARY BYPASS SURGERY OFF PUMP WITH IABP	108000
CM0023 : CABG OFF PUMP WITHOUT IABP	89100
CM0024 : CABG WITH ANEURYSMAL REPAIR	111600
CM0025 : CABG WITH VENTRICULAR RUPTURE REPAIR	135000
CM0026 : CABG WITH VALVE REPLACEMENT WITH MECHANICAL VALVE	130500
CM0027 : CABG WITH VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE	157500
CM0028 : DOUBLE VALVE REPLACEMENT WITH MECHANICAL VALVE	136800
CM0029 : DOUBLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE	180000
CM0030 : SINGLE VALVE REPLACEMENT WITH MECHANICAL VALVE	117000
CM0031 : SINGLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE	144000
CM0032 : TRIPLE VALVE REPLACEMENT WITH MECHANICAL VALVE	180000
CM0033 : TRIPLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE	180000
CM0034 : COARCTATION-AORTA REPAIR WITH GRAFT	43200
CM0035 : COARCTATION-AORTA REPAIR WITHOUT GRAFT	34200
CM0036 : ANEURYSM RESECTION & GRAFTING	115200
CM0037 : INTRATHORACIC ANEURYSM - NOT REQUIRING BYPASS	65700
CM0038 : INTRATHORACIC ANEURYSM - REQUIRING BYPASS (WITH GRAFT)	90000
CM0039 : DISSECTING ANEURYSMS	74700
CM0040 : AORTO-AORTO BYPASS WITHOUT GRAFT	52200
CM0041 : AORTO-AORTO BYPASS WITH GRAFT	65700
CM0042 : ANNULUS AORTIC ECTASIA WITH VALVED CONDUITS	142200
CM0043 : ARTERIAL SWITCH	131400
CM0044 : SENNINGS PROCEDURE	110700
CM0045 : SURGERY FOR INTRACARDIAC TUMORS	82800
CM0046 : RUPTURED SINUS OF VALSULVA CORRECTION	100000
CM0047 : TAPVC CORRECTION	100000
CM0048 : SYSTEMIC PULMONARY SHUNTS WITH GRAFT	46800
CM0049 : SYSTEMIC PULMONARY SHUNTS WITHOUT GRAFT	37800
CM0050 : TOTAL CORRECTION OF TETRALOGY OF FALLOT - ANY TYPE	92700
CM0051 : INTRA CARDIAC REPAIR OF ASD	73800
CM0052 : INTRA CARDIAC REPAIR OF VSD	73800
CM0053 : SURGERY-PDA	34200
CM0054 : WITH SPECIAL CONDUITS	109800
CM0055 : WITHOUT SPECIAL CONDUITS	90000
CM0056 : WITH PROSTHETIC RING	90000
CM0057 : WITHOUT PROSTHETIC RING	87300
CM0058 : OPEN PULMONARY VALVOTOMY	72000
CM0059 : CLOSED MITRAL VALVOTOMY	45000
CM0060-A : PERICARDIECTOMY	34200
CM0060-B : PERICARDIOSTOMY	14400
CM0061 : PERICARDIOCENTESIS	14400
CM0062 : MITRAL VALVOTOMY (OPEN)	49500
CM0063 : CORONARY ARTERY FISTULA REPAIR	69300
CM0064 : THORACIC DUCT LIGATION FOR CHYLOTHORAX	51300
CM0067 : LUNG CYST	52200
CM0069 : CARDIAC INJURIES SURGERY WITHOUT CARDIO PULMONARY BYPASS	48600
CM0070 : CARDIAC INJURIES SURGERY WITH CARDIO PULMONARY BYPASS	75600
CM0071 : TRACHEAL RESECTION WITH MONTGOMERY TUBE	58500
CM0072 : MINIMAL ACCESS SURGERY- ASD	90000
CM0073 : MINIMAL ACCESS SURGERY- VSD	90000
CM0074 : MINIMAL ACCESS SURGERY- VALVE REPLACEMENT	23400
CM0075 : MINIMAL ACCESS SURGERY- CABG	36000
CM0076 : INGUINAL BLOCK DISSECTION ONE SIDE	10753
CM0077 : ABDOMNO PERINEAL RESECTION (APR) + SACRECTOMY	33242
CM0078-A : LAPROSCOPIC APR	37616
CM0078-B : EXTRALEVATOR APR	28139
CM0078-C : TRANS ABDOMINAL	28139
CM0078-D : TRANS ANAL	28139
CM0078-E : INTERSPHINCTERIC RESECTION	28139
CM0078-F : LOW ANTERIOR RESECTION	31784
CM0079 : ABDOMINAL WALL TUMORS RESECTION WITH RECONSTRUCTION	32441
CM0080 : ABDOMINAL WALL TUMORS RESECTION WITHOUT RECONSTRUCTION	23328
CM0081 : BILATERAL PELVIC LYMPH NODE DISSECTION(BPLND) ANY SITE	16038
CM0082-A : RADICAL VAGINECTOMY WITHOUT RECONSTRUCION a) WITH LND	20594
CM0082-B : RADICAL VAGINECTOMY WITHOUT RECONSTRUCION b) WITHout LND	18772
CM0083-A : RADICAL VAGINECTOMY WITH RECONSTRUCION a) WITH LND	30071
CM0083-B : RADICAL VAGINECTOMY WITH RECONSTRUCION b) WITHOUT LND	26426
CM0084-A : RADICAL HYSTERECOMY+BILATERAL PELVIC LYMPH NODE DISSECTION+BILATERAL SALPHINGO OOPHERECTOMY	27155
CM0084-B : OVARIAN TRANSPOSITION	32258
CM0085-A : ANTERIOR EXENTRATION - ANY SITE	42100
CM0085-B : POSTERIOR EXENTRATION- ANY SITE	30436
CM0086 : TOTAL PELVIC EXENTRATION - ANY SITE	51577
CM0087 : EXTRALEVATOR EXENTRATION - ANY SITE	29342
CM0088 : SUPRALEVATOR EXENTRATION - ANY SITE	29342
CM0089 : TOTAL ABDOMINAL HYSTERECTOMY+BILATERAL SALPHINGO OOPHERECTOMY+BILATERAL PELVIC LYMPH NODE DISSECTION+OMENTECTOMY	25296
CM0090-A : RETRO PERITONEAL LYMPH NODE DISSECTION(RPLND) (FOR RESIDUAL DISEASES /STAGING	15491
CM0090-B : RETRO PERITONEAL LYMPH NODE DISSECTION(RPLND) (FOR RESIDUAL DISEASES /WITH VASCULAR RECONSTRUCTION	22964
CM0091-A : OESOPHAGECTOMY WITH TWO FIELD LYMPADENECTOMY	43922
CM0091-B : OESOPHAGECTOMY WITH THREE FIELD LYMPADENECTOMY	53035
CM0092-A : VERMILIONECTOMY WITHOUT WEDGE EXCISION	12211
CM0092-B : VERMILIONECTOMY WITH WEDGE EXCISION	13669
CM0093 : EMASCULATION	18006
CM0094 : PALATECTOMY ANY TYPE	18407
CM0095 : RADICAL TRACHELECTOMY	24968
CM0096 : SUBSTERNAL BYPASS	19865
CM0097 : ABBE OPERATION	13669
CM0098 : CYTOREDUCTIVE SURGERY	16949
CM0099 : VULVECTOMY	11117
CM0100-a-I : BREAST CANCER - Dose Dense AC (Adriamycin/Cyclophosphamide) ; (Day 1: Doxorubicin 60mg/m2 IV, Cyclophosphamide 600mg/m2 IV) ; Repeat cycle - every 14 days for 4 cycles; Followed by Paclitaxel for 4 cycles	3000
CM0100-a-II : BREAST CANCER - Paclitaxel (Preceeded by Dose Dense AC - 4 cycles) ; (Day 1: Paclitaxel 175mg/m2) Repeat cycle - every 14 days for 4 cycles	7000
CM0100-b : BREAST CANCER - TC (Doectaxel & Cyclophosphamide) ; Day 1: Docetaxel 75mg/m2 IV, Cyclophosphamide 600mg/m2 IV ; Repeat cycle - every 21 days for 4 cycles	6000
CM0100-c : BREAST CANCER - CMF (Cyclophosphamide/Methotrexate/Fluorouracil) - (includes day 1 & day 8) ; Days 1-14: Cyclophosphamide 100mg/m2 orally ; Days 1 and 8: Methotrexate 40mg/m2 IV ; Days 1 and 8: 5-fluorouracil 600mg/m2 IV. ; Repeat cycle - every 28 days for 6 cycles	2700
CM0100-d : BREAST CANCER - EC (Epirubicin/Cyclophosphamide) ; Day 1: Epirubicin 100mg/m2 IV ; Day 1: Cyclophosphamide 830mg/m2 IV. ; Repeat cycle - every 21 days for 8 cycles	5100
CM0100-e-I : BREAST CANCER - FEC/CEF followed by T (Fluorouracil/Epirubicin/Cyclophosphamide) - followed by Docetaxel or followed by weekly Paclitaxel) ; Day 1: 5-fluorouracil 500mg/m2 IV ; Day 1: Epirubicin 100mg/m2 IV ; Day 1: Cyclophosphamide 500mg/m2 IV. ; Repeat cycle every 21 days for 3 cycles	5100
CM0100-e-II : BREAST CANCER - Docetaxel - (Preceeded by FEC/CEF ) ; Day 1: Docetaxel 100mg/m2 IV. ; Repeat cycle - every 21 days for 3 cycles	5500
CM0100-e-III : BREAST CANCER - Paclitaxel - weekly - (Preceeded by FEC/CEF ) ; Paclitaxel 100mg/m2 IV ; Repeat cycle - once weekly for 8 weeks	3500
CM0100-f-I : BREAST CANCER - FAC followed by T (Fluorouracil/Adriamycin/Cyclophosphamide) - followed by weekly Paclitaxel ; 5-fluorouracil 500mg/m2 IV Days 1 and 8 OR 1 and 4: ; Day 1: Doxorubicin 50mg/m2 IV ; Day 1: Cyclophosphamide 500mg/m2 IV. ; Repeat cycle - every 21 days for 6 cycles	3200
CM0100-f-II : BREAST CANCER - Paclitaxel - weekly - Preceeded by FAC ; Paclitaxel 80mg/m2 IV ; Repeat Cycle weekly for 12 weeks.	3500
CM0100-g : BREAST CANCER - TAC (Docetaxel/Adriamycin/Cyclophosphamide) ; Day 1: Doxorubicin 60mg/m2 IV ; Day 1: Cyclophosphamide 600mg/m2 IV. ; Day 1: Docetaxel 100mg/m2 IV. ; Repeat cycle every 21 days for 4 cycles,	5600
CM0100-h-I : BREAST CANCER - AC - followed by Paclitaxel + Trastuzumab +/- Pertuzumab ; Day 1: Doxorubicin 60mg/m2 IV ; Day 1: Cyclophosphamide 600mg/m2 IV. ; Repeat cycle - every 21 days for 4 cycle	3000
CM0100-h-II : BREAST CANCER - Paclitaxel (Preceeded by AC) ; (To be choosen along with Trastuzumab package - CM0100-h-III or CM0100-h-IV or CM0100-h-V) ; Paclitaxel 80mg/m2 IV. ; Repeat Cycle weekly for 12 weeks.	3500
CM0100-h-III : BREAST CANCER - Trastuzumab (6mg) ; (to be choosen along with Paclitaxel package CM0100-h-II) ; Day 1: Trastuzumab 6mg/kg IV ; Repeat cycle every 21 days to complete 1 year. ; (to be approved with Paclitaxel Cycle 1, 4, 7, 10 and standalone for the upto 1 year every 21 days)	30500
CM0100-h-IV : BREAST CANCER - Trastuzumab 4mg (Followed by Trastuzumab 2mg subsequent weeks) ; (to be choosen along with Paclitaxel package CM0100-h-II) ; Day 1: Trastuzumab 4mg/kg IV with first dose of paclitaxel. ; (First dose - only to be approved with Paclitaxel Cycle 1. Subsequent cycles - 2mg package only)	30500
CM0100-h-V : BREAST CANCER - Trastuzumab 2mg (Subsequent doses) ; (to be choosen along with Paclitaxel package CM0100-h-II) ; Day 1: Trastuzumab 2mg/kg IV weekly Till one year from Day 1 of AC. ; (to be approved with Paclitaxel Cycles 2 - 12 and standalone for the upto 1 year every week)	11500
CM0100-i-I : BREAST CANCER - TC (Docetaxel/Carboplatin) ; (To be choosen along with Trastuzumab package - CM0100-i-II or CM0100-i-III or CM0100-i-IV) ; Day 1: Docetaxel 75mg/m2 IV; Carboplatin AUC 6mg per min/mL IV. ; every 21 days for 6 cycles	7100
CM0100-i-II : BREAST CANCER - Trastuzumab (6mg) ; (to be choosen along with TC package CM0100-i-I) ; Trastuzumab 6mg/kg IV ; Repeat cycle every 21 days to complete 1 year. ; (to be approved with TC Cycle 1 to 6 and standalone for the upto 1 year every 21 days (or) after completion of weekly trastuzumab for 18 weeks as standalone for the upto 1 year every 21 days)	30500
CM0100-i-III : BREAST CANCER - Trastuzumab 4mg (First dose - only) - followed by 2mg ; (to be choosen along with TC package CM0100-i-I) ; Day 1: Trastuzumab 4mg/kg IV ; (First dose - only to be approved with TC Cycle 1. Subsequent cycles - 2mg package only)	30500
CM0100-i-IV : BREAST CANCER - Trastuzumab 2mg (Subsequent doses - Weekly) ; Trastuzumab 2mg/kg IV ; (to be approved weekly for 17 weeeks may overlap with TC Cycles 2 - 6. To be followed by Trastuzumab (6mg) package upto 1 year	11500
CM0100-j-I : BREAST CANCER - AC - followed by Docetaxel + Trastuzumab ; Day 1: Doxorubicin 60mg/m2 IV; Day 1: Cyclophosphamide 600mg/m2 IV. ; Repeat cycle every 21 days for 4 cycles,	3000
CM0100-j-II : BREAST CANCER - Docetaxel (preceeded by AC) + Trastuzumab ; (To be choosen along with Trastuzumab package - CM0100-j-III or CM0100-j-IV or CM0100-j-V) ; Day 1: Docetaxel 100mg/m2 IV. ; Repeat cycle every 21 days for 4 cycles	5400
CM0100-j-III : BREAST CANCER - Trastuzumab (6mg) ; (to be choosen along with Docetaxel package CM0100-j-II) ; Day 1: Trastuzumab 6mg/kg IV ; Repeat every 21 days till 1 year ; (to be approved with Docetaxel Cycle 1 to 4 and standalone for the upto 1 year every 21 days (or) or from 13 th week after completion of 12 weeks of weekly Trastuzumab - upto 1 year every 21 days)	30500
CM0100-j-IV : BREAST CANCER - Trastuzumab 4mg (First dose - only) - followed by 2mg ; (to be choosen along with Docetaxel package CM0100-j-II) ; Trastuzumab 4mg/kg IV ; (First dose - only to be approved with Docetaxel Cycle 1. Subsequent cycles - 2mg package only)	30500
CM0100-j-V : BREAST CANCER - Trastuzumab 2mg (Subsequent doses) ; Trastuzumab 2mg/kg IV ; (to be approved weekly for 11 weeeks may overlap with Docetaxel Cycles 2 - 4. To be followed by Trastuzumab (6mg) package upto 1 year)	11500
CM0100-k-I : BREAST CANCER - Docetaxel + Cyclophosphamide - with Trastuzumab ; (To be choosen along with Trastuzumab package - CM0100-k-II or CM0100-k-III or CM0100-k-IV) ; Day 1: Docetaxel 75mg/m2 IV; Cyclophosphamide 600mg/m2 IV. ; Repeat cycle every 21 days for 4 cycles,	5000
CM0100-k-II : BREAST CANCER - Trastuzumab (6mg) ; (to be choosen along with Docetaxel + Cyclophosphamide package CM0100-k-I) ; Day 1: Trastuzumab 6mg/kg IV ; (to be approved with Docetaxel + Cyclophosphamide Cycle 1 to 4 and standalone for the upto 1 year every 21 days (or) after completion of weekly trastuzumab for 12 weeks as standalone for the upto 1 year every 21 days)	30500
CM0100-k-III : BREAST CANCER - Trastuzumab 4mg (First dose - only) - followed by 2mg ; (to be choosen along with Docetaxel + Cyclophosphamide package CM0100-k-I) ; Trastuzumab 4mg/kg IV ; (First dose - only to be approved with Docetaxel + Cyclophosphamide Cycle 1. Subsequent cycles - 2mg package only)	30500
CM0100-k-IV : BREAST CANCER - Trastuzumab 2mg (Subsequent doses) ; Trastuzumab 2mg/kg IV ; (to be approved weekly for 11 weeeks may overlap with Docetaxel + Cyclophosphamide Cycles 2 - 4. To be followed by Trastuzumab (6mg) package upto 1 year)	11500
CM0100-L-I : BREAST CANCER - Paclitaxel - (with Trastuzumab) ; (To be choosen along with Trastuzumab package - CM0100-L-III or CM0100-L-IV) ; Paclitaxel 80mg/m2 IV. ; Repeat Cycle weekly for 12 weeks.	3000
CM0100-L-II : BREAST CANCER - Trastuzumab (6mg) ; trastuzumab 6mg/kg IV ; Repeat every 21 days ; (to be approved after completion of weekly trastuzumab for 12 weeks as standalone for the upto 1 year every 21 days)	30500
CM0100-L-III : BREAST CANCER - Trastuzumab 4mg (First dose - only) - followed by 2mg ; (to be choosen along with Paclitaxel package CM0100-L-I) ; Trastuzumab 4mg/kg IV with first dose of paclitaxel. ; (First dose - only to be approved with Paclitaxel Cycle 1. Subsequent cycles - 2mg package only)	30500
CM0100-L-IV : BREAST CANCER - Trastuzumab 2mg (Subsequent doses) ; (to be choosen along with Paclitaxel package CM0100-L-I) ; Day 1: Trastuzumab 2mg/kg IV weekly ; (to be approved with Paclitaxel Cycles 2 - 12. May be approved as standalone for the upto 1 year every week or Trastuzumab 6mg Package may be used once every 21 days upto 1 year)	11500
CM0100-M : BREAST CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents) ; (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0101-a-I : BLADDER CANCER - DDMVAC ; Day 1: Methotrexate 30mg/m2 IV; Day 2: Vinblastine 3mg/m2 IV, doxorubicin 30mg/m2 IV, cisplatin 70mg/m2 IV; ; Repeat every 2 weeks for 3-4 cycles	3800
CM0101-a-II : BLADDER CANCER - Gemcitabine + cisplatin ; Days 1, 8, and 15: Gemcitabine 1,000mg/m2 IV; Day 2: Cisplatin 70mg/m2. ; Repeat every 4 weeks for 4 cycles.	6400
CM0101-a-III : BLADDER CANCER - Cisplatin + methotrexate + vinblastine (CMV) ; Day 1: Methotrexate 30mg/m2 IV, vinblastine 4mg/m2 IV; Day 2: Cisplatin 100mg/m2 IV, leucovorin 15mg oral or IV every 6 hours for 4 doses; Day 8: Methotrexate 30mg/m2 IV, vinblastine 4mg/m2 IV Day 9: Leucovorin 15mg oral every 6 hours for 4 doses ; Repeat every 3 weeks for 3 cycles.	4800
CM0101-b : BLADDER CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents) ; (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0102-i-a : LUNG CANCER - Mesothelioma - Pemetrexed + cisplatin ; Day 1: Pemetrexed 500mg/m2 IV, cisplatin 75mg/m2 ; Repeat every 21 days up to 12 cycles.	14500
CM0102-i-b : LUNG CANCER - Mesothelioma - Pemetrexed + carboplatin ; Day 1: Pemetrexed 500mg/m2 IV, carboplatin AUC 5mg/min/mL IV. ; Repeat every 21 days for a max of 9 cycles.	16500
CM0102-i-c : LUNG CANCER - Mesothelioma - Cisplatin & Gemcitabine ; Day 1: Cisplatin 80-100mg/m2 IV ; Days 1, 8, and 15: Gemcitabine 1000-1250mg/m2 IV ; Repeat every 21 - 28 days for 6 cycles.	7600
CM0102-i-d : LUNG CANCER - Mesothelioma - Vinorelbine ; Vinorelbine 25-30mg/m2 (max 60mg) IV ; Repeat every week for 12 weeks.	9000
CM0102-i-e : LUNG CANCER - Mesothelioma - Pemetrexed ; Day 1: Pemetrexed 500mg/m2 IV. ; Repeat every 21 days for 4 cycles (If First line) or Repeat every 21 days for 8 cycles (If Second line)	14500
CM0102-i-f : LUNG CANCER - Mesothelioma - Gemcitabine ; Days 1, 8, and 15: Gemcitabine 1250mg/m2 IV. ; Repeat every 28 days for a max of 10 cycles.	7600
CM0102-i-g : LUNG CANCER - Mesothelioma - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents) ; (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0102-ii-a : LUNG CANCER - NSCLC - Cisplatin & Vinorelbine - (i) ; Days 1 and 8: Cisplatin 50mg/m2 IV and Days 1, 8, 15 and 22: Vinorelbine 25mg/m2 IV ; (or) ; Day 1: Cisplatin 100mg/m2 IV and Days 1, 8, 15 and 22: Vinorelbine 30mg/m2 IV. ; Repeat cycle every 4 weeks for 4 cycles.	33600
CM0102-ii-b : LUNG CANCER - NSCLC - Cisplatin & Vinorelbine - (ii) ; Day 1: Cisplatin 75-80mg/m2 ; Days 1 and 8: Vinorelbine 25-30mg/m2. ; Repeat every 3 weeks for 4 cycles	17900
CM0102-ii-c : LUNG CANCER - NSCLC - Cisplatin & Etoposide ; Day 1: Cisplatin 100mg/m2 IV ; Days 1-3: Etoposide 100mg/m2 IV. ; Repeat cycle every 4 weeks for 4 cycles	4900
CM0102-ii-d : LUNG CANCER - NSCLC - Cisplatin & Docetaxel ; Day 1: Docetaxel 75mg/m2 IV, cisplatin 75mg/m2 IV. ; Repeat every 3 weeks for 4 cycles.	6300
CM0102-ii-e : LUNG CANCER - NSCLC - Cisplatin & Gemcitabine ; Day 1: Cisplatin 75mg/m2 IV ; Days 1 and 8: Gemcitabine 1,250mg/m2 IV. ; Repeat every 3 weeks for 4 cycles	6100
CM0102-ii-f : LUNG CANCER - NSCLC - Pemetrexed + cisplatin (for Non Squamous Cell CA) ; Day 1: Cisplatin 75mg/m2 IV, pemetrexed 500mg/m2 IV. ; Repeat every - 21 days for 4 cycles.	14500
CM0102-ii-g : LUNG CANCER - NSCLC - Paclitaxel/Carboplatin ; Day 1: Paclitaxel 200mg/m2 IV, carboplatin AUC 6mg per min/mL IV. ; Repeat cycle every 3 weeks for 4 cycles.	8100
CM0102-ii-h : LUNG CANCER - NSCLC - Cisplatin & Etoposide ; Days 1, 8, 29 and 36: Cisplatin 50mg/m2 IV ; Days 1-5 and 29-33: Etoposide 50mg/m2 IV ; Concurrent thoracic radiotherapy 1.8Gy/day for 5 days/week (total dose, 61Gy).	8500
CM0102-ii-i : LUNG CANCER - NSCLC - Cisplatin & Vinblastine ; Days 1 and 29: Cisplatin 100mg/m2 IV ; Days 1, 8, 15, 22 and 29: Vinblastine 5mg/m2 IV ; concurrent thoracic radiotherapy (total dose, 60Gy).	8200
CM0102-ii-j : LUNG CANCER - NSCLC - Carboplatin + Pemetrexed ; Day 1: Carboplatin AUC 5mg per min/mL IV ; Day 1: Pemetrexed 500 mg/m2 IV ; with concurrent thoracic radiotherapy. ; Repeat every 3 weeks for 4 cycles.	16500
CM0102-ii-k : LUNG CANCER - NSCLC - Cisplatin + Pemetrexed ; Day 1: Cisplatin 75 mg/m2 IV. ; Day 1: Pemetrexed 500 mg/m2 IV ; with concurrent thoracic radiotherapy. ; Repeat every 3 weeks for 3 cycles.	14900
CM0102-ii-l : LUNG CANCER - NSCLC - Paclitaxel + Carboplatin ; Paclitaxel 45mg/m2 IV + carboplatin AUC 2mg per min/mL IV ; with concurrent thoracic radiotherapy (total dose, 60Gy) ; Repeat weekly for 6 weeks	3300
CM0102-ii-m : LUNG CANCER - NSCLC - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0102-iii-a : LUNG CANCER - SCLC - Cisplatin & Etoposide ; Day 1: Cisplatin 60mg/m2 IV, Days 1-3: Etoposide 120mg/m2 IV. ; Repeat cycle every 3 weeks for at least 4 cycles. ;(OR) ; Day 1: Cisplatin 80mg/m2 IV, Days 1-3: Etoposide 100mg/m2 IV. ; Repeat cycle every 4 weeks for 4-6 cycles.	4900
CM0102-iii-b : LUNG CANCER - SCLC - Carboplatin & Etoposide ; Day 1: Carboplatin AUC 5-6mg per min/mL IV ; Days 1-3: Etoposide 100mg/m2 IV. ; Repeat cycle every 21 days or 28 days for 4 - 6 cycles	6500
CM0102-iii-c : LUNG CANCER - SCLC - Cisplatin + Irinotecan ; Day 1: Cisplatin 60mg/m2 IV. ; Days 1, 8, and 15: Irinotecan 60mg/m2 IV. ; Repeat cycle every 4 weeks for 4 cycles.	5800
CM0102-iii-d : LUNG CANCER - SCLC - Cisplatin + Irinotecan ; Day 1 and 8: Cisplatin 30mg/m2 IV, irinotecan 65mg/m2 IV. ; Repeat cycle every 3 weeks for 4-6 cycles.	5700
CM0102-iii-e : LUNG CANCER - SCLC - Carboplatin & Irinotecan ; Day 1: Carboplatin AUC 5mg per min/mL IV ; Days 1, 8, and 15: Irinotecan 50mg/m2 IV. ; Repeat cycle every 4 weeks for 4 cycles	7700
CM0102-iii-f : LUNG CANCER - SCLC - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents) ; (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0103-i-a : ESOPHAGEAL CANCER - Neo Adjuvant - Paclitaxel + Carboplatin ; Day 1: Paclitaxel 50mg/m2 IV + carboplatin AUC 2mg/min/mL IV. ; Repeat weekly for 5 weeks	3300
CM0103-i-b : ESOPHAGEAL CANCER - Neo Adjuvant - Fluorouracil & Cisplatin ; Days 1 and 29: Cisplatin 75-100mg/m2 IV ; Days 1-4 and 29-32: 5-FU 750-1,000mg/m2 IV.	12000
CM0103-i-c : ESOPHAGEAL CANCER - Neo Adjuvant - Fluorouracil & Cisplatin ; Days 1-5: Cisplatin 15mg/m2 IV daily ; Days 1-5 and Days 22-26: 5-FU 800 mg/m2 IV ; Repeat every 21 days for 2 cycles	7100
CM0103-i-d : ESOPHAGEAL CANCER - Neo Adjuvant - Fluorouracil + Oxaliplatin + Leucovorin ; Day 1: Oxaliplatin 85mg/m2, leucovorin 200mg/m2 and 5-FU 400mg/m2 bolus, with 1,600mg/m2 infusion; ; Repeat every 14 days for 6 cycles	4600
CM0103-i-e : ESOPHAGEAL CANCER - Neo Adjuvant - Cisplatin + capecitabine ; Day 1: Cisplatin 30mg/m2 IV ; Days 1-5: Capecitabine 800mg/m2 orally twice daily ; Repeat cycle weekly for 5 weeks	2500
CM0103-i-f : ESOPHAGEAL CANCER - Neo Adjuvant - Fluorouracil & Oxaliplatin ; Days 1, 15, and 29: Oxaliplatin 85mg/m2 IV ; Days 1-33: 5-FU 180mg/m2/day IV	25800
CM0103-i-g : ESOPHAGEAL CANCER - Neo Adjuvant - Oxaliplatin + capecitabine ; Days 1, 15, and 29: Oxaliplatin 85mg/m2 IV ; Days 1-5: Capecitabine 625mg/m2 orally twice daily for 5 weeks.	8900
CM0103-i-h : ESOPHAGEAL CANCER - Neo Adjuvant - Irinotecan & Cisplatin ; Days 1, 8, 22, and 29: Irinotecan 65mg/m2 IV, cisplatin 30mg/m2 IV.	9700
CM0103-i-i : ESOPHAGEAL CANCER - Neo Adjuvant - Fluorouracil & Paclitaxel ; Day 1: Paclitaxel 45mg/m2 IV ; Days 1-5: 5-FU 300mg/m2/day IV infusion. ; Repeat cycle weekly for 5 weeks.	5500
CM0103-i-j : ESOPHAGEAL CANCER - Neo Adjuvant - Paclitaxel + capecitabine ; Day 1: Paclitaxel 45-50mg/m2 IV ; Days 1-5: Capecitabine 625-825mg/m2 orally twice daily. ; Repeat cycle weekly for 5 weeks.	12200
CM0103-i-k : ESOPHAGEAL CANCER - Neo Adjuvant - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0103-ii-a : ESOPHAGEAL CANCER - Peri-Operative - ECF (Epirubicin/Cisplatin/Fluorouracil) ; Day 1: Epirubicin 50mg/m2 IV; cisplatin 60mg/m2 IV ; Days 1-21: 5-FU 200mg/m2 IV continuous infusion once daily; ; Repeat every 21 days for 3 cycles preoperatively and 3 cycles postoperatively	16700
CM0103-ii-b : ESOPHAGEAL CANCER - Peri-Operative - EOF (Epirubicin/Cisplatin/Fluorouracil) ; Day 1: Epirubicin 50mg/m2 IV; oxaliplatin 130mg/m2 IV ; Days 1-21: 5-FU 200mg/m2 IV; ; Repeat every 21 days for 3 cycles preoperatively and 3 cycles postoperatively.	18700
CM0103-ii-c : ESOPHAGEAL CANCER - Peri-Operative - EOC (Epirubicin/Cisplatin/Fluorouracil) ; Day 1: Epirubicin 50mg/m2 IV; oxaliplatin 130mg/m2 IV ; Days 1-21: Capecitabine 625mg/m2 orally twice daily. ; Repeat every 21 days for 3 cycles preoperatively and 3 cycles postoperatively.	7800
CM0103-ii-d : ESOPHAGEAL CANCER - Peri-Operative - Fluorouracil & Cisplatin ; Days 1 and 29: Cisplatin 75-100mg/m2 IV ; Days 1-4 and 29-32: 5-FU 750-1,000mg/m2 IV ; Repeat cycle every 28 days for 2-4 cycles	12000
CM0103-ii-e : ESOPHAGEAL CANCER - Peri-Operative - Fluorouracil & Cisplatin ; Days 1-5: Cisplatin 15mg/m2 IV daily ; Days 1-5: 5-FU 800 mg/m2 IV continuous infusion over 24 hours. ; Cycled every 21 days for 2 cyclesCycled every 21 days for 2 cycles	7100
CM0103-ii-f : ESOPHAGEAL CANCER - Peri-Operative - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0103-iii-a : ESOPHAGEAL CANCER - Post-Operative - Fluorouracil + Leucovorin (i) ; Days 1-5: 5-FU 425mg/m2/day IV and leucovorin 20mg/m2/day IV, followed by 4 weeks break and CCRT ; RT Days 1-4 and 23-25: 5-FU 400mg/m2/day IV and leucovorin 20mg/m2/day IV followed by one month Break and ; Days 1-5: 5-FU 425mg/m2/day IV and leucovorin 20mg/m2/day IV followed by one month Break and ; Days 1-5: 5-FU 425mg/m2/day IV and leucovorin 20mg/m2/day IV.	25400
CM0103-iii-b : ESOPHAGEAL CANCER - Post-Operative - Fluorouracil + Leucovorin (ii) ; Days 1, 2, 15, and 16: Leucovorin 200mg/m2 IV, 5-FU 400mg/m2 IV push and 5-FU 600mg/m2 infusion	9000
CM0103-iii-c : ESOPHAGEAL CANCER - Post-Operative - Capecitabine (i) ; Days 1-14: Capecitabine 750-1000mg/m2 orally twice daily; ; Repeat every 28 days; 1 cycle before and 2 cycles after chemoradiation	3100
CM0103-iii-d : ESOPHAGEAL CANCER - Post-Operative - Capecitabine (ii) ; Days 1-5 OR Days 1-7: Capecitabine 625-825mg/m2 orally twice daily, ; once weekly for 5 weeks.	1600
CM0103-iii-e : ESOPHAGEAL CANCER - Post-Operative - FluorouracilDays 1-5 OR Days 1-7: 5-FU 200-250mg/m2 IV continuous infusion over 24 hours daily, ; once weekly for 5 weeks.once weekly for 5 weeks.	6500
CM0103-iii-f : ESOPHAGEAL CANCER - Post-Operative - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0103-iv-a : ESOPHAGEAL CANCER - Definitive - Fluorouracil & Cisplatin (i) ; Days 1 and 29: Cisplatin 75-100mg/m2 IV ; Days 1-4 and 29-32: 5-FU 750-1,000mg/m2 IV	12000
CM0103-iv-b : ESOPHAGEAL CANCER - Definitive - Fluorouracil & Cisplatin (ii) ; Days 1-5: Cisplatin 15mg/m2 IV daily ; Days 1-5: 5-FU 800 mg/m2 IV continuous infusion over 24 hours. ; Cycled every 21 days for 2 cycles	7100
CM0103-iv-c : ESOPHAGEAL CANCER - Definitive - Fluorouracil & Oxaliplatin ; Days 1, 15, and 29: Oxaliplatin 85mg/m2 IV ; Days 1-33: 5-FU 180mg/m2/day continuous IV infusion.	25800
CM0103-iv-d : ESOPHAGEAL CANCER - Definitive - Cisplatin + capecitabine ; Day 1: Cisplatin 30mg/m2 IV ; Days 1-5: Capecitabine 800mg/m2 orally twice daily ; Repeat cycle weekly for 5 weeks	2000
CM0103-iv-e : ESOPHAGEAL CANCER - Definitive - Oxaliplatin + capecitabine ; Days 1, 15, and 29: Oxaliplatin 85mg/m2 IV ; Days 1-5: Capecitabine 625mg/m2 orally twice daily for 5 weeks	8900
CM0103-iv-f : ESOPHAGEAL CANCER - Definitive - Paclitaxel + Carboplatin ; Day 1: Paclitaxel 50mg/m2 IV and carboplatin 2mg/min/mL IV ; Repeat weekly for 5 weeks.	3300
CM0103-iv-g : ESOPHAGEAL CANCER - Definitive - Cisplatin with Docetaxel (i) ; Days 1 and 22: Docetaxel 60mg/m2 IV ; Days 1 and 22: Cisplatin 60-80mg/m2 IV given for 1 cycle	8900
CM0103-iv-h : ESOPHAGEAL CANCER - Definitive - Cisplatin with Docetaxel (ii) ; Day 1: Docetaxel 20-30mg/m2 IV ; Day 1: Cisplatin 20-30mg/m2 IV ; Repeat weekly for 5 weeks	3000
CM0103-iv-i : ESOPHAGEAL CANCER - Definitive - Cisplatin with Paclitaxel ; Days 1, 8, 15, and 22: Paclitaxel 60mg/m2 IV ; Day 1: Cisplatin 75mg/m2 IV given for 1 cycle.	13100
CM0103-iv-j : ESOPHAGEAL CANCER - Definitive - Irinotecan & Cisplatin ; Days 1, 8, 22, and 29: Irinotecan 65mg/m2 IV ; Days 1, 8, 22, and 29: Cisplatin 30mg/m2 IV.	9700
CM0103-iv-k : ESOPHAGEAL CANCER - Definitive - Fluorouracil & Paclitaxel ; Day 1: Paclitaxel 45mg/m2 IV ; Days 1-5: 5-FU 300mg/m2/day IV ; Repeat cycle weekly for 5 weeks.	5500
CM0103-iv-l : ESOPHAGEAL CANCER - Definitive - Paclitaxel + capecitabine ; Day 1: Paclitaxel 45-50mg/m2 IV ; Days 1-5: Capecitabine 625-825mg/m2 PO twice daily. ; Repeat cycle weekly for 5 weeks.	12200
CM0103-iv-m : ESOPHAGEAL CANCER - Definitive - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0104-i-a : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Paclitaxel + Carboplatin ; Day 1: Paclitaxel 50mg/m2 IV, carboplatin AUC 2mg/min/mL IV. ; Repeat cycle weekly for 5 weeks.	3300
CM0104-i-b : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Fluorouracil & Cisplatin (i) ; Days 1 and 29: Cisplatin 75-100mg/m2 IV ; Days 1-4 and 29-32: 5-FU 750-1000mg/m2/day IV	12000
CM0104-i-c : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Fluorouracil & Cisplatin (ii) ; Days 1-5: Cisplatin 15mg/m2 IV once daily, 5-FU 800mg/m2/day IV ; Repeat cycle every 21 days for 2 cycles.	7100
CM0104-i-d : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Fluorouracil & Oxaliplatin (i)Days 1, 15, and 29: Oxaliplatin 85mg/m2 IV ; Days 1-33: 5-FU 180mg/m2/day IV.	25800
CM0104-i-e : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Fluorouracil & Oxaliplatin (ii)Day 1: Oxaliplatin 85mg/m2 and leucovorin 400mg/m2 followed by 5-FU 400mg/m2 bolus, then 800mg/m2 24-hour continuous infusion over days 1 and 2; the first 3 cycles were delivered during radiotherapy (RT), the other 3 after RT; 6 bimonthly (14 days) cycles.	6100
CM0104-i-f : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Cisplatin + capecitabine ; Day 1: Cisplatin 30mg/m2 IV ; Days 1-5: Capecitabine 800mg/m2 orally twice daily. ; Repeat cycle weekly for 5 weeks.	2000
CM0104-i-g : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Oxaliplatin + capecitabine ; Days 1, 15, and 29: Oxaliplatin 85mg/m2 IV ; Days 1-5: Capecitabine 625mg/m2 orally twice daily for 5 weeks	8900
CM0104-i-h : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Fluorouracil & Paclitaxel ; Day 1: Paclitaxel 45-50mg/m2 IV weekly ; Days 1-5: 5-FU 300mg/m2 IV ; Repeat cycle weekly for 5 weeks	5500
CM0104-i-i : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Paclitaxel + capecitabine ; Day 1: Paclitaxel 45-50mg/m2 IV ; Days 1-5: Capecitabine 625-825mg/m2 orally twice daily. ; Repeat cycle weekly for 5 weeks.	3100
CM0104-i-j : GASTRIC CANCER - Preoperative Chemoradiation (esophagogastric junction and gastric cardia) - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0104-ii-a : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) - ECF (Epirubicin/Cisplatin/Fluorouracil) ; Day 1: Epirubicin 50mg/m2 IV, cisplatin 60mg/m2 IV ; Days 1-21: 5-FU 200mg/m2/day IV ; Repeat cycle every 21 days for 3 cycles preoperatively and 3 cycles postoperatively	16700
CM0104-ii-b : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) - EOF (Epirubicin/ oxaliplatin /Fluorouracil) ; Day 1: Epirubicin 50mg/m2 IV; oxaliplatin 130mg/m2 IV ; Days 1-21: 5-FU 200mg/m2 IV; ; Repeat every 21 days for 3 cycles preoperatively and 3 cycles postoperatively.	18700
CM0104-ii-c : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) - epirubicin + cisplatin + capecitabine ; Day 1: Epirubicin 50mg/m2 IV + cisplatin 60mg/m2 IV ; Days 1-21: Capecitabine 625mg/m2 orally twice daily. ; Repeat cycle every 21 days for 3 cycles preoperatively and 3 cycles postoperatively.	5900
CM0104-ii-d : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) - ECF modification (epirubicin + oxaliplatin + capecitabine) ; Day 1: Epirubicin 50mg/m2 IV + oxaliplatin 130mg/m2 IV ; Days 1-21: Capecitabine 625mg/m2 orally twice daily. ; Repeat cycle every 21 days for 3 cycles preoperatively and 3 cycles postoperativelyRepeat cycle every 21 days for 3 cycles preoperatively and 3 cycles postoperatively	7800
CM0104-ii-e : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) - Fluorouracil & Cisplatin ; Day 1: Cisplatin 75-80mg/m2 IV ; Days 1-5: 5-FU 800mg/m2 IV ; Repeat cycle every 28 days for 2-3 cycles preoperatively and 3-4 cycles postoperatively for a total of 6 cycles.	6900
CM0104-ii-f : GASTRIC CANCER - Perioperative Chemotherapy (including esophagogastric junction) - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0104-iii-a : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Fluorouracil + Leucovorin (i) ; Cycles 1, 3, and 4 (before and after radiation) Days 1-5: Leucovorin 20mg/m2 IV, 5-FU 425mg/m2/day IV ; Repeat cycle every 28 days. ; Cycle 2 (with radiation) Days 1-4 and 31-33: Leucovorin 20mg/m2 IVP ; Days 1-4: 5-FU 400mg/m2/day IVP. ; Repeat cycle every 35 days	25400
CM0104-iii-b : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Fluorouracil + Leucovorin (ii) ; Days 1, 2, 15, and 16: Leucovorin 400mg/m2 IV, 5-FU 400mg/m2 IV and 5-FU 1200mg/m2 infusion; ; 1 cycle before and 2 cycles after chemoradiation. ; Repeat cycle every 28 daysRepeat cycle every 28 days	14900
CM0104-iii-c : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Capecitabine (i) ; Days 1-14: Capecitabine 750-1000mg/m2 orally twice daily. ; Repeat cycle every 28 days; 1 cycle before and 2 cycles after chemoradiation.	3100
CM0104-iii-d : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Capecitabine (ii) ; Days 1-5 OR Days 1-7: Capecitabine 625-825mg/m2 orally twice daily; weekly for 5 weeks.	1600
CM0104-iii-e : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Fluorouracil ; Days 1-5 OR Days 1-7: 5-FU 200-250mg/m2 IV; ; weekly for 5 weeks.	6500
CM0104-iii-f : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Cisplatin + capecitabine ; Day 1: Cisplatin 60mg/m2 IV. ; Days 1-14: Capecitabine 1000mg/m2 orally twice daily ; Repeat cycle every 21 days for 6 cycles.	4000
CM0104-iii-h : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Oxaliplatin + capecitabine ; Day 1: Oxaliplatin 130mg/m2 IV. ; Days 1-14: Capecitabine 1000mg/m2 orally twice daily ; Repeat cycle every 21 days for 8 cycles.Repeat cycle every 21 days for 8 cycles.	6000
CM0104-iii-i : GASTRIC CANCER - Postoperative Chemoradiation (including esophagogastric junction) - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0105-i-a : COLORECTAL CARCINOMA - FOLFOX (Stage - III) - (Oxaliplatin, Leucovorin, 5-FU) ; Day 1: Oxaliplatin 85mg/m2 IV, leucovorin 400mg/m2 IV , 5-FU 400mg/m2 IV, followed by 5-FU 1,200mg/m2/day IV x 2 days (total 2,400mg/m2) over 46-48-hour continuous infusion. ; Repeat cycle every 2 weeks- upto 12 cycles	8000
CM0105-i-b : COLORECTAL CARCINOMA - CAPEOX (Stage - III) (Oxaliplatin, Capecitabine) ; Day 1: Oxaliplatin 130mg/m2 IV over 2 hours ; Days 1-14: Capecitabine 1,000mg/m2 orally twice daily. ; Repeat cycle every 3 weeks for 6 months	6500
CM0105-i-c : COLORECTAL CARCINOMA - FLOX (Stage - III) (5-FU, leucovorin, oxaliplatin) ; 5-FU 500mg/m2 IV bolus weekly x 6, leucovorin 500mg/m2 IV weekly x 6, each ; oxaliplatin 85mg/m2 IV on weeks 1, 3, and 5 ; 8-week cycle x 3 cycles ;	30000
CM0105-i-d : COLORECTAL CARCINOMA - Capecitabine ; Capecitabine 1,250mg/m2 - BD / TDS D 1-14 ; every 3 weeks * 24 weeks	4300
CM0105-i-e : COLORECTAL CARCINOMA - Fluorouracil + Leucovorin (i) ; Leucovorin 500mg/m2 weekly x 6 weeks, ; 5-FU 500mg/m2 weekly x 6 weeks. ; Repeat cycle every 8 weeks for 4 cycles.	23700
CM0105-i-f : COLORECTAL CARCINOMA - Fluorouracil + Leucovorin (ii)Simplified biweekly infusion. ; Leucovorin 400mg/m2 IV, 5-FU bolus 400mg/m2 and then 1,200mg/m2/day x 2 days (total 2,400mg/m2 over 46-48 hours) ; Repeat cycle every 2 weeks for 6 cycles.	5200
CM0105-i-g : COLORECTAL CARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0105-ii-a : COLORECTAL CARCINOMA - Concurrent - 5FU - with XRT ; Days 1-5 OR 1-7: 5-FU 225mg/m2 IV ; with External beam radiotherapy	3800
CM0105-ii-b : COLORECTAL CARCINOMA - Concurrent - Fluorouracil + Leucovorin - with XRT ; Days 1-4: 5-FU 400mg/m2 IV + leucovorin 20mg/m2 IV. ; Repeat cycle during weeks 1 and 5 of XRT.	6100
CM0105-ii-c : COLORECTAL CARCINOMA - Concurrent - Capecitabine - with XRT ; Capecitabine Tablet 825mg / m2 twice daily on Days 1-5 ; Repeat cycle weekly for 5 weeks.	1300
CM0105-ii-d : COLORECTAL CARCINOMA - Concurrent - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0106-i-a : OSTEOSARCOMA/ BONE TUMORS / Dedifferentiated chondrosarcoma - Cisplatin + doxorubicin ; Days 1-3: Doxorubicin 25mg/m2/day IV, ; Day 1: Cisplatin 100mg/m2 IV ; Repeat cycle every 3 weeks for 6 cycles	5600
CM0106-i-b-1 : OSTEOSARCOMA/ BONE TUMORS / Dedifferentiated chondrosarcoma - MAP (high-dose methotrexate + cisplatin + doxorubicin) - PRE OPERATIVE ; Days 1 and 28: Methotrexate 8g/m2 IV ; Days 7-9 and 34-36: Cisplatin 120mg/m2 by infusion for 72 hours. ; Days 9 and 36: Doxorubicin 60mg/m2 IV	24200
CM0106-i-b-2 : OSTEOSARCOMA/ BONE TUMORS / Dedifferentiated chondrosarcoma - MAP (high-dose methotrexate + cisplatin + doxorubicin) - POST OPERATIVE NECROSIS < 90% ; Days 1, 48, 96, and 144: Doxorubicin 45mg/m2/day for 2 consecutive days ; Days 21, 69, and 117: Methotrexate 8g/m2 IV ; Days 27, 75, and 123: Cisplatin 120mg/m2 by infusion for 72 hours.	40100
CM0106-i-b-3 : OSTEOSARCOMA/ BONE TUMORS / Dedifferentiated chondrosarcoma - MAP (high-dose methotrexate + cisplatin + doxorubicin) - POST OPERATIVE NECROSIS > 90%Postoperative Chemotherapy (Necrosis	59100
CM0106-i-c : Doxorubicin + cisplatin + ifosfamide + high-dose methotrexate (surgery to be done also)	111505
CM0106-i-d : OSTEOSARCOMA/ BONE TUMORS / Dedifferentiated chondrosarcoma - Ifosfamide + cisplatin + epirubicin ; Day 1: Epirubicin 90mg/m2 IV, cisplatin 100mg/m2 IV ; Days 2-4: Ifosfamide 2.0g/m2 with mesna ; Repeat cycle every 21 days. (3 cycles preoperatively and 3 cycles postoperatively).	8300
CM0106-ii-a : Other bone tumors - Chordroma - Imatinib ; Imatinib 800 mg once daily	4500
CM0106-ii-b : Other bone tumors - Chordroma - Imatinib + cisplatin ; Imatinib 400mg OD + cisplatin 25mg/m2 weekly.	4500
CM0106-ii-c : Other bone tumors - Chordroma - Imatinib + sirolimus ; Imatinib 400mg OD + sirolimus 2mg OD	6000
CM0106-ii-d : Other bone tumors - Chordroma - Erlotinib ; Erlotinib 150mg OD	2200
CM0106-ii-e : Other bone tumors - Chordroma - Sunitinib ; Sunitinib 37.5mg OD	28500
CM0106-iii-a :Other bone tumors - Giant Cell Tumor of Bone - Denosumab ; Denosumab 120mg subcutaneous on Week 1,2 and 3 of a 4 week cycle	56000
CM0106-iii-b :Other bone tumors - Giant Cell Tumor of Bone - Interferon alfa ; interferon alfa- 2a thrice weekly	4600
CM0106-iii-c :Other bone tumors - Giant Cell Tumor of Bone - Peginterferon ; Peginterferon alfa-2a 1.0mcg/kg SQ injection weekly.	3500
CM0106-iv-a : VAC and IE cycles	6420
CM0106-iv-b : Other bone tumors - Mesenchymal Chordosarcoma VAIA ; Day 1: Vincristine 1.5mg/m2 IV ; Days 1-3: Ifosfamide 2,000mg/m2 IV + mesna ; Days 1, 3, and 5: Dactinomycin 0.5mg/m2 IV ; Days 2 and 4: Doxorubicin 30mg/m2 IV. ; Repeat cycle every 3 weeks.	7600
CM0106-v : Other bone tumors - Mesenchymal Chordosarcoma Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0107-a : WILMS TUMOR - Vincristine & Actinomycin D ; Dactinomycin 45mcg/kg - week - 0, 3, 6,9,12,15,18 ; Vincristine 1.5 mg/m2 - week - 1,2,3,4,5,6,7,8,9,10,12,15,18	19400
CM0107-b : WILMS TUMOR - Dactinomycin, Vincristine & Adriamycin ; Dactinomycin 1.35 mg /m2 - week - 0, 6, 12, 18,24 ; Adriyamycin 30-45 mg /m2- week - 3, 9, 15, 21 ; Vincristine 2mg max- week - 1,2,3,4,5,6,7,8,9,10,12,15,18,21,24	23200
CM0107-c : WILMS TUMOR - Adriamycin, Cyclophosphamide, Etoposide, Vincristine ; Cyclophosphamide 440mg/m2/day - week 3, 9, 15, 21 for 5 days, week - 6,12,18,24 for 3 days ; Adriyamycin 30-45mg /m2- week -0, 6, 12, 18,24 ; Vincristine 2mg (max)- week - 1,2,4,5,6,7,8,10,11, 12,13,18,24 ; Etoposide 100mg /m2- week - 3,9,15,21	53700
CM0107-d : WILMS TUMOR - Cyclophosphamide, Etoposide, Carboplatin ; Cyclophosphamide 440mg/m2/day - week 6,15,24 5 days / week ; Carboplatin 500mg/m2 - week - 0,3,9,12,18,21 2 days / week ; Etoposide 100mg/m2 - week - 0,3,9,12,18,21 *5 days / week	84500
CM0107-e : WILMS TUMOR - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0108-a : HEPATOBLASTOMA- OPERABLE - PLADO - Cisplatin + Doxorubicin ; cisplatin (PLA) (80mg/m2 / iv), doxorubicin (DO) (30 mg/m2 IV ; Every 21 days for 6 cycles	2800
CM0108-b : HEPATOBLASTOMA- OPERABLE - Cisplatin + Vincristine +5FU ; cisplatin (90 mg/m2), vincristine (1.5mg/m2), 5-FU(5-Flurouracil- 600 mg/m2) ; Every 21 days for 6 cycles	2400
CM0108-c : HEPATOBLASTOMA- OPERABLE - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0109-a : HEPATOCELLULAR CARCINOMA - Sorafenib ; Sorafenib 400 mg PO BID	5800
CM0109-b : HEPATOCELLULAR CARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0110A : Neuroblastoma ALL STAGES - VINCRISTINE/CISPLATIN/ETOPOSIDE/CYCLOPHOSPHAMIDE/CARBOPLATIN	8000
CM0110B : Neuroblastoma ALL STAGES - CYCLOPHOSPHAMIDE/ADRIAMYCIN/VINCRISTINE ; D1-D5 - CYCLOPHOSPHAMIDE 300mg/m2 ; ADRIAMYCIN 60mg/m2 ; VINCRISTINE 1.5mg/m2	7100
CM0110C : Neuroblastoma ALL STAGES - Cisplatin & Etoposide ; Days 1-5 : Cisplatin - 20mg/m2 ; Days 1-5 : Etoposide - 70 mg/m2	4900
CM0110D : Neuroblastoma ALL STAGES - Carboplatin & Etoposide ; Days 1-2 : Carboplatin - 500mg/m2 ; Days 1-5: Etoposide 100mg/m2	6500
CM0110E : Neuroblastoma ALL STAGES - For Stage IV Palliative Chemotherapy only	10000
CM0110F : Neuroblastoma ALL STAGES - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0111-a : RETINOBLASTOMA - Melphalan - Intra-arterial ; Melphalan - 3-7.5mg - Intra-arterial	9700
CM0111-b : RETINOBLASTOMA - Carboplatin - Intra-arterial ; Carboplatin 15-30 mg - Intra-arterial	8900
CM0111-c : RETINOBLASTOMA - Topotecan - Intra-arterial ; Topotecan 0.15-1.5 mg - Intra-arterial	9900
CM0111-d : RETINOBLASTOMA - Methotrexate - Intra-arterial ; Methotrexate 6-12 mg - Intra-arterial	8600
CM0111-e : RETINOBLASTOMA - Carboplatin - Peri Ocular ; Carboplatin 20mg/m2 - Peri Ocular	1900
CM0111-f : RETINOBLASTOMA - Topotecan - Peri Ocular ; Topotecan 0.09 - 0.27 - Peri Ocular	4300
CM0111-g : RETINOBLASTOMA - Melphalan - Intra-vitreal ; Melphalan 20-30 mcg / 0.1cc - Intra-vitreal	270
CM0111-h : RETINOBLASTOMA - Carboplatin - Intra-vitreal ; Carboplatin 3-6mcg / 0.05cc - Intra-vitreal	1900
CM0111-i : RETINOBLASTOMA - Methotrexate - Intra-vitreal ; Methotrexate 400mcg/0.1cc - Intra-vitreal	1600
CM0111-j : RETINOBLASTOMA - Carboplatin + Etoposide + Vincristine ; Carboplatin 560mg/m2 ; Etoposide 150mg/m2 ; Vincristine 1.5mg/m2	6800
CM0111-k : RETINOBLASTOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0112-a : HISTIOCYTOSIS - Prednisolone and Vinblastine - 1; Prednisolone and Vinblastine - 1 ; Prednisolone - 6 weeks oral ; Vinblastine 1,2,3,4,5,6	6100
CM0112-b : HISTIOCYTOSIS - Prednisolone and Vinblastine - 2; Prednisolone and Vinblastine - 1 ; Prednisolone - 6 weeks oral ; Vinblastine 1,2,3,4,5,6	6800
CM0112-c : HISTIOCYTOSIS - Prednisolone and Vinblastine - continuation; Prednisolone and Vinblastine - continuation after either course 1 or both 1 & 2 ; Prednisolone - 5 days a week oral ; Vinblastine -IV ; repeat every 3 weeks till 1 year	1800
CM0112-d : HISTIOCYTOSIS - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0113-a : RHABDOMYOSARCOMA - VAC (Vincristine + Dactinomycin + Cyclophosphamide + Mesna ) ; Day -1 - Vincristine 1.5 mg /m2 IV (2 mg max), Doxorubicin 75 mg /m2 IV , cyclophosphamide 1200 mg /m2 IV + mesna ; Repeat at 21 day intervals for 4-6 cycles	3800
CM0113-b : RHABDOMYOSARCOMA - IVA (Vincristine + Dactinomycin + Ifosfamide + Mesna ) ; Day 1,2 - Ifosfamide IV 3 g/m2 + mesna ; Day 1 - Vincristine IV 1.5 mg/m2 (max 2 mg), Actinomycin-D IV 1.5 mg/m2 (max 2 mg) ; Repeat at 21 day intervals for 6 cycles	5600
CM0113-c : RHABDOMYOSARCOMA - IVAD (Vincristine + Doxorubicin + Ifosfamide + Mesna ) ; Days 1 and 2 - Ifosfamide 3 g/m2 + Mesna, Doxorubicin 30mg/m2 ; Day 1 - vincristine 1.5 mg/m2, Actinomycin-D 1.5 mg/m2 ; Repeat at 21 day intervals for 6 cycles	5500
CM0113-d : RHABDOMYOSARCOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0114-i-a : EWINGS SARCOMA - Induction Treatment - VIDE ; Day 1:Vincristine 1.5mg/m2(max 2mg) IV ; Days 1-3:Doxorubicin 20mg/m2 IV, ifosfamide 3g/m2IV, mesna continuous IV, etoposide 150mg/m2 IV ; Repeat cycle every 3 weeks for up to 6 cycles	8300
CM0114-i-c : EWINGS SARCOMA - Induction Treatment - VAIA - 4 day Regimen ; Day 1:Vincristine 1.5mg/m2IV ; Days 1-3: Ifosfamide 2,000mg/m2 IV + mesna ; Days 1, 3, and 5: Dactinomycin 0.5mg/m2 IV ; Days 2 and 4: Doxorubicin 30mg/m2 IV. ; Repeat cycle every 21 days for 4 cycles, then local therapy, followed by 10 additional cycles of VAIA for High risk and ; 10 additional cycles of VAIA or 10 cycles of VACA for standard-risk patients	7600
CM0114-i-d : EWINGS SARCOMA - Induction Treatment - VAIA - 24 day Regimen ; Days 1, 8, 15, and 22: Vincristine 1.5mg/m2 IV ; Days 1, 2, 22, 23, 43, and 44 : Ifosfamide 3,000mg/m2 IV + mesna ; Days 1, 2, 43, and 44 : Doxorubicin 30mg/m2 IV ; Days 22, 23, and 24: Dactinomycin 0.5mg/m2 IV ; After completion of one 9-week cycle, local therapy followed by 3 additional cycles.	17700
CM0114-ii-a : EWINGS SARCOMA - Maintenance Treatment - Etoposide/Ifosfamide ; Days 1-5: Ifosfamide 1,800mg/m2/day IV + mesna ; Days 1-5: Etoposide 100mg/m2/day IV.	8200
CM0114-iii : EWINGS SARCOMA - Maintenance Treatment - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0115 : PALLIATIVE CHEMOTHERAPY (Any Regimen)- Maximum Payable	10000
CM0116-a : CERVICAL CANCER - CISPLATIN ; Cisplatin 40mg/m2 IV once weekly for up to 6 cycles	1800
CM0116-b : CERVICAL CANCER - Cisplatin & 5FU with RT ; Days 1-5 of radiotherapy: Cisplatin 75mg/m2 IV, 5-FU 4,000mg/m2 IV over 96 hours ; Repeat cycle every 3 weeks for 3	9200
CM0116-c : CERVICAL CANCER - Cisplatin & 5FU ; Days 1 and 29: Cisplatin 50mg/m2 IV ; Days 2-5, and 30-33: 5-FU 1,000mg/m2 IV	8900
CM0116-d : CERVICAL CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0117-a : VULVAL CANCER - Cisplatin ; Day 1 : 40 mg/m 2 IV	1800
CM0117-b : VULVAL CANCER - Cisplatin + 5FU ; Days 1-5 of radiotherapy: Cisplatin 75mg/m2 IV, 5-FU 4,000mg/m2 ; Repeat cycle every 3 weeks - total 3 cycles	4700
CM0117-c : VULVAL CANCER - 5-FU + Mitomycin ; 5-FU + Mitomycin ; Days 1-4 and 29-32: 5-FU 1,000mg/m2/day continuous IV infusion ; Days 1 and 29: Mitomycin 10mg/m2 IV bolus (maximum 20mg per course),	11400
CM0117-d : VULVAL CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0118-a : VAGINAL CANCER - Cisplatin ; Cisplatin 75mg/m2 ; once weekly for up to 6 doses	1800
CM0118-b : VAGINAL CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0119-a : OVARIAN CANCER - Paclitaxel + Cisplatin ; Day 1: Paclitaxel 135mg/m2 continuous IV ; Day 2: Cisplatin 75-100mg/m2 ; Day 8: Paclitaxel 60mg/m2 ; Repeat every 3 weeks for 6 cycles.	8800
CM0119-b : OVARIAN CANCER - Paclitaxel + Carboplatin ; Day 1: Paclitaxel 175mg/m2 IV, Carboplatin AUC 5-6 mg/min/mL IV ; Repeat every 3 weeks for 6 cycles	7000
CM0119-c : OVARIAN CANCER - Docetaxel + Carboplatin ; Day 1: Docetaxel 60-75mg/m2 IV, Carboplatin AUC 5-6 mg/min/mL ; Repeat every 3 weeks for 6 cycles	8700
CM0119-d : OVARIAN CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0120 : ENDOMETRIAL CANCER (Palliative Chemotherapy only)	10000
CM0121-a : OVARY- GERM CELL TUMOR - BEP (Bleomycin + Etoposide + Cisplatin) ; Days 1,8,15 : Bleomycin 30 units/wk IV, Etoposide 100 mg/m 2/day IV ; Days 1-5 : Cisplatin 20 mg/m 2/day IV ; Repeat every 21 days 3-4 cycles	10800
CM0121-b : OVARY- GERM CELL TUMOR - EP ( Etoposide + Carboplatin) ; Day 1 : Carboplatin 400 mg/m 2 IV on days 1-3 ; Repeat every 28 days for three cycles	6500
CM0121-c : OVARY- GERM CELL TUMOR - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0122-a : GESTATIONAL TROPHOBLAST DISEASES - Methotrexate (5 days regimen) ; Days 1-5: MTX 0.4 mg/kg/day IV or IM for 5 days, not to exceed 25 mg/day ; Repeat cycle every 14 days	2100
CM0122-b : GESTATIONAL TROPHOBLAST DISEASES - Methotrexate (8-day alternating regimen) ; Days 1, 3, 5, and 7 : MTX 1 mg/kg IM, ; Days 2, 4, 6, and 8 : Folinic acid 15 mg ; Repeat cycle every 14 days	2900
CM0122-c : GESTATIONAL TROPHOBLAST DISEASES - Methotrexate + Folinic Acid ; Day 1 : MTX 100 mg/m 2 IVP, then 200 mg/m 2 infusion ; Day 2 : Folinic acid 15 mg IM/PO q12h for 4 doses ; Repeat cycle every 18 days	2000
CM0122-d : GESTATIONAL TROPHOBLAST DISEASES - Methotrexate - Weekly ; MTX 30-50 mg/m 2 IM weekly	1300
CM0122-e : GESTATIONAL TROPHOBLAST DISEASES - Act-D ; Act-D 10-13 mcg/kg or 0.5-mg flat dose IV qd for 5d ; Repeat cycle every 14 days	7800
CM0122-f : GESTATIONAL TROPHOBLAST DISEASES - Actinomycin ; Actinomycin 1.25 mg/m 2 IV ; Repeat every 2 weeks	2200
CM0122-g : GESTATIONAL TROPHOBLAST DISEASES - EMA-CO (complete) ; Day 1 : Act-D - 0.5 mg IV, Etoposide - 100 mg/m2 IV, MTX - 300 mg/m2 IV ; Day 2 : Act-D - 0.5 mg IV, Etoposide - 100 mg/m2 IV, Leucovorin - 15 mg PO/IM q12h 4 doses ; Day 8 : Vincristine - 0.8 mg/m2 IV, Cyclophosphamide - 600 mg/m2 IV ; Repeat cycle every 14 days	6400
CM0122-h : GESTATIONAL TROPHOBLAST DISEASES - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0123-a : TESTICULAR CANCER - EP ; Days 1-5: Etoposide 100mg/m2, cisplatin 20mg/m2 ; Repeat cycle every 3 weeks for 4 cycles.	5400
CM0123-b : TESTICULAR CANCER - BEP ; Days 1-5: Cisplatin 20mg/m2, etoposide 100mg/m2 ; Days 1, 8, and 15 OR Days 2, 9, or 16: Bleomycin 30 units IV ; Repeat cycle every 3 weeks for 3 cycles.	10000
CM0123-c : TESTICULAR CANCER - VIP ; Day 1 (before ifosfamide): Mesna 120mg/m2 IV ; Days 1-5: Etoposide 75mg/m2 IV, mesna 1,200mg/m2 IV, ifosfamide 1,200mg/m2 IV + cisplatin 20mg/m2. ; Repeat cycle every 3 weeks for 4 cycles.	6300
CM0123-d : TESTICULAR CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0124-a : PROSTATE CANCER - Docetaxel + prednisone ; Day 1: Docetaxel 75mg/m2 IV, prednisone 5mg orally twice daily. ; once every 3 weeks, Repeat for up to 10 cycles if tolerated	3600
CM0124-b : PROSTATE CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0125-a : FEBRILE NEUTROPENIA - First-line monotherapy ; Piperacillin-tazobactam 4.5 g ; Cefepime 2 g ; Meropenem 1 g ; Imipenem-cilastatin 500 mg	13500
CM0125-b : FEBRILE NEUTROPENIA - Second-line dual therapy ; Piperacillin-tazobactam 4.5 g IV plus an aminoglycoside ; Meropenem 1 g IV plus an aminoglycoside ; Imipenem-cilastatin 500 mg IV plus an aminoglycoside	19500
CM0125-c : Other Regimen	10000
CM0126-a : THYROID CANCER - sorafenib ; sorafenib 400 mg PO BID	2900
CM0126-b : THYROID CANCER - sunitinib ; sunitinib 50 mg	28500
CM0126-c : THYROID CANCER - pazopanib	9500
CM0126-d : THYROID CANCER - Doxorubicin ; Doxorubicin 60 mg/m2 as monotherapy or in combination with cisplatin 40 mg/m2	4400
CM0126-e : THYROID CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0127-a : THYMOMA - CAP ; Day 1: Cisplatin 50mg/m2 IV, doxorubicin 50mg/m2 IV, cyclophosphamide 500mg/m2 IV. ; Repeat every 21 days for a max of 8 cycles.	4600
CM0127-b : THYMOMA - CAPP ; Day 1: Cyclophosphamide 500mg/m2 IV ; Days 1-3: Cisplatin 30mg/m2 IV ; Days 1-3: Doxorubicin 20mg/m2 ; Days 1-5: Prednisone 100mg. ; Repeat every 3 weeks for 3 cycles.	6800
CM0127-c : THYMOMA - ADOC ; Day 1: Cisplatin 50mg/m2 IV, doxorubicin 40mg/m2 IV ; Day 3: Vincristine 0.6mg/m2 IV ; Day 4: Cyclophosphamide 700mg/m2 IV. ; Repeat every 3 weeks for 5 cycles.	5900
CM0127-d : THYMOMA - PE ; Day 1: Cisplatin 60mg/m2 IV ; Days 1-3: Etoposide 120mg/m2 IV ; Repeat every 3 weeks for a max of 8 cycles.	5100
CM0127-e : THYMOMA - VIP ; Days 1-4: Etoposide 75mg/m2 IV, ifosfamide 1.2g/m2 IV, cisplatin 20mg/m2 IV. ; Repeat every 3 weeks for 4 cycles	7600
CM0127-f : THYMOMA - Carboplatin+paclitaxel ; Day 1: Paclitaxel 225mg/m2 IV, carboplatin AUC = 6 IV ; Repeat every 3 weeks for a max of 6 cycles.	9300
CM0127-g : THYMOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0128-i-a : BRAIN CARCINOMA - Systemic Therapy for Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma - Combination PCV (lomustine + procarbazine + vincristine) ; Day 1: Lomustine 110mg/m2 orally. ; Days 8-21: Procarbazine 60mg/m2 orally once daily. ; Days 8 and 29: Vincristine 1.4mg/m2 (maximum 2mg) IV. ; Repeat every 6 weeks.	3800
CM0128-i-b : BRAIN CARCINOMA - Systemic Therapy for Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma - Temozolomide (7 weeks) ; Days 1-49: Temozolomide 75mg/m2 orally. ; Repeat cycle every 11 weeks (7 weeks on/4 weeks off) for 6 cycles.	6500
CM0128-i-c : BRAIN CARCINOMA - Systemic Therapy for Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma - Temozolomide monthly 5-day course ; Temozolomide monthly 5-day courses at doses of 180 - 200mg/m2/day	2100
CM0128-i-d : BRAIN CARCINOMA - Systemic Therapy for Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma - Temozolomide (3 weeks) ; Days 1-21: Temozolomide 75mg/m2/day orally. ; Repeat cycle every 28 days.	3400
CM0128-ii-a : BRAIN CARCINOMA - Systemic Therapy for Anaplastic Gliomas - Temozolomide monthly 5-day course ; Days 1-5: Temozolomide 200mg/m2/day orally. ; Repeat cycle every 4 weeks until disease progression or for up to 24 cycles.	2100
CM0128-ii-b : BRAIN CARCINOMA - Systemic Therapy for Anaplastic Gliomas - PCV with deferred RT (lomustine + procarbazine + vincristine) ; Day 1: Lomustine 110mg/m2 orally ; Days 8-21: Procarbazine 60mg/m2 orally once daily ; Days 8 and 29: Vincristine 1.4mg/m2 (maximum 2mg) IV. ; Repeat every 6 weeks	3800
CM0128-ii-d : Adjuvant Temozolomide	2100
CM0128-ii-e : BRAIN CARCINOMA - Systemic Therapy for Anaplastic Gliomas - PCV for 1p19q co-deleted (with Radiotherapy) ; Day 1: Lomustine 110mg/m2 orally ; Days 8-21: Procarbazine 60mg/m2 orally once daily ; Days 8 and 29: Vincristine 1.4mg/m2 (maximum 2mg) IV. ; Repeat every 6 weeks. for 6 cycles	3800
CM0128-iii-a : BRAIN CARCINOMA - Systemic Therapy for Glioblastoma - Concurrent Temozolomide (with RT) - followed by adjuvant temozolomide ; Daily oral temozolomide (75mg/m2/day, 7 days per week from the first to the last day of radiotherapy)	7200
CM0128-iii-b : BRAIN CARCINOMA - Systemic Therapy for Glioblastoma - Adjuvant Temozolomide (preceeded by Concurrent temozolzmide) ; Days 1-5: Temozolomide 150-200mg/m2/day orally for 5 days. ; Repeat cycle every 28 days for 6 cycles.	2100
CM0128-iii-c : BRAIN CARCINOMA - Systemic Therapy for Glioblastoma - Temozolomide (post RT) ; Days 1-5: Temozolomide 150-200mg/m2/day orally for 5 days. ; Repeat cycle every 28 days	2100
CM0128-iii-d : BRAIN CARCINOMA - Systemic Therapy for Glioblastoma - Temozolomide (200mg) with standard RT ; Days 1-5: Temozolomide 200mg/m2, orally	2100
CM0128-iv-a : BRAIN CARCINOMA - Systemic Therapy for Adult Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor (PNET) - Vincristine + cisplatin + lomustine ; Day 1: Lomustine 75mg/m2 orally ; Day 2: Cisplatin 75mg/m2 IV ; Days 2, 8 and 15: Vincristine 1.5mg/m2 IV bolus, max 2mg bolus; ; During Cranio-spinal RT	4400
CM0128-iv-b : BRAIN CARCINOMA - Systemic Therapy for Adult Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor (PNET) - Vincristine + cisplatin + cyclophosphamide ; Day 1: Cisplatin 75mg/m2 IV ; Days 2, 8 and 15: Vincristine 1.5mg/m2 IV bolus, max 2mg bolus ; Days 22, 23: Cyclophosphamide 1,000mg/m2 IV.	5500
CM0128-v-a-1 : BRAIN CARCINOMA - Primary CNS Lymphoma - High dose Methotrexate + Cytarabine ; Day 1: MTX 3.5g/m2 ; Days 2-3: Cytarabine 2g/m2 IV twice a day.	6600
CM0128-v-a-2 : BRAIN CARCINOMA - Primary CNS Lymphoma - High dose Methotrexate + leucovorin + Ifosfamide + mesna ; Day 1: MTX 4gm/m2 IV, ; Days 2-5: leucovorin 20-25mg IV (upto 40mg) ; Days 3-5: Ifosfamide 1.5gm/m2 IV + mesna 400mg IV	9500
CM0128-v-b-1 : BRAIN CARCINOMA - Primary CNS Lymphoma - Rituximab + MTX + vincristine +procarbazine ; Day 1: Rituximab 500mg/m2 IV ; Day 2: MTX 3.5mg/m2 IV plus vincristine 1.4mg/m2 ; Procarbazine 100mg/m2/day administered for 7 days with odd-numbered cycles	41900
CM0128-v-c-1 : BRAIN CARCINOMA - Primary CNS Lymphoma - High dose methotrexate Induction ; MTX 8g/m2 IV ; Repeat every 2 weeks until complete response achieved or max of 8 cycles reached. ;	7900
CM0128-v-c-2 : BRAIN CARCINOMA - Primary CNS Lymphoma - High dose methotrexate Consolidation ; MTX 8g/m2 IV administered ; Repeat every 2 weeks for 2 cycles.	7900
CM0128-v-c-3-i : BRAIN CARCINOMA - Primary CNS Lymphoma - High dose methotrexate Maintanance (Cycles 1-4) ; Day 1: MTX 8g/m2 IV, Rituximab 375mg/m2 IV. ; Repeat every 4 weeks for 4 cycles	32400
CM0128-v-c-3-ii : BRAIN CARCINOMA - Primary CNS Lymphoma - High dose methotrexate Maintanance (cycles 5-11) ; MTX 8g/m2 IV administered every 4 weeks for 11 cycles. ; Repeat cycle every 4 weeks for 4 cycles	7900
CM0128-v-d-1 : BRAIN CARCINOMA - Primary CNS Lymphoma - Rituximab + Temozolomide regimen - Induction ; Day 1: Rituximab 375mg/m2 IV, followed by ; Days 1-5: Temozolomide 150-200mg/m2 orally daily, after rituximab infusion. ; Repeat cycle every 4 weeks for 4 cycles.	26600
CM0128-v-d-2 : BRAIN CARCINOMA - Primary CNS Lymphoma - Rituximab + Temozolomide regimen - MaintananceDays 1-5: Temozolomide 150-200mg/m2 orally daily. ; Repeat cycle every 4 weeks for 8 cycles.	1600
CM0128-v-e-1 : BRAIN CARCINOMA - Meningioma - Interferon-alfaInterferon-alfa ; alpha-IFN 106 units/m2 SC every other day for 4 weeks. ; Repeat cycle every 4 weeks. ;	6000
CM0128-v-e-2 : BRAIN CARCINOMA - Meningioma -Somatostatin analog ; Sandostatin LAR Depot 10-30mg IM ; Repeat every 4 weeks. ;	5400
CM0128-v-e-3 : BRAIN CARCINOMA - Meningioma - Sunitinib ; Days 1-28: Sunitinib 50mg orally daily. ; Repeat cycle every 42 days.	2900
CM0129-i-a : HEAD AND NECK CANCER - HIgh Dose Cisplatin ; Cisplatin 100mg/m2 IV + concurrent radiotherapy; Repeat cycle every 3 weeks for 3 cycles	2000
CM0129-i-b : HEAD AND NECK CANCER - Carboplatin + infusional 5-FU ; Days 1-4: 5-FU 600mg/m2/day as continuous IV I, carboplatin 70mg/m2/day IV ; Repeat every 3 weeks for 3 cycles (given concurrently with radiotherapy).	4700
CM0129-i-c : HEAD AND NECK CANCER - 5-FU + hydroxyurea ; Day 1: Hydroxyurea 1,000mg orally every 12 hours (11 doses/cycle), 5-FU 800mg/m2/day ; Repeat every other week for 7 cycles. with Concurrent radiotherapy	2300
CM0129-i-d : HEAD AND NECK CANCER - Cisplatin + paclitaxel ; Day 1: Paclitaxel 30mg/m2 IV (every Monday), ; Day 2: Cisplatin 20mg/m2 IV (every Tuesday). ; Repeat cycle every week for 7 cycles, with Concurrent radiotherapy	3400
CM0129-i-e : HEAD AND NECK CANCER - Cisplatin + infusional 5-FU ; Day 1: Cisplatin 60mg/m2 over ; Days 1-5: 5-FU 800mg/m2/day ; Repeat every other week for 7 cycles. with Concurrent radiotherapy	5300
CM0129-i-f : HEAD AND NECK CANCER - Carboplatin + paclitaxel ; Day 1: Paclitaxel 40-45mg/m2, carboplatin 100mg/m2 ; Repeat cycle every week for 8 cycles, with Concurrent radiotherapy	3500
CM0129-i-g : HEAD AND NECK CANCER - Weekly cisplatin ; Cisplatin 40mg/m2 IV per week	1800
CM0129-i-h : HEAD AND NECK CANCER - Cisplatin (For high risk oropharyngeal carcinoma) ; Days 1, 22, and 43: Cisplatin 100mg/m2 IV + radiotherapy.	5300
CM0129-i-i : HEAD AND NECK CANCER - Docetaxel + cisplatin + 5-FU ; Day 1: Docetaxel 75mg/m2 IV, cisplatin 75mg/m2 IV, ; Days 1-5: 5-FU 750mg/m2/day IV. ; Repeat every 3 weeks for up to 4 cycles.	6700
CM0129-i-j : HEAD AND NECK CANCER - Paclitaxel + cisplatin+ infusional 5-FU ; Day 1: Paclitaxel 175mg/m2 ; Day 2: Cisplatin 100mg/m2 ; Day 2-6: 5-FU 500mg/m2/day IV ; Repeat every 3 weeks for 3 cycles.	7900
CM0129-ii-a-1 : Nasopharynx Cancer - Concurrent Cisplatin (followed by concurrent Cisplatin +5FU) ; Day 1: Cisplatin 100mg/m2 IV; plus radiotherapy. ; Repeat cycle every 3 weeks for 3 cycles; followed by concurrent Cisplatin +5FU	2000
CM0129-ii-a-2 : Nasopharynx Cancer - concurrent Cisplatin +5FU - Preceeded by (Concurrent Cisplatin 3 cycles) ; Days 1-4: Cisplatin 80mg/m2/day, 5-FU 1,000mg/m2/day IV ; Repeat cycle every 4 weeks for 3 cycles	6700
CM0129-ii-b-1 : Nasopharynx Cancer - Concurrent Carboplatin - (followed by concurrent Carboplatin +5FU) ; Day 1: Carboplatin AUC 6mg/min/mL IV. ; Repeat cycle every 3 weeks for 3 cycles;	4300
CM0129-ii-b-2 : Nasopharynx Cancer - concurrent Carboplatin +5FU - Preceeded by (Concurrent Carboplatin ) ; Day 1: Carboplatin AUC 5mg/min/mL IV ; Days 1-4: 5-FU 1,000mg/m2/day IV ; Repeat cycle every 3 weeks for 3 cycles.	13500
CM0129-ii-c : Nasopharynx Cancer - Concurrent Cisplatin ; Cisplatin 40mg/m2 ; Repeat weekly for 7 cycles	1800
CM0129-ii-d-1 : Nasopharynx Cancer - Docetaxel + cisplatin + 5-FU - followed by Cisplatin after 3 cycles ; Day 1: Docetaxel 70mg/m2 IV, cisplatin 75mg/m2 IV ; Days 1-4: 5-FU 1,000mg/m2/day IV ; Repeat every week for 3 cycles	6200
CM0129-ii-d-2 : Nasopharynx Cancer - Cisplatin - weekly - Preceded by 3 cycles of Docetaxel + 5-FU ; Day 1: Cisplatin 100mg/m2; ; Repeat every 3 weeks, Till radiation	2800
CM0129-ii-e-1 : Nasopharynx Cancer - Docetaxel + cisplatin - followed by Cisplatin after 2 cycles ; Day 1: Docetaxel 75mg/m2 IV + cisplatin 75mg/m2 IV ; Repeat every 3 weeks for two cycles	3900
CM0129-ii-e-2 : Nasopharynx Cancer - Cisplatin - weekly - Preceded by 2 cycles of Docetaxel + cisplatin ; Cisplatin 40mg/m2 IV ; weekly concurrent with radiotherapy.	2300
CM0129-ii-f : Nasopharynx Cancer - Cisplatin + 5-FU ; Day 1: Cisplatin 100mg/m2/day IV. ; Days 1-4: 5-FU 1,000mg/m2/day continuous IV infusion for 4 days. ; Repeat cycle every 3 weeks for a minimum of 6 cycles	5100
CM0129-iii : HEAD AND NECK CANCER (or) Nasopharynx Cancer - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0130-a : Pazopanib	19000
CM0130-b : Sunitinib	29000
CM0130-c : Sorafenib	5800
CM0130-d : Other Regimen	10000
CM0131-i-a : UNKNOWN PRIMARY - Adenocarcinoma - Paclitaxel + carboplatin + etoposide ; Day 1: Paclitaxel 200 mg/m 2 IV, carboplatin AUC 6 ; Days 1-10: etoposide 50 mg PO alternating with 100 mg daily ; Repeat every 21days for 2-3 cycles; restage, can be treated upto 8 cycles	8000
CM0131-i-b : UNKNOWN PRIMARY - Adenocarcinoma - Paclitaxel + carboplatin ; Day 1: Paclitaxel 200 mg/m 2, carboplatin AUC 6 ; Repeat cycle every 3 weeks, Maximum 8 cycles	7200
CM0131-i-c : UNKNOWN PRIMARY - Adenocarcinoma - Docetaxel + carboplatin ; Day 1: Docetaxel 65mg/m2 IV, carboplatin AUC 6 ; Repeat cycle every 3 weeks, Maximum 8 cycles.	3800
CM0131-i-d : UNKNOWN PRIMARY - Adenocarcinoma - Gemcitabine + cisplatin ; Day 1: Cisplatin 100mg/m2 IV ; Day 1 and 8: Gemcitabine 1250mg/m2 IV. ; Repeat cycle every 3 weeks for 4 cycles.	5300
CM0131-i-e : UNKNOWN PRIMARY - Adenocarcinoma - Gemcitabine + docetaxel ; Day 1 and 8: Gemcitabine 1000mg/m2 IV over 30 minutes ; Day 8: Docetaxel 75mg/m2 IV ; Repeat cycle every 3 weeks for a maximum of 6 cycles	5800
CM0131-i-f : UNKNOWN PRIMARY - Adenocarcinoma - Gemcitabine + irinotecan ; Days 1 and 8: Irinotecan 100mg/m2 IV, gemcitabine 1000mg/m2 IV. ; Repeat cycle every 3 weeks for 6 cycles.restage every 2-3 cycles	5600
CM0131-ii-a : UNKNOWN PRIMARY - Squamous cell carcinoma - Paclitaxel + cisplatin + 5-FU ; Paclitaxel 175 mg/m 2 IV, ; Day 2: cisplatin 100 mg/m 2 IV, ; Day 5-FU (5-fluorouracil) 500 mg/m 2/day IV ; Repeat every 21d	6200
CM0131-ii-b : UNKNOWN PRIMARY - Squamous cell carcinoma - Docetaxel + cisplatin + 5-FU ; Day 1: Docetaxel 75mg/m2 IV, cisplatin 75mg/m2 IV. ; Days 1-5: 5-FU 750mg/m2/day IV ; Repeat cycle every 3 weeks for 3 cycles.	6800
CM0131-iii-b : UNKNOWN PRIMARY - Neuroendocrine tumors - Etoposide + cisplatin ; Days 1-3: Etoposide 100 mg/m 2 ; Days 2-3: cisplatin 45 mg/m 2 IV ; Repeat every 28 days	5000
CM0131-iv : UNKNOWN PRIMARY - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0132-a : CA HEPATO BILIARY /CA COMMON BILE DUCT/CA GALLBLADDER/ CHOLANGIOCARCINOMA - Gemcitabine + cisplatin ; Days 1 and 8: Cisplatin 25mg/m2 IV, gemcitabine 1,000mg/m2 IV ; Repeat every 21 days for 4 cycles, re-evaluate and continue an additional 4 cycles if warranted	3700
CM0132-b : CA HEPATO BILIARY /CA COMMON BILE DUCT/CA GALLBLADDER/ CHOLANGIOCARCINOMA - 5-FU ; 5 - FU IV	4100
CM0132-c : CA HEPATO BILIARY /CA COMMON BILE DUCT/CA GALLBLADDER/ CHOLANGIOCARCINOMA - Capecitabine ; Capecitabine oral ; Repeat every 21 days	3600
CM0132-d : CA HEPATO BILIARY /CA COMMON BILE DUCT/CA GALLBLADDER/ CHOLANGIOCARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0133-i-a : PANCREAS CARCINOMA - Patients with resectable pancreatic cancer - Locally Advanced Gemcitabine ; Days 1, 8, and 15: Gemcitabine 1,000mg/m2 IV ; Repeat every 4 weeks for six cycles	6600
CM0133-ii-a : PANCREAS CARCINOMA - Adjuvant chemotherapy and chemoradiation - 5-FU + Leucovorin ; Days 1-5: Leucovorin 20mg/m2 IV, 5-FU 425mg/m2 IV ; Repeat cycle every 4 weeks	5000
CM0133-ii-b : PANCREAS CARCINOMA - Adjuvant chemotherapy and chemoradiation - Gemcitabine & 5FU ; Prior to chemoradiation: ; Days 1, 8 and 15: Gemcitabine 1,000mg/m2 IV; initiate 1-2 weeks prior to chemoradiation (50.4Gy + 5-FU 250mg/m2/day). ; After chemoradiation: ; Days 1, 8 and 15: Gemcitabine 1,000mg/m2 IV; initiate 3-5 weeks following chemoradiation. ; Repeat cycle every 4 weeks for 3 months.	6700
CM0133-ii-c : PANCREAS CARCINOMA - Adjuvant chemotherapy and chemoradiation - Continuous infusion 5-FU (with Radiation) ; Prior to chemoradiation: ; Days 1-21: 5-FU 250mg/m2/day continuous IV infusion; initiate 1-2 weeks prior to chemoradiation (50.4Gy + 5-FU 250mg/m2/day). ; After chemoradiation: ; Days 1-28: 5-FU 250mg/m2/day continuous IV infusion; initiate 3-5 weeks following chemoradiation. ; Repeat cycle every 6 weeks for 3 months.	20700
CM0133-iii-a : PANCREAS CARCINOMA - Neoadjuvant therapy - CapecitabineCapecitabine ; Capecitabine ; Repeat cycle every 3 weeks for up to 52 weeks.	3600
CM0133-iv : PANCREAS CARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0134-a : PERI AMPULLARY CARCINOMA - 5-FU ; Fluorouracil 425 mg/m2 administered on days 1 to 5 and 29-33	5300
CM0134-b : PERI AMPULLARY CARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0135-b : NEURO ENDOCRINE CARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0136-i-a : SARCOMA - Gastrointestinal Stromal Tumor - GIST - Imatinib ; Imatinib 400mg orally once daily to twice daily	3000
CM0136-ii-a : SARCOMA - SOFT TISSUE SARCOMA - Doxorubicin + dacarbazine (AD) ; Days 1-4: Doxorubicin 60mg/m2 + dacarbazine 750mg/m2 ; Repeat cycle every 3 weeks	11500
CM0136-ii-b : SARCOMA - SOFT TISSUE SARCOMA - Doxorubicin + ifosfamide + mesna ; Days 1 and 2: Doxorubicin 30mg/m2/day IV, ifosfamide 3,750mg/m2/day IV, mesna 750mg/m2 IV ; Repeat cycle every 3 weeks	9200
CM0136-ii-c : SARCOMA - SOFT TISSUE SARCOMA - Mesna + doxorubicin + ifosfamide + dacarbazine (MAID) ; Days 1-3: Doxorubicin 20mg/m2/day, ifosfamide 2,500mg/m2/day, dacarbazine 300mg/m2/day IV ; Days 1-4: Mesna 2,500mg/m2/day IV for 84 to 96 hours. ; Repeat cycle every 3 weeks.	10700
CM0136-ii-d : SARCOMA - SOFT TISSUE SARCOMA - Ifosfamide + epirubicin + mesna ; Days 1 and 2: Epirubicin 60mg/m2/day IV ; Days 1-5: Ifosfamide 1.8g/m2/day IV + mesna. ; Repeat cycle every 3 weeks for 5 cycles.	12800
CM0136-ii-e : SARCOMA - SOFT TISSUE SARCOMA - Gemcitabine + docetaxel ; Days 1 and 8: Gemcitabine 900mg/m2 IV ; Day 8: Docetaxel 100mg/m2 IV. ; Repeat cycle every 3 weeks	5100
CM0136-ii-f : SARCOMA - SOFT TISSUE SARCOMA - Gemcitabine + vinorelbine ; Days 1 and 8: Vinorelbine 25mg/m2 IV, gemcitabine 800mg/m2 IV ; Repeat cycle every 3 weeks	14700
CM0136-ii-g : SARCOMA - SOFT TISSUE SARCOMA - Gemcitabine + dacarbazine ; Day 1: Gemcitabine 1,800mg/m2 IV + dacarbazine 500mg/m2 IV. ; Repeat cycle ever 2 weeks for a total of 12 cycles;	3300
CM0136-ii-h : SARCOMA - SOFT TISSUE SARCOMA - Doxorubicin ; Doxorubicin 60-75mg/m2 IV ; once every 3 weeks	2900
CM0136-ii-i : SARCOMA - SOFT TISSUE SARCOMA - Ifosfamide ; Days 1-3: Ifosfamide 2,000-3,000mg/m2/day IV for 3 to 4 days + mesna ; Repeat every 3 weeks.	10000
CM0136-ii-j : SARCOMA - SOFT TISSUE SARCOMA - Ifosfamide ; Day 1: Ifosfamide 5,000mg/m2 + mesna 5,000mg/m2 IV ; Day 2: mesna 400-600mg/m2 IV ; Ifosfamide, mesna ; Repeat every 3 weeks	1900
CM0136-ii-k : SARCOMA - SOFT TISSUE SARCOMA - Epirubicin ; Epirubicin 160mg/m2 IV ; Repeat every 3 weeks	5900
CM0136-ii-l : SARCOMA - SOFT TISSUE SARCOMA - Gemcitabine ; Days 1 and 8: Gemcitabine 1,200mg/m2 IV ; Repeat cycle every 3 weeks.	3600
CM0136-ii-m : SARCOMA - SOFT TISSUE SARCOMA - Dacarbazine (i) ; Dacarbazine 250mg/m2/day IV for 5 days ; Repeat every 3 weeks.	6200
CM0136-ii-n : SARCOMA - SOFT TISSUE SARCOMA - Dacarbazine (ii) ; Dacarbazine 800-1,000mg/m2 IV ; Repeat every 3 weeks.	2400
CM0136-ii-o : SARCOMA - SOFT TISSUE SARCOMA - Liposomal doxorubicin ; Liposomal doxorubicin 30-50mg/m2 IV ; Repeat every 4 weeks.	7900
CM0136-ii-p : SARCOMA - SOFT TISSUE SARCOMA - Temozolomide ; Temozolomide 200mg/m2 orally twice daily for 5 days, followed by 9 doses of 90mg/m2 orally ; Repeat every 4 weeks	4200
CM0136-iii : SARCOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0137-a : PRIMITIVE NEURO ECTODERMAL TUMOR - Weekly vincristine ; vincristine 1.5mg/m2 IV, max 2mg ; for 5 to 6 weeks	1700
CM0137-b : PRIMITIVE NEURO ECTODERMAL TUMOR - Vincristine + cisplatin + lomustine ; During craniospinal radiotherapy (RT) ; Day 1: Lomustine 75mg/m2 orally ; Day 2: Cisplatin 75mg/m2 IV ; Days 2, 8 and 15: Vincristine 1.5mg/m2 IV bolus, max 2mg bolus; up to max 8 doses	4400
CM0137-c : PRIMITIVE NEURO ECTODERMAL TUMOR - Vincristine + cisplatin + cyclophosphamide ; Day 1: Cisplatin 75mg/m2 IV ; Days 2, 8 and 15: Vincristine 1.5mg/m2 IV, max 2mg ; Days 22, 23: Cyclophosphamide 1,000mg/m2 IV	7600
CM0137-d : PRIMITIVE NEURO ECTODERMAL TUMOR - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0137-vi : Other Regimen	10000
CM0138 : MELANOMA - No primary regimens only RT. For advanced unresectable and metastatic disease - Pallitive Chemotherapy	10000
CM0139-a : ANAL CANAL CANCER - 5-FU + Mitomycin ; Days 1-4 and 29-32: 5-FU 1,000mg/m2/day IV ; Days 1 and 29: Mitomycin 10mg/m2 IV bolus (maximum 20mg per course), with Concurrent radiotherapy	11400
CM0139-b : ANAL CANAL CANCER - Capecitabine + Mitomycin (i) ; Days 1-5: Capecitabine 825mg/m2 orally twice daily weekly for 6 weeks, ; Days 1 and 29: Mitomycin 10mg/m2 IV bolus, with Concurrent radiotherapy.	8100
CM0139-c : ANAL CANAL CANCER - Capecitabine + Mitomycin (ii) ; Days 1-5: Capecitabine 825mg/m2 orally twice daily weekly for 6 weeks, ; Day 1: Mitomycin 12mg/m2 IV bolus, with Concurrent radiotherapy	6800
CM0139-d : ANAL CANAL CANCER - Cisplatin + 5-FU ; Days 1-5: 5-FU 1,000mg/m2/day IV ; Day 2: Cisplatin 100mg/m2 IV ; Repeat cycle every 4 weeks, with Concurrent radiotherapy	6700
CM0139-e : ANAL CANAL CANCER - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0180 : TOTAL ELBOW REPLACEMENT	34263
CM0181 : SHOULDER REPLACEMENT	34992
CM0182 : RADIAL HEAD REPLACEMENT	24057
CM0183 : SURGICAL CORRECTION OF LONGBONE FRACTURE-FRACTURE NECK/ SHAFT OF FEMUR/FRACTURE SHAFT OF OTHER LONG BONES (HUMERUS,BOTH BONES OF FOREARM, BOTH BONES OF LEG)	16220
CM0184 : CORRECTION OF NON-UNION FRACTURES - NON-UNION OF FRACTURE OF FEMUR/BOTH BONE OF LEG/ NON-UNION OF OTHER LONG BONES -HUMERUS/ BOTH BONES OF FOREARM WITH OR WITHOUT BONE GRAFTING	16220
CM0185 : SKELETAL SKULL TRACTION	22125
CM0186A : IMPLANT EXIT- K-WIRES /SCREWS/OTHER MINOR IMPLANTS	5650
CM0186B : IMPLANT EXIT- PLATES (SPINE IMPLANTS/OTHER MAJOR IMPLANT)	14945
CM0187 : ARTHRODESIS OF JOINTS -SHOULDER/ HIP / KNEE /ELBOW/ ANKLE / WRIST / HAND / FOOT	19683
CM0192 : ILIZAROV RING FIXATOR APPLICATION-FEMUR - DEFORMITY CORRECTION / LIMB LENGTHENING/TIBIA - DEFORMITY CORRECTION / LIMB LENGTHENING /PLATING/EXTERNAL FIXATOR/K WIRES	28978
CM0193 : SURGERY FOR NEGLECTED CTEV/RECURRENT CTEV-CTEV CORRECTIVE SURGERY /CTEV PONSETTI CORRECTION (FOLLOW UP PROCEDURES)/CTEV ILIZAROV	32623
CM0195 : KNEE LIGAMENT RECONSTRUCTION-ACL RECONSTRUCTION/PCL RECONSTRUCTION/MPFL RECONSTRUCTION	21870
CM0203 : SURGICAL CORRECTION FOR PELVIC BONE FRACTURES	23510
CM0204 : CORRECTION SACRO ILLIAC JOINT / ACETABULAR FRACTURES	21506
CM0205 : TOTAL KNEE REPLACEMENT	65000
CM0206A : TOTAL HIP REPLACEMENT- CEMENTED	60075
CM0206B : TOTAL HIP REPLACEMENT-UNCEMETED	69075
CM0209 : ACQUIRED HEART DISEASE WITH CONGESTIVE CARDIAC FAILURE	12393
CM0210 : INBORN ERROR OF METABOLISM	29160
CM0211 : HEMOPHAGOCYTIC LYMPHO HISTIOCYTOSIS	21870
CM0212 : HYPOPLASTIC/APLASTIC ANEMIA (FANCONI ANEMIA)	2260
CM0213 : NECROTISING ENTEROCOLITIS - CLINICAL SEPSIS /HYPERBILIRUBINEMIA /NON VENTILATED	18225
CM0214 : VITAMIN D RESISTANT RICKETS	7290
CM0215 : ADRENAL FAILURE INCLUDING PRIMARY ADRENAL FAILURE AND CAH	18225
CM0216 : PRIMARY IMMUNO DEFICIENCY DISORDERS	109350
CM0217 : TERM/PRETERM NEONATAL CHOLESTASIS WITH OR WITHOUT SEPSIS	18225
CM0218 A : TERM BABY WITH CULTURE POSITIVE SEPSIS / CLINICAL SEPSIS WITHOUT MECHANICAL VENTILATION / CPAP	14580
CM0218 B : TERM BABY WITH CULTURE POSITIVE SEPSIS / CLINICAL SEPSIS WITH CPAP	18225
CM0218 C : TERM BABY WITH CULTURE POSITIVE SEPSIS / CLINICAL SEPSIS WITH MECHANICAL VENTILATION	29160
CM0219 A : TERM BABY HYPERBILIRUBINEMIA - EXCHANGE TRANSFUSION WITHOUT MECHANICAL VENTILATION / CPAP	14580
CM0219 B : TERM BABY HYPERBILIRUBINEMIA - EXCHANGE TRANSFUSION WITH CPAP	18225
CM0219 C : TERM BABY HYPERBILIRUBINEMIA - EXCHANGE TRANSFUSION WITH MECHANICAL VENTILATION	29160
CM0220 A : TERM BABY PERSISTENT PULMONARY HYPERTENSION / MECONIUM ASPIRATION SYNDROME / PERINATAL ASPHYXIA / WITHOUT MECHANICAL VENTILATION / CPAP	18225
CM0220 B : TERM BABY PERSISTENT PULMONARY HYPERTENSION / MECONIUM ASPIRATION SYNDROME / PERINATAL ASPHYXIA / WITH CPAP	32805
CM0220 C : TERM BABY PERSISTENT PULMONARY HYPERTENSION / MECONIUM ASPIRATION SYNDROME / PERINATAL ASPHYXIA / WITH MECHANICAL VENTILATION	47385
CM0221 A : PRETERM BABY WITH CULTURE POSITIVE SEPSIS / CLINICAL SEPSIS WITHOUT MECHANICAL VENTILATION / CPAP	25515
CM0221 B : PRETERM BABY WITH CULTURE POSITIVE SEPSIS / CLINICAL SEPSIS WITH CPAP	40095
CM0221 C : PRETERM BABY WITH CULTURE POSITIVE SEPSIS / CLINICAL SEPSIS WITH MECHANICAL VENTILATION	54675
CM0222 A : PRETERM BABY HYPERBILIRUBINEMIA / EXCHANGE TRANSFUSION WITHOUT MECHANICAL VENTILATION / CPAP	25515
CM0222 B : PRETERM BABY HYPERBILIRUBINEMIA - EXCHANGE TRANSFUSION WITH CPAP	32805
CM0222 C : PRETERM BABY HYPERBILIRUBINEMIA - EXCHANGE TRANSFUSION WITH MECHANICAL VENTILATION	40095
CM0223 A : TERM BABY - PNEUMONIA/BRONCHIOLITIS /TRANSIENT TACHYPNEA OF NEW BORN WITH CPAP	18225
CM0223 B : TERM BABY - PNEUMONIA/BRONCHIOLITIS /TRANSIENT TACHYPNEA OF NEW BORN WITH VENTILATOR	29160
CM0224 A : PRETERM BABY - PNEUMONIA/BRONCHIOLITIS /TRANSIENT TACHYPNEA OF NEW BORN WITH CPAP	32805
CM0224 B : PRETERM BABY - PNEUMONIA/BRONCHIOLITIS /TRANSIENT TACHYPNEA OF NEW BORN WITH VENTILATOR	40095
CM0225 A : TERM - WITH OR WITHOUT /SEVERE PERINATAL ASPHYXIA /SEPTIC SHOCK /SEIZURES /RENAL FAILURE/ - NON VENTILATED	18225
CM0225 B : TERM - WITH OR WITHOUT /SEVERE PERINATAL ASPHYXIA /SEPTIC SHOCK /SEIZURES /RENAL FAILURE/ - VENTILATED	29160
CM0226 : PRETERM - WITH OR WITHOUT /SEVERE PERINATAL ASPHYXIA /SEPTIC SHOCK /SEIZURES /RENAL FAILURE/ - VENTILATED	40095
CM0227 A : PRETERM BABY RDS WITHOUT SURFACTANT WITH CPAP	29160
CM0227 B : PRETERM BABY RDS WITH SURFACTANT WITH CPAP	43740
CM0227 C : PRETERM BABY RDS WITH SURFACTANT WITH MECHANICAL VENTILATION	58320
CM0228 : TERM BABY-CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE- WITH VENTILATION	36450
CM0229 : TERM BABY - CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE- WITHOUT VENTILATION	25515
CM0230 : PRETERM BABY-CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE- WITH VENTILATION	43740
CM0231 : PRETERM BABY - CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE- WITHOUT VENTILATION	32805
CM0232 A : TERM NEONATAL SEPTIC ARTHRITIS	21870
CM0232 B : PRETERM NEONATAL SEPTIC ARTHRITIS	29160
CM0233 : SEVERE BRONCHIOLITIS/SEVERE BRONCHO PNEUMONIA / SEVERE ASPIRATION PNEUMONIA (NON-VENTILATED)	10935
CM0234 : SEVERE BRONCHIOLITIS/SEVERE BRONCHO PNEUMONIA/ SEVERE ASPIRATION PNEUMONIA (VENTILATED)	21870
CM0235 : INTRA CRANIAL BLEED /HEMORRHAGIC DISEASE OF NEWBORN INTRACRANIAL BLEED	21870
CM0236 : ACUTE GASTRO INTESTINAL BLEED	25515
CM0237 A : ACUTE PANCREATITIS	25515
CM0237 B : ACUTE HEPATITIS	21870
CM0238 : ACUTE HEPATITIS WITH HEPATIC ENCEPHALOPATHY	29160
CM0239 : SNAKE BITE REQUIRING VENTILATOR	45000
CM0240 : SNAKE BITE - NON VENTILATED / COAGULOPATHY	21870
CM0241 : SCORPION STING WITH MYOCARDITIS AND CARDIOGENIC SHOCK REQUIRING VENTILATORY ASSISTANCE	29160
CM0242 : POISON INGESTION (INCLUDING HYDROCARBONS) / ASPIRATION REQUIRING VENTILATORY ASSISTANCE	36450
CM0243 : ACUTE BRONCHO/ LOBAR PNEUMONIA WITH EMPYEMA/ PLEURAL EFFUSION/ PYOPNEUMOTHORAX	18225
CM0244 : ACUTE STRIDOR/FOREIGN BODY OBSTRUCTION	29160
CM0245 : NEPHROTIC SYNDROME /ACUTE GLOMERULONEPHRITIS	18225
CM0246 : RECURRENT URINARY TRACT INFECTION WITH COMPLICATIONS LIKE PYELONEPHRITIS AND RENAL FAILURE	18225
CM0247 : ADVERSE EVENTS FOLLOWING IMMUNISATION	29160
CM0248 : OESOPHAGEAL ATRESIA/INTESTINAL ATRESIA WITHOUT OBSTRUCTION	36450
CM0249 : OESOPHAGEAL ATRESIA/INTESTINAL ATRESIA WITH OBSTRUCTION	36450
CM0250 : BILIARY ATRESIA & CHOLEDOCHAL CYST (INCLUDES OPERATIVE CHOLANGIOGRAM)	36450
CM0251 : ANORECTAL MALFORMATIONS - STAGE 1 /COLOSTOMY	21870
CM0252 : ANORECTAL MALFORMATIONS - STAGE 2/PULLTHROUGH	29160
CM0253 : ANORECTAL MALFORMATION - STAGE 3/CLOSURE	21870
CM0254 A : HIRSCHPRUNGS DISEASE - STAGE 1	30618
CM0254 B : HIRSCHPRUNGS DISEASE - STAGE 2	36450
CM0255 : CONGENITAL HYDRONEPHROSIS	36450
CM0256 : EXSTROPHY BLADDER - STAGE 1/2	40095
CM0257 : POSTERIOR URETHRAL VALVES (VESICOSTOMY / URETEROSTOMY)	21870
CM0258 : POSTERIOR URETHRAL VALVES (CYSTOSCOPIC FULGRATION)	25515
CM0259 : POSTERIOR URETHRAL VALVES (VESICOSTOMY / URETEROSTOMY CLOSURE)	21870
CM0260 : HAMARTOMA EXCISION	14580
CM0261 : HEMANGIOMA EXCISION(INCLUDING MEDICAL MANAGEMENT)	18225
CM0262 : LYMPHANGIOMA EXCISION	29160
CM0263 : NEUROBLASTOMA	32805
CM0264 A : PAEDIATRIC OESOPHAGEAL OBSTRUCTIONS-SURGICAL CORRECTION	21870
CM0264 B : PAEDIATRIC OESOPHAGEAL OBSTRUCTIONS-OESOPHAGEAL SUBSTITUTIONS	43740
CM0266 : THORACOSCOPIC CYST EXCISION	32805
CM0267 : THORACIC DUPLICATION	32805
CM0268 : LAPAROSCOPIC PULL THROUGH FOR ANO RECTAL ANOMALIES	38637
CM0269 : LAPAROSCOPIC PULL THROUGH FOR HD	38637
CM0270 : GASTRIC OUTLET OBSTRUCTIONS	25515
CM0271 : INTERSEX	30618
CM0272 A : SURGICAL CORRECTION FOR URACHAL ANOMALY	29160
CM0272 B : SURGICAL CORRECTION FOR CLOACAL ANOMALY	32805
CM0273 : CONGENITAL UROGENITAL ANOMALY STAGED CORRECTION	32805
CM0274 : BLADDER AUGMENTATION AND SUBSTITUTION	40095
CM0275 A : URETEROSTOMY	29160
CM0275 B : URETEROSTOMY CLOSURE	21870
CM0276 : CONGENITAL LUNG LESIONS (CLE, CCAM)	90000
CM0277 : SURGICAL CORRECTION FOR ANY CONGENITAL ANOMALY	36450
CM0278 : PATENT VITELLO INTESTINAL DUCT	29160
CM0279 A : VUR - CYSTOSCOPY/STING PROCEDURE (INSTILLATION OF HYALURONIC ACID) - UNILATERAL	32805
CM0279 B : VUR - CYSTOSCOPY/STING PROCEDURE (INSTILLATION OF HYALURONIC ACID) - BILATERAL	58320
CM0280 : RECTAL POLYP - POLYPECTOMY	25515
CM0281 : INTESTINAL POLYPOSIS SURGICAL CORRECTION	36450
CM0282 : ENCEPHALOCELE	29160
CM0283 : SCROTAL TRANSPOSITION REPAIR	21870
CM0284 : OPEN CYSTECTOMY	25515
CM0285 : LAP CYSTECTOMY	25515
CM0286 A : NECROTISING ENTEROCOLITIS - FLANK DRAINAGE	18225
CM0286 B : NECROTISING ENTEROCOLITIS - /LAPAROTOMY	29160
CM0287 : CONGENITAL HYDROCELE REPAIR	18225
CM0288 : VULVAL SYNECHIAE	10935
CM0289 : THORACIC/ABDOMINAL WALL DEFECTS -CORRECTION	36450
CM0290 : TUMORS (NEONATES/PAEDIATRICS)	36450
CM0291 : CRANIOTOMY AND EVACUATION OF HAEMATOMA	42464
CM0292A : EXCISION OF BRAIN TUMORS - [PRIMARY /BENIGN ) ( SUPRATENTORIAL- FRONTAL/PARIETAL/TEMPORAL/SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA)	46109
CM0292B : EXCISION OF BRAIN TUMORS - [PRIMARY /BENIGN ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDES SUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR)	49754
CM0293A : EXCISION OF BRAIN TUMORS - [MALIGNANT ) ( SUPRATENTORIAL- FRONTAL/PARIETAL/TEMPORAL/SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA)	46109
CM0293B : EXCISION OF BRAIN TUMORS - [MALIGNANT ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDES SUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR)	49754
CM0294A : EXCISION OF BRAIN TUMORS - [SECONDARIES ) ( SUPRATENTORIAL- FRONTAL/PARIETAL/TEMPORAL/SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA)	46109
CM0294B : EXCISION OF BRAIN TUMORS - [SECONDARIES ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDES SUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR)	49754
CM0295A : SHUNT SURGERIES-VENTRICULOATRIAL / VENTRICULOPERITONEAL SHUNT/ VENTRICULOPLEURAL SHUNT	19647
CM0295B : LUMBAR PERITONEAL/SYRINGO SUBARACHANOID /CYSTO PERITONEAL	21105
CM0296A : SHUNT SURGERIES-SHUNT DYSFUNTION - SHUNT SURGERIES-VENTRICULOATRIAL / VENTRICULOPERITONEAL SHUNT/ VENTRICULOPLEURAL SHUNT-REVISION	19647
CM0296B : SHUNT SURGERIES-SHUNT DYSFUNTION - SHUNT SURGERIES-VENTRICULOATRIAL / VENTRICULOPERITONEAL SHUNT/ VENTRICULOPLEURAL SHUNT- REPLACEMENT	21834
CM0296C : SHUNT SURGERIES-SHUNT DYSFUNTION - FAILURE/REVISION OF SHUNT ;LUMBAR PERITONEAL/SYRINGO SUBARACHANOID /CYSTO PERITONEAL - REVISION	21105
CM0296D : SHUNT SURGERIES-SHUNT DYSFUNTION - FAILURE/REVISION OF SHUNT ;LUMBAR PERITONEAL/SYRINGO SUBARACHANOID /CYSTO PERITONEAL - REPLACEMENT	23292
CM0297 : SHUNT SURGERIES - VP SHUNT WITH PROGRAMMABLE SHUNT	29853
CM0298 : TWIST DRILL CRANIOSTOMY	14544
CM0299 : SUBDURAL TAPPING	14544
CM0300 : VENTRICULAR TAPPING	14544
CM0301 : BRAIN ABSCESS & OTHER INFECTIVE LESION - BURR HOLE /TAPPING	14545
CM0302 : CRANIOTOMY / EXCISION OF ABSCESS & OTHER INFECTIVE LESION	19867
CM0303 : C.S.F. RHINORRHOEA & ACF REPAIR	38819
CM0304 : CRANIOPLASTY	29342
CM0305 : EXTERNAL VENTRICULAR DRAINAGE (EVD)	20084
CM0306 : EXCISION OF LOBE (FRONTAL, TEMPORAL, PARIETAL , CEREBELLUM ETC)	41006
CM0307 : PARASAGITAL LESION (INCLUDES VENTRICULAR LESIONS & CYSTS )	38819
CM0308 : BASAL LESION	43922
CM0309 : BRAIN STEM LESION	53399
CM0310 : C P ANGLE LESION	53399
CM0311 : STEREOTACTIC PROCEDURES- SURGICAL PROCEDURE	36268
CM0312 : STEREOTACTIC PROCEDURES- ABLATION	77092
CM0313 : STEREOTACTIC PROCEDURES- BIOPSY	36268
CM0314 : DE-COMPRESSIVE CRANIECTOMY (NON TRAUMATIC / CVA INFARCT)	42464
CM0315 : INTRA-CEREBRAL HEMATOMA EVACUATION	42464
CM0316 : SUBDURAL HEMORRHAGE/ DECOMPRESSION FOR CONTUSION & ICH	42464
CM0317A : DECOMPRESSION - OPTIC NERVE LESION (INCLUDES PROPTOSIS)	47932
CM0317B : EXCISION - OPTIC NERVE LESION (INCLUDES PROPTOSIS)	47203
CM0317C : DECOMPRESSION - ORBITAL TUMOR (INCLUDES PROPTOSIS)	34664
CM0317D : EXCISION - ORBITAL TUMOR (INCLUDES PROPTOSIS)	34664
CM0318 : TEMPORAL LOBECTOMY	31529
CM0319 : LESIONECTOMY	89120
CM0320 : TEMPORAL LOBECTOMY PLUS DEPTH ELECTRODES	35830
CM0321 : MICROVASCULAR DECOMPRESSION FOR TRIGEMINAL NEURALGIA	39402
CM0322 : MENINGO ENCEPHALOCELE /MENINGO MYELOCELE /MENINGOCELE EXCISION/LIPOMENINGOCELE (AT ANY LEVEL REPAIR)	23729
CM0323 : DERMAL SINUS WITH INTRADURAL EXTENSION/TETHERED CORD /RELEASE OF TIGHT FILUM	23000
CM0324 : ARNOLD CHIARI MALFORMATION - FORAMEN MAGNUM DECOMPRESSION	44870
CM0325 : INTRACRANIAL FOREIGN BODY REMOVAL	42464
CM0326A : DEPRESSED FRACTURE ( WITH HEMATOMA) - EXCISION- TRAUMA /OTHER THAN TRAUMA FOR 3 CM SQ	17460
CM0326B : DEPRESSED FRACTURE ( WITH HEMATOMA) - ELEVATION /SCREW & FIXATION -TRAUMA /OTHER THAN TRAUMA FOR 3 CM SQ	24093
CM0326C : DEPRESSED FRACTURE ( WITH HEMATOMA) - BONE FLAP REMOVAL POST CRANIOPLASTY TRAUMA /OTHER THAN TRAUMA	36486
CM0326D : DEPRESSED FRACTURE ( WITH HEMATOMA) - ELEVATION /SCREW & FIXATION -TRAUMA /OTHER THAN TRAUMA FOR MORE THAN 3 CM SQ	30654
CM0326E : DEPRESSED FRACTURE ( WITHOUT HEMATOMA) - EXCISION- TRAUMA /OTHER THAN TRAUMA	14252
CM0326F : DEPRESSED FRACTURE ( WITHOUT HEMATOMA) - ELEVATION /SCREW & FIXATION -TRAUMA /OTHER THAN TRAUMA FOR 3 CM SQ	21177
CM0326G : DEPRESSED FRACTURE ( WITHOUT HEMATOMA) - BONE FLAP REMOVAL POST CRANIOPLASTY TRAUMA /OTHER THAN TRAUMA	27738
CM0326H : DEPRESSED FRACTURE ( WITHOUT HEMATOMA) - ELEVATION /SCREW & FIXATION -TRAUMA /OTHER THAN TRAUMA MORE THAN FOR 3 CM SQ	27738
CM0327A : BONY LESION OF SKULL (PRIMARY BENIGN /MALIGNANT, SECONDARIES) FOR 3 CM SQ	33148
CM0327B : BONY LESION OF SKULL (PRIMARY BENIGN /MALIGNANT, SECONDARIES) FOR MORE THAN 3 CM SQ	34606
CM0328A : SPONTANEOUS ICH - CRANIOTOMY & EVACUATION	43558
CM0328B : SPONTANEOUS ICH - DECOMPRESSIVE CRANIECTOMY	38455
CM0329A : DEEP BRAIN STIMULATION E-COG with Brain mapping (MRI, FMRI with 3D- Mapping)	67615
CM0329B : DEEP BRAIN STIMULATION with E-COG, Brain mapping, intra-operative neuronavigation techniques & I-O CT/ MRI guided Stereotactic Stimulation	85840
CM0330 : INTRATHECAL PUMP IMPLANT	31529
CM0331 : NEURO ENDOSCOPY PROCEDURES-EXCISION OF INTRAVENTRICULAR LESION	42683
CM0332 : NEURO ENDOSCOPY PROCEDURES-EXCISION OF SUPRATENTORIAL LESION	45234
CM0333 : NEURO ENDOSCOPY PROCEDURES-SPINAL ENDOSCOPY FOR DISCECTOMY	29561
CM0334 : NEURO ENDOSCOPY PROCEDURES-ENDOSCOPIC THIRD VENTRICULOSTOMY	34299
CM0335 : CERVICAL / LUMBAR SYMPATHECTOMY	23656
CM0336 : D V T - IVC FILTER	52743
CM0337 : PERIPHERAL EMBOLECTOMY WITHOUT GRAFT	20048
CM0338 : EXCISION OF ARTERIO VENOUS MALFORMATION - SMALL	28978
CM0339 : EXCISION OF ARTERIO VENOUS MALFORMATION - LARGE	53946
CM0340 : ARTERIAL EMBOLECTOMY	20594
CM0341 : VASCULAR TUMORS	28832
CM0342 : SMALL ARTERIAL ANEURYSMS - REPAIR	13851
CM0343 : MEDIUM SIZE ARTERIAL ANEURYSMS - REPAIR	33899
CM0344 : MEDIUM SIZE ARTERIAL ANEURYSMS WITH SYNTHETIC GRAFT	53582
CM0345 : THORACO ABDOMINAL ANEURYSM REPAIR WITH RENO / MESENTRIC REVASCULARISATION	50483
CM0346 : VISCERAL ARTERY ANEURSYM REPAIR / RENAL ARTERY ANEURYSM REPAIR	33352
CM0347A : AORTO - BILLIAC - BIFEMORAL BYPASS WITH VEIN	57773
CM0347B : AORTO - BILLIAC - BIFEMORAL BYPASS WITH SYNTHETIC GRAFT	67615
CM0348 : AXILLO BIFEMORAL BYPASS WITH SYNTHETIC GRAFT	68708
CM0349 : FEMORO DISTAL BYPASS WITH VEIN GRAFT	41006
CM0350 : FEMORO DISTAL BYPASS WITH SYNTHETIC GRAFT	57409
CM0351 : AXILLO BRACHIAL BYPASS USING SYNTHETIC GRAFT	45380
CM0352 : BRACHIO - RADIAL BYPASS WITH SYNTHETIC GRAFT	34810
CM0353 : FEMORO- POPLITEAL BYPASS WITH GRAFT	40642
CM0354 : FEMORO- POPLITEAL BYPASS WITHOUT GRAFT	22052
CM0355 : FEMORO ILEAL BYPASS WITH GRAFT	32987
CM0356 : FEMORO ILEAL BYPASS WITHOUT GRAFT	16949
CM0357 : FEMORO FEMORAL BYPASS WITH GRAFT	32623
CM0358 : FEMORO FEMORAL BYPASS WITHOUT GRAFT	17678
CM0359 : AORTO RENAL BYPASS	36268
CM0360 : AORTO MESENTRIC BYPASS	36268
CM0361 : CAROTID SUBCLAVIAN ARTERY BYPASS WITH SYNTHETIC GRAFT	54128
CM0362 : AXILLO AXILLARY BYPASS WITH SYNTHETIC GRAFT	37361
CM0363 : SUBCLAVIAN SUBCLAVIAN BYPASS WITH SYNTHETIC GRAFT	38090
CM0364 : CAROTID BODY TUMOR - EXCISION	31566
CM0365 : CAROTID ARTERY BYPASS WITH SYNTHETIC GRAFT	67250
CM0366 : SURGERY WITHOUT GRAFT FOR ARTERIAL INJURIES OR VENOUS INJURIES	7837
CM0367 : VASCULAR INJURY IN UPPER LIMBS - AXILLARY, BRANCHIAL, RADIAL AND ULNAR - REPAIR WITH VEIN GRAFT	24786
CM0368 : MAJOR VASCULAR INJURY -REPAIR - LOWER LIMBS(INCLUDING FOOT)	30436
CM0369 : MINOR VASCULAR INJURY REPAIR -LOWER LIMBS (INCLUDING FOOT)	13304
CM0370 : SURGERY WITH VEIN GRAFT	12029
CM0371 : WITH PROSTHETIC GRAFT	29160
CM0372 : NECK VASCULAR INJURY - CAROTID VESSELS	66157
CM0373 : ABDOMINAL VASCULAR INJURIES - AORTA, ILLAC ARTERIES, IVC, ILIAC VEINS	66157
CM0374 : THORACIC VASCULAR INJURIES	66157
CM0375 : VARICOSE VEINS RFA FOR B/L	27338
CM0376 : COVERED STENT PLACEMENT FOR ANEURSYM / MURAL THROMBOSIS- Aorto-illiac	104794
CM0377A : THROMBOLYSIS FOR DEEP VEIN THROMBOSIS (CATHETER DIRECTED THROMBOLYSIS) - STK	36268
CM0377B : THROMBOLYSIS FOR DEEP VEIN THROMBOSIS (CATHETER DIRECTED THROMBOLYSIS) - RTPA	53035
CM0378 : BRACHIO - BASILIC TRANSPOSITION FOR HEMODIALYSIS ACCESS	16038
CM0379 : VERTEBRAL ARTERY STENTING WITH EMBOLIC PROTECTION DEVICE	51577
CM0380A : END ARTERECTOMY FOR PERIPHERAL ARTERIES	25515
CM0380B : END ARTERECTOMY FOR PERIPHERAL ARTERIES / PATCH CLOSURE	29160
CM0381 : END ARTERECTOMY FOR LARGE ARTERIES	36268
CM0382 : THROMBIN INJECTION UNDER DUPLEX GUIDANCE FOR PSEUDOANEURYSM	13851
CM0383 : PSEUDOANEURYSM MANAGEMENT WITH USG COMPRESSION THERAPY	7108
CM0384 : PSEUDOANEURYSM LIGATION	25333
CM0385 : PROFUNDA PLASTY	22052
CM0388 : SYSTEMIC THROMBOLYSIS IN PERIPHERAL ARTERY DISEASE	10935
CM0389A : REDO BYPASS AFTER GRAFT THROMBOSIS - VEIN GRAFT	36268
CM0389B : REDO BYPASS AFTER GRAFT THROMBOSIS - SYNTHETIC GRAFT	41371
CM0390A : ENDOVASCULAR AORTIC REPAIR - WITHOUT PATCH	45927
CM0390B : ENDOVASCULAR AORTIC REPAIR - WITH PATCH	71624
CM0391A : THORACIC ENDOVASCULAR AORTIC REPAIR - WITHOUT PATCH	66886
CM0391B : THORACIC ENDOVASCULAR AORTIC REPAIR - WITH PATCH	86933
CM0392 : HYBRID / OPEN INCLUDING COVERED STENT PLACEMENT - UNILATERAL	111537
CM0393 : HYBRID / OPEN INCLUDING COVERED STENT PLACEMENT - BILATERAL	142520
CM0394 : TUMOR RESECTION WITH VASCULAR RECONSTRUCTION	48879
CM0395 : GRAFT THROMBECTOMY BYPASS / AV ACCESS SURGERY	15491
CM0396 : SARTORIUS/ GRACILIS MUSCLE FLAP COVER FOR VASCULAR COVER	21323
CM0412 : EXPANSION SPHINTERO PLASTY	12867
CM0413 : ZETA PLASTY	14325
CM0415 : EXISION OF TUMOR IN PHARYNX / PARAPHARYNX (BENIGN)	14799
CM0416 : EXCISION OF TUMOR IN PHARYNX / PARAPHARYNX ( MALIGNANT)	18079
CM0417 : EXCISION OF TUMOR NASAL CAVITY (BENIGN /ANGIOFIBROMA NOSE)	14799
CM0424 : LABYRINTHECTOMY	16220
CM0427 : NASAL BONE FRACTURE REDUCTION	5723
CM0428A : MICRO DEBRIDER	18735
CM0428B : CO-ABLATION TURBINOPASTY	12029
CM0429 : CUT THROAT INJURY NECK - EXPLORATION & REPAIR WITHOUT VASCULAR INTERVENTION	8712
CM0430 : CUT THROAT INJURY NECK - EXPLORATION & REPAIR WITH VASCULAR INTERVENTION	11336
CM0431 : TRANS ORAL LASER EXCISION OF LARYNGEAL TUMOR (TOLMS) - BENIGN	21177
CM0432 : TRANS ORAL LASER EXCISION OF LARYNGEAL TUMOR (TOLMS) - MALIGNANT	23729
CM0433 : EXTERNAL ETHMOIDECTOMY	10971
CM0434 : FRACTURE ZYGOMA OPEN REDUCTION	10971
CM0435 : RADIO FREQUENCY ABLATION OF TONGUE	14835
CM0436 : THERAPEUTIC PENETRATING KERATOPLASTY / OPTICAL PENETRATING KERATOPLASTY	9951
CM0437 : LAMELLAR KERATOPLASTY	11773
CM0438 : SCLERAL PATCH GRAFT	5431
CM0439 : DOUBLE Z-PLASTY	3463
CM0441 : COLLAGEN CROSS LINKING FOR KERATOCONUS	6634
CM0442 : REMOVAL OF SILICON OIL OR GAS	4702
CM0443 : VITRECTOMY ANTERIOR	6087
CM0444 : VITRECTOMY - MEMBRANE PEELING- ENDOLASER,SILICON OIL OR GAS	15418
CM0445 : MONTHLY INTRAVITREAL ANTI-VEGF FOR MACULAR DEGENERATION - PER INJECTION (MAXIMUM - 6)	5650
CM0446A : DIABETIC MACULAR EDEMA-AVASTIN	4848
CM0446B : DIABETIC MACULAR EDEMA-INTRA VITREAL LUCENTIS	14762
CM0447 : SCLERAL BUCKLE FOR RETINAL DETACHMENT	9878
CM0448 : PHOTOCOAGULATION FOR DIABETIC RETINOPATHY / INDICATIONS OTHER THAN DIABETIC RETINOPATHY - PER SITTING	1203
CM0449 : DERMIS FAT GRAFT	6087
CM0450 : ORBITOTOMY	8347
CM0454 : LID RECONSTRUCTION SURGERY /BLEPHEROPLASTY	9003
CM0455 : PAEDIATRIC CATARACT SURGERY (PHACO EMULSIFICATION IOL/SICS IOL)	12794
CM0456 : PHOTOCOAGULATION FOR RETINOPATHY OF PREMATURITY	5468
CM0458 : LASER NDYAG PERIPHERAL IRIDOTOMY/ CAPSULOTOMY	1565
CM0460 : SURGICAL MANAGEMENT FOR SECONDARY GLAUCOMA	9732
CM0464 : LATERAL TARSORRHAPHY	3900
CM0466 : CORNEAL PATCH GRAFT	3827
CM0467 : SOCKET RECONSTRUCTION	7618
CM0468 : OBLIQUE MUSCLE SURGERY	6816
CM0471 : ECLAMPSIA WITH COMPLICATIONS REQUIRING VENTILATORY SUPPORT	20230
CM0472 : ECLAMPSIA WITH COMPLICATIONS & HELLP SYNDROME	16949
CM0473 : ABRUPTIO-PLACENTA WITH OUT COAGULATION DEFECTS (DIC)	14252
CM0474 : ABRUPTIO-PLACENTA WITH COAGULATION DEFECTS (DIC)	18626
CM0477 : SLINGS WITH MESH REPAIR FOR PROLAPSE	13158
CM0478A : VAULT PROLAPSE ABDOMINAL REPAIR WITHOUT MESH	11700
CM0478B : VAULT PROLAPSE ABDOMINAL REPAIR WITH MESH	12429
CM0480 : LAPAROSCOPIC MYOMECTOMY	15345
CM0481 A : RECANALISATION ANY TYPE- open	10607
CM0481 B : RECANALISATION ANY TYPE- lap	13887
CM0482 : STAGING LAPROTOMY FOR OVARIAN AND UTERINE CA	19683
CM0484 : LAPAROSCOPIC SLING OPERATIONS	17168
CM0485A : PPH SURGICAL MANAGEMENT - HYSTERECTOMY	13887
CM0485B : PPH SURGICAL MANAGEMENT -LIGATION/ EMBOLIZATION	11700
CM0487 : ACUTE MI (CONSERVATIVE MANAGEMENT WITHOUT ANGIOGRAM)	18000
CM0488 : ACUTE MI (CONSERVATIVE MANAGEMENT WITH ANGIOGRAM)	27000
CM0489 : ACUTE MI WITH CARDIOGENIC SHOCK	32400
CM0490 : ACUTE MI REQUIRING IABP PUMP	48600
CM0491 : CONGESTIVE CARDIAC FAILURE	45000
CM0492 : INFECTIVE ENDOCARDITIS	27000
CM0493 : PULMONARY EMBOLISM	36000
CM0494 : ARRYTHMIAS (SUPRAVENTRICULLAR / VENTRICULAR) - INVASIVE MANAGEMENT	90000
CM0496 : PERICARDIAL EFFUSION/TAMPONADE	27000
CM0497 : CARDIAC CATHETERISATION AND RIGHT & LEFT HEART STUDY	13500
CM0498A : PROSTHETIC VALVE THROMBOSIS- THROMBOLYSIS - FOR SK	21600
CM0498B : PROSTHETIC VALVE THROMBOSIS- THROMBOLYSIS - FOR RTPAS	52200
CM0498-A : PROSTHETIC VALVE THROMBOSIS- THROMBOLYSIS - FOR SK	11482
CM0498-B : PROSTHETIC VALVE THROMBOSIS- THROMBOLYSIS - FOR RTPAS	35721
CM0499 : TENECTEPLASE/TPA ADDITIONAL FOR MI MANAGEMENT	31500
CM0501 : ACUTE BRONCHITIS AND PNEUMONIA WITH RESPIRATORY FAILURE	29160
CM0502 : REQUIRING VENTILATORY SUPPORT -OP POISIONING / METABOLIC COMA/SCORPION STING/ SNAKE BITE / BITES & STINGS - MAX 7 DAYS	22050
CM0503 : DIPTHERIA COMPLICATED	18225
CM0504 : CRYPTOCOCCAL MENINGITIS	18225
CM0505 : CEREBRAL MALARIA	14580
CM0506 : CORROSIVE OESOPHAGEAL INJURY	20521
CM0507 : ACUTE PANCREATITIS WITH PSEUDOCYST (INFECTED)	21870
CM0508 : CHRONIC PANCREATITIS WITH SEVERE PAIN I) SEMS- SELF EXPANDABLE METALLIC STENT FOR BILIARY OBSTRUCTION (OBSTRUCTIVE JAUNDICE)- MALIGNANT/BENIGN	51285
CM0509 : CHRONIC PANCREATITIS WITH SEVERE PAIN- II) ENDOSCOPIC PANCREATIC SPINCTEROTOMY AND /OR PANCREATIC DUCT STENTING	12211
CM0510 : CHRONIC PANCREATITIS WITH SEVERE PAIN-PANCREATIC DUCT STENTING- PANCRETIC DUCT LEAKS, PSEUDOCYST OF PANCREAS, PANCREATIC STRICTURE, PANCREATIC STONE DISEASE	12211
CM0511 : NON VARICEAL BLEED- HEATER PROBE (UPPER & LOWER GI BLEED) INCLUDES GAVE, ULCER, RADIATION PROCTITIS/COLITIS, POST POLYPECTOMY BLEED, DIEULAFOYS LESION, ANGIODYSPLASIA,MALLORY WEISS TEAR.	11992
CM0512 : RAPIDLY PROGRESSIVE RENAL FAILURE (RPRF)	26496
CM0513 : MAINTANENCE HEMODIALYSIS FOR CRF (8 DIALYSIS) INCLUDING SEROPOSITIVE	8000
CM0514 : PERITONEAL DIALYSIS/CAPD	12080
CM0515 : CHRONIC INFLAMMATORY DEMYELINATING POLY NEUROPATHY	10607
CM0516A : HEMORRHAGIC STROKE	21870
CM0516B : ISCHEMIC STROKE	13122
CM0521 : BRONCHIECTASIS WITH REPEATED HOSPITALISATION>6PER YEAR	13815
CM0522 : ACUTE RESPIRATORY FAILURE (WITHOUT VENTILATOR)	19756
CM0523 : ACUTE RESPIRATORY FAILURE (WITH VENTILATOR - FOR MINIMUM 5 DAYS )	40970
CM0524 : LUNG ABSCESS, NON - RESOLVING	11591
CM0525 : PNEUMOTHORAX ( LARGE / RECURRENT )	18881
CM0526 : HYDROPNEUMOTHORAX	18881
CM0527a : MALIGNANT PLEURAL EFFUSION	11445
CM0527B : MASSIVE HEMOPTYSIS	34117
CM0528 : PNEUMOCONIOSIS	16475
CM0529 A : SLE- PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE OR TACROLIMUS OR HYDROXYCHLOROQUINE	11664
CM0529 B : SLE- PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE OR TACROLIMUS OR HYDROXYCHLOROQUINE/ MYCOPHENOLATE MOFETIL	18954
CM0530 : SLE -WITH INTERNAL ORGAN INVOLVEMENT ON PULSE CYCLOPHOSPHAMIDE THERAPY	15309
CM0531 : SLE WITH COMPLICATIONS	36450
CM0532 : SCLERODERMA RENAL CRISIS	13122
CM0533 : PRIMARY SJOGRENS SYNDROME- PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE OR TACROLIMUS OR HYDROXYCHLOROQUINE,PULSE CYCLOPHOSPHAMIDE THERAPY/MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ WITH GANGRENE ON IV PROSTACYCLIN/ PNEUMOCOCCAL VACCINATION	14580
CM0534 : SYSTEMIC SCLEROSIS -METHOTREXATE OR AZATHIOPRINE OR HYDROXYCHLOROQUINE/PULSE CYCLOPHOSPHAMIDE THERAPY/MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ WITH GANGRENE ON IV PROSTACYCLIN	18225
CM0535 : INTERVENTIONS LIMITED TO ACUTE RHEUMATIC FEVER AND RELATED CONDITIONS / ACUTE EXACERBATION OF CHRONIC RHEUMATIC CONDITIONS	10935
CM0536 : ANTIPHOSPHOLIPID SYNDROME (PRIMARY / SECONDARY)	10935
CM0537 : CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME	36450
CM0543 : FULMINANT HEPATIC FAILURE	35743
CM0544 : PRIMARY BILIARY CIRRHOSIS	20325
CM0545 : CHRONIC LIVER DISEASE -COMPENSATED/ DECOMPENSATED	21928
CM0547A : RT. HEPATECTOMY.	46292
CM0547B : NON ANATOMICAL RESECTION OF LIVER	29160
CM0548A : LT. HEPATECTOMY	46292
CM0548B : NON ANATOMICAL RESECTION OF LIVER	29160
CM0549 : SPLENORENAL ANASTOMOSIS	43740
CM0550 : SURGERY FOR BLEEDING ULCERS	29160
CM0551 : I STAGE-SUB TOTAL COLECTOMY + ILEOSTOMY	43740
CM0552 : II STAGE - J-POUCH	25515
CM0553 : III STAGE-ILEOSTOMY CLOSURE	16038
CM0554 A : HEPATICO JEJUNOSTOMY - BILIARY STRICTURE	54675
CM0554 B : HEPATICO JEJUNOSTOMY - INJURY / EXTERNAL BILIARY FISTULA MANAGEMENT	32805
CM0555A : BILIARY PANCREATITIS - CBD CALCULI - OTHER STENTS	16038
CM0555B : BILIARY PANCREATITIS - CBD CALCULI - SEMS	25515
CM0556 : REPAIR SURGERY FOR INJURIES DUE TO FB	36450
CM0557A : SURGICAL REMOVAL OF FOREIGN BODY FROM GIT (INVASIVE)	36450
CM0557B : SURGICAL REMOVAL OF FOREIGN BODY FROM GIT (NON INVASIVE )	14580
CM0558 : GASTRO STUDY FOLLOWED BY THORACOTOMY & SURGICAL MANAGEMENT FOR OESOPHAGEAL INJURY FOR CORROSIVE INJURIES/FB	40460
CM0559 : HAEMANGIOMA SOL LIVER HEPATECTOMY + WEDGE RESECTION	29160
CM0560 : LIENORENAL SHUNT	43740
CM0563A : ANAL SPHINCTER RECONSTRUCTION	25515
CM0563B : LEVATOROPLASTY	29160
CM0564 : GRACILOPLASTY	29160
CM0565 : BILIARY PERITONITIS -EMERGENCY LAPAROTOMY	29160
CM0566 : SPLEEN SPARING DEVASCULARISATION	29160
CM0567 : LIVER SEGMENTECTOMY	32805
CM0568 : PORTOCAVAL ANASTOMOSIS	58320
CM0569 : DEVASCULARISATION WITH OESOPHAGEAL TRANSECTION	58320
CM0570 : WARREN SHUNT	43740
CM0571 : PANCREAS DIVISUM	21870
CM0572 A : RENAL TRANSPLANTATION SURGERY INCLUDES --POST RENAL TRANSPLANT REJECTION A.STEROID RESISTANT B.STEROID SENSITIVE/ POST RENAL TRANSPLANT INFECTION - LIFE TREATENING TREATMENT FOR FUNGAL INFECTIONS ( LIPOSOMAL AMP OR EICHNOCANDINS) - LIVING DONAR	200000
CM0572 B : RENAL TRANSPLANTATION SURGERY INCLUDES --POST RENAL TRANSPLANT REJECTION A.STEROID RESISTANT B.STEROID SENSITIVE/ POST RENAL TRANSPLANT INFECTION - LIFE THREATENING TREATMENT FOR FUNGAL INFECTIONS ( LIPOSOMAL AMP OR EICHNOCANDINS) - CADAVERIC	200000
CM0573 A : CYSTOLITHOTRIPSY	10206
CM0573 B : CYSTOLITHOTRIPSY - LASER LITHOTRIPSY	12393
CM0573 C : RETROGRADE INTRARENAL SURGERY	20412
CM0574 : PERCUTANEOUS NEPHROLITHOTOMY	22599
CM0575 : EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY	14580
CM0576 : URETERO RENOSCOPIC LITHOTRIPSY	16038
CM0577 : SINGLE STAGE URETHROPLASTY FOR STRICTURE URETHRA	33534
CM0578 : BUCCAL MUCOSAL GRAFT- URETHROPLASTY	25515
CM0579 A : DOUBLE STAGE URETHROPLASTY FOR STRICTURE URETHRA - STAGE I	18225
CM0579 B : DOUBLE STAGE URETHROPLASTY FOR STRICTURE URETHRA - STAGE II	25515
CM0580 : DOUBLE STAGE URETHROPLASTY FOR STRICTURE URETHRA - RECONSTRUCTION PROCEDURE	25515
CM0581 : ANATROPHIC PEYLOLITHOTOMY FOR STAGHORN CALCULUS	32805
CM0582 A : RENAL CYST EXCISION - LAP	18225
CM0582 B : RENAL CYST EXCISION - OPEN	18225
CM0583 A : NEPHRECTOMY PYONEPHROSIS/XANTHO GRANULOMATOUS PYELONEPHRITIS - LAP	29160
CM0583 B : NEPHRECTOMY PYONEPHROSIS/XANTHO GRANULOMATOUS PYELONEPHRITIS - OPEN	29160
CM0584 : ENDOSCOPE REMOVAL OF STONE IN BLADDER	10206
CM0585 : URETERIC INJURY REPAIR	21870
CM0586 : BLADDER INJURY REPAIR	21870
CM0587 : URETERIC REIMPLANTATION	29160
CM0588 : VESICO VAGINAL FISTULA	21870
CM0589 : CLOSURE OF URETHRAL FISTULA	16038
CM0590 : OPTICAL URETHROTOMY	18225
CM0591 : PERINEAL URETHROSTOMY	14580
CM0592 : ANDERSON HYNES PYELOPLASTY	25515
CM0593 A : CAECO CYSTOPLASTY / AUGMENTATION - CYSTOPLASTY	23328
CM0593 B : BLADDER NECK INCISION (BNI)	14580
CM0594 : SUPRA PUBLIC CYSTOSTOMY	5832
CM0595 : DIVERTICULECTOMY /PERSISTENT URACHUS	14580
CM0596 : URACHAL SINUS/TUMOR / EXCISION	14580
CM0597 : INCONTINENCE URINE- (MALE)/ (FEMALE-INCLUDING CYSTOSCOPY OTIS URETHROTOMY)	10935
CM0598 : TRANSURETHRAL RESECTION OF PROSTATE (TURP)	19683
CM0599 : TURP WITH CYSTOLITHOTRIPSY	20412
CM0600 : CHORDEE CORECTION	10935
CM0612 : THOROCOPLASTY ( BRONCHOPLEURAL FISTULA/OTHERS)	30071
CM0613 : MYOPLASTY ( BRONCHOPLEURAL FISTULA/OTHERS)	26426
CM0614-II : TRANSPLEURAL BPF CLOSURE	31311
CM0615-II : CAROTID EMBOLECTOMY	35612
CM0616-II : PULMONARY EMBOLECTOMY WITH IVC FILTER	53582
CM0617-II : RENAL ANGIOPLASTY	41371
CM0618-II : VERTERBRAL ANGIOPLASTY	45745
CM0619 : EXISION OF TUMORS IN NASOPHARYNX (BENIGN )	15236
CM0620-I : EXCISION OF TUMOR IN NASOPHARYNX( MALIGNANT)	15236
CM0620-II : EXCISION OF TUMOR IN NASOPHARYNX( MALIGNANT)	15236
CM0621-I : ENDOSCOPIC DCR	11263
CM0621-II : ENDOSCOPIC DCR	11263
CM0624-I : WERTHEIMS / RADICAL HYSTERECTOMY	20813
CM0624-II : WERTHEIMS / RADICAL HYSTERECTOMY	20813
CM0625-I : AMPUTATIONS - FORE QUARTER / HIND QUARTER WITH OR WITHOUT HEMIPELVECTOMY	29160
CM0625-II : AMPUTATIONS - FORE QUARTER / HIND QUARTER WITH OR WITHOUT HEMIPELVECTOMY	29160
CM0626 A : DENGUE SHOCK SYNDROME -(ADULT/PAEDIATRICS)	16038
CM0626 B : DENGUE HEMORRHAGIC FEVER -(ADULT/PAEDIATRICS)	13122
CM0628-I : NEPHROSTOMY	5832
CM0628-II : NEPHROSTOMY	5832
CM0629-I : OBSCURE/ NON VARICEAL BLEED- CLIPPING / ARGON PLASMA COAGULATION/ INJECTION/CONSERVATIVE	33643
CM0629-II : OBSCURE/ NON VARICEAL BLEED- CLIPPING / ARGON PLASMA COAGULATION/ INJECTION/CONSERVATIVE	33643
CM0630 A-I : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY	11664
CM0630 A-II : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY	11664
CM0630 B : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ WITH GANGRENE ON IV PROSTACYCLIN/ PNEUMOCOCCAL VACCINATION )	21870
CM0631A-I : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY )	8748
CM0631A-II : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY )	8748
CM0631B-I : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY / INTERNAL ORGAN INVOLVEMENT REQUIRING INTRAVENOUS IMMUNOGLOBULIN/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ PNEUMOCOCCAL VACCINATION)	145800
CM0631B-II : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY / INTERNAL ORGAN INVOLVEMENT REQUIRING INTRAVENOUS IMMUNOGLOBULIN/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ PNEUMOCOCCAL VACCINATION)	145800
CM0632-I : FULL THICKNESS BUCCAL MUCOSAL RESECTION & RECONSTRUCTION	30509
CM0632-II : FULL THICKNESS BUCCAL MUCOSAL RESECTION & RECONSTRUCTION	30509
CM0633-I : ORBITAL EXENTERATION/ EVISCERATION WITH IMPLANT	17241
CM0633-II : ORBITAL EXENTERATION/ EVISCERATION WITH IMPLANT	17241
CM0634 K : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( Kidney) - per month	8000
CM0634 L : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( Kidney) - per month	8000
CM0635-I : OPEN PROSTATECTOMY	21870
CM0635-II : OPEN PROSTATECTOMY	21870
CM0636-I : RADICAL PROSTATECTOMY	36450
CM0636-II : RADICAL PROSTATECTOMY	36450
CM0640 : USG GUIDED MAJOR PROCEDURES ( EG. LIVER ABSCESS,POST OP COLLECTIONS)DRAINAGE PIGTAIL INSERTION	6926
CM0641A-I : USG GUIDED MAJOR PROCEDURES (RF ABLATION Solid organs)	21141
CM0641B-I : USG GUIDED MAJOR PROCEDURES (RF ABLATION other organs )	18225
CM0641C-I : USG GUIDED MAJOR PROCEDURES (ETHANOL ABLATION Solid organs)	15674
CM0641D-I : USG GUIDED MAJOR PROCEDURES (ETHANOL ABLATION other organs)	28431
CM0642A-I : USG GUIDED MINOR PROCEDURES (FNAC & BIPOSY)	1094
CM0642B-I : USG GUIDED MINOR PROCEDURES (SINOGRAPHY)	1458
CM0642C-I : USG GUIDED MINOR PROCEDURES (TAPPING)	1094
CM0643-II : RENAL ARTERY EMBOLIZATION WITH MULTIPLE COILS AND MICRO CATHETER	69437
CM0644-II : EMBOLIZATION OF AV MALFORMATION OF PERIPHERAL EXTREMITY, CRANIOFACIAL AND VISCERAL PER SITTING	48661
CM0645-II : GASTROINTESTINAL VISCERAL ARTERIAL EMBOLIZATION IN UPPER AND LOWER GASTROINTESTINAL BLEEDING WITH MICROCATHETER	55586
CM0645-III : GASTROINTESTINAL VISCERAL ARTERIAL EMBOLIZATION IN UPPER AND LOWER GASTROINTESTINAL BLEEDING WITH MICROCATHETER	55586
CM0646-II : BRONCHIAL ARTERY EMBOLIZATION IN HEMOPTYSIS USING PVA AND MICRO CATHETER	40642
CM0646-III : BRONCHIAL ARTERY EMBOLIZATION IN HEMOPTYSIS USING PVA AND MICRO CATHETER	40642
CM0647-II : EMBOLIZATION OF POSTOPERATIVE/ POST TRAUMATIC BLEEDING	59596
CM0648-II : UTERINE ARTERY EMBOLIZATION IN SEVERE MENORRHAGIA SECONDARY TO PPH/UTERINE FIBROIDS / AVM	38455
CM0649-II : PREOPERATIVE PORTAL VEIN EMBOLIZATION FOR LIVER TUMORS	51212
CM0649-III : PREOPERATIVE PORTAL VEIN EMBOLIZATION FOR LIVER TUMORS	51212
CM0650-II : EMBOLIZATION OF PULMONARY AV MALFORMATION	53399
CM0650-III : EMBOLIZATION OF PULMONARY AV MALFORMATION	53399
CM0651-II : EMBOLIZATION OF AV MALFORMATION OF BRAIN PER SITTING WITH ONYX	55586
CM0652-II : EMBOLIZATION OF CARATICO-CAVERNOUS FISTULA	67615
CM0652-III : EMBOLIZATION OF CARATICO-CAVERNOUS FISTULA	67615
CM0653-II : PLAIN SIMPLE COILING OF ANEURYSM	34810
CM0654-II : BRAIN AVM EMBOLIZATION	71260
CM0654-III : BRAIN AVM EMBOLIZATION	71260
CM0655-II : TUMOR EMBOLIZATION	61054
CM0655-III : TUMOR EMBOLIZATION	61054
CM0656-II : PERIPHERAL AVM EMBOLIZATION	55951
CM0657-II : TRANS ARTERIAL CHEMOEMBOLIZATION	66886
CM0658-II : HEAD AND NECK TUMOR EMBOLIZATION	53764
CM0659-II : PSEUDOANEURYSM EMBOLIZATION	33352
CM0660-II : PROSTATIC ARTERY EMBOLIZATION	31529
CM0661-A-II : SPINAL AVM EMBOLIZATION	35539
CM0661-A-III : SPINAL AVM EMBOLIZATION	35539
CM0661-B-II : SPINAL AVM EMBOLIZATION	42829
CM0661-B-III : SPINAL AVM EMBOLIZATION	42829
CM0662-II : SPINAL DURAL FISTULA EMBOLIZATION	45016
CM0662-III : SPINAL DURAL FISTULA EMBOLIZATION	45016
CM0663 : BALLOON RETERO GRADE VARICEAL EMBOLIZATION	41371
CM0664-II : LIVER HEMANGIOMA EMBOLIZATION	58867
CM0665-II : VEIN OF GALEN EMBOLIZATION	48296
CM0666-II : DURAL FISTULA EMBOLIZATION	59231
CM0668-II : SUPERFICIAL FEMORAL ARTERY ANGIOPLASTY ANY STENTING	78185
CM0669-II : FISTULA SALVAGE ANGIOPLASTY	53399
CM0670-II : CAROTID ARTERY STENTING WITH EMBOLIC PROTECTION DEVICE	96775
CM0671-II : ILIAC / IVC STENTING / HIGH END VASCULAR REVASCULARISATION PROCEDURE	80372
CM0672-II : VENOUS / POLY TETRA FLUORO ETHYLENE PATCH ANGIOPLASTY	41735
CM0673-II : SUBCLAVIAN, ILIAC, SUPERFICIAL FEMORAL ARTERY STENTING EACH WITH ONE STENT	76363
CM0674-II : TIBIAL ANGIOPLASTY IN CRITICAL LIMB ISCHEMIA	67979
CM0675-II : MESENTERIC ARTERY ANGIOPLASTY & STENTING IN ACUTE & CHRONIC MESENTERIC ISCHEMIA - SINGLE STENT	67979
CM0676-II : CENTRAL VENOUS STENTING FOR CENTRAL VENOUS OCCLUSION (BRACHIOCEPHALIC, SUBCLAVIAN VEIN AND SUP VENA CAVA) SINGLE METALLIC STENT	71624
CM0677-II : INTRACRANIAL VENOUS STENTING	89849
CM0678-II : INTRACRANIAL ARTERIAL STENTING	89849
CM0679-II : PERIPHERAL STENT GRAFT FOR PERIPHERAL ANEURYSMS AND AV FISTULA	89849
CM0680-II : PERIPHERAL ANGIOPLASTY	42464
CM0681-II : PERIPHERAL ANGIOPLASTY AND STENTING	46109
CM0682-II : SVC ANGIOPLASTY AND STENTING	76910
CM0683-II : IVC ANGIOPLASTY	46292
CM0684-II : IVC ANGIOPLASTY AND STENTING	79826
CM0685-II : BELOW KNEE ANGIOPLASTY	38819
CM0686-II : SUBCLAVIAN ANGIOPLASTY STENTING	79279
CM0687-II : RENAL ANGIOPLASTY STENTING	43558
CM0688-II : DURAL SINUS ANGIOPLASTY AND STENTING	47932
CM0689-I : HEPATIC VEIN ANGIOPLASTY AND STENTING	38455
CM0689-III : HEPATIC VEIN ANGIOPLASTY AND STENTING	38455
CM0690-II : CENTRAL VEIN STENOSIS ANGIOPLASTY	76545
CM0692-II : ACUTE STROKE THROMBOLYSIS (R TPA )	54857
CM0693-II : INFERIOR VENA CAVA FILTER PLACEMENT	57227
CM0694-I : BILIARY DRAINAGE PROCEDURES/ERCP - EXTERNAL DRAINAGE AND STENT PLACEMENT - METALLIC BILIARY STENT / POST OP BILIARY STRICTURE/LEAK/CHOLANGITIS/BILIARY PANCREATITIS/CHOLEDOCHAL CYST/BILE DUCT STONES	68125
CM0694-II : BILIARY DRAINAGE PROCEDURES/ERCP - EXTERNAL DRAINAGE AND STENT PLACEMENT - METALLIC BILIARY STENT / POST OP BILIARY STRICTURE/LEAK/CHOLANGITIS/BILIARY PANCREATITIS/CHOLEDOCHAL CYST/BILE DUCT STONES	68125
CM0695-II : CAROTID STENTING SINGLE STENT WITH EMBOLIC PROTECTION DEVICE	82195
CM0703 : IMMUNOGLOBULIN THERAPY - HEREDITARY MOTOR SENSORY NEUROPATHIES/HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY/PLEXOPATHY (LUMBOSACRAL/ BRACHIAL)/PERIPHERAL NEUROPATHY (WITH NERVE BIOPSY) (HANSEN, NUTRITIONAL, TOXIC, INFECTIVE, IMMUNE)/CARPAL TUNNEL SYNDROME/ACUTE ENTRAPMENT/ COMPRESSIVE NEUROPATHY / GBS/DOG BITE CATEGORY III/OTHERS	200000
CM0706-I : EXCISION OF LINGUAL THYROID	14981
CM0707-I : ACUTE PANCREATITIS - CONSERVATIVE MANAGEMENT / MILD / MODERATE / SEVERE MEDICAL / IMAGE GUIDED DRAINAGE OF PANCREATIC COLLECTIONS	40788
CM0707-II : ACUTE PANCREATITIS - CONSERVATIVE MANAGEMENT / MILD / MODERATE / SEVERE MEDICAL / IMAGE GUIDED DRAINAGE OF PANCREATIC COLLECTIONS	40788
CM0709 A-I : LAP NEPHRECTOMY SIMPLE/HEMI/PARTIAL.	32805
CM0709 A-II : LAP NEPHRECTOMY SIMPLE/HEMI/PARTIAL.	32805
CM0709 A-III : LAP NEPHRECTOMY SIMPLE/HEMI/PARTIAL.	32805
CM0709 B-I : LAP NEPHRECTOMY-RADICAL	32805
CM0709 B-II : LAP NEPHRECTOMY-RADICAL	32805
CM0709 B-III : LAP NEPHRECTOMY-RADICAL	32805
CM0710 A-I : NEPHROURETERECTOMY OPEN	29160
CM0710 A-II : NEPHROURETERECTOMY OPEN	29160
CM0710 B-I : NEPHROURETERECTOMY LAP	29160
CM0710 B-II : NEPHROURETERECTOMY LAP	29160
CM0711 : BRONCHOSCOPY FOREIGN BODY REMOVAL	7217
CM0713-I : TRACHEOSTOMY	3681
CM0713-II : TRACHEOSTOMY	3681
CM0714-I : THOROCOSTOMY	31639
CM0714-II : THOROCOSTOMY	31639
CM0722-I : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MANDIBLE, MAXILLA	14616
CM0722-II : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MANDIBLE, MAXILLA	14616
CM0723-I : HEAD & NECK CANCER COMPOSITE RESECTION	27228
CM0723-II : HEAD & NECK CANCER COMPOSITE RESECTION	27228
CM0724-I : HEAD & NECK CANCER COMPOSITE RESECTION WITH RECONSTRUCTION	34154
CM0724-II : HEAD & NECK CANCER COMPOSITE RESECTION WITH RECONSTRUCTION	34154
CM0725-I : SKIN TUMOR/SOFT TISSUE/BONE TUMORS - EXCISION / AMPUTATION/RESECTION WITH RECONSTRUCTION	17970
CM0725-III : SKIN TUMOR/SOFT TISSUE/BONE TUMORS - EXCISION / AMPUTATION/RESECTION WITH RECONSTRUCTION	17970
CM0725-IV : SKIN TUMOR/SOFT TISSUE/BONE TUMORS - EXCISION / AMPUTATION/RESECTION WITH RECONSTRUCTION	17970
CM0727-I : TRACHEO OESOPHAGEAL FISTULA - REPAIR / RECONSTRUCTION	30509
CM0728-I : OESOPHAGEAL GROWTH / FISTULA / STRICTURE / PERFORATION / LUMINAL STENTING	52379
CM0729-I : DIAPHRAGMATIC HERNIA	29160
CM0729-II : DIAPHRAGMATIC HERNIA	29160
CM0730 A-I : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - U/L OPEN	29160
CM0730 A-II : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - U/L OPEN	29160
CM0730 B-I : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - U/L LAP	29160
CM0730 B-II : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - U/L LAP	29160
CM0730 C-II : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - B/L OPEN	40095
CM0730 C-III : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - B/L OPEN	40095
CM0730 D-II : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - B/L LAP	40095
CM0730 D-III : URETERIC REIMPLANTATIONS/MEGA URETER OBSTRUCTIVE /REFLUXING - B/L LAP	40095
CM0731-I : HYPOSPADIAS	21870
CM0731-II : HYPOSPADIAS	21870
CM0732-I : EPISPADIAS	30618
CM0732-II : EPISPADIAS	30618
CM0733-I : TORSION TESTIS	18225
CM0733-II : TORSION TESTIS	18225
CM0734-I : URETEROCELE SURGERY	21870
CM0734-II : URETEROCELE SURGERY	21870
CM0735 A-I : OPEN CHOLECYSTECTOMY- RADICAL WITH OR WITHOUT CBD EXPLORATION	36450
CM0735 A-II : OPEN CHOLECYSTECTOMY- RADICAL WITH OR WITHOUT CBD EXPLORATION	36450
CM0735 B-I : OPEN CHOLECYSTECTOMY- ANY TYPE/ CBD EXPLORATION	16038
CM0735 B-II : OPEN CHOLECYSTECTOMY- ANY TYPE/ CBD EXPLORATION	16038
CM0736 A-I : LAP CHOLECYSTECTOMY- RADICAL WITH /WITHOUT CBD EXPLORATION	36450
CM0736 A-II : LAP CHOLECYSTECTOMY- RADICAL WITH /WITHOUT CBD EXPLORATION	36450
CM0736 B-I : LAP CHOLECYSTECTOMY- ANY TYPE/ CBD EXPLORATION	16038
CM0736 B-II : LAP CHOLECYSTECTOMY- ANY TYPE/ CBD EXPLORATION	16038
CM0737-I : LAP CHOLECYSTOSTOMY WITH /WITHOUT EXPLORATION CBD	16038
CM0737-II : LAP CHOLECYSTOSTOMY WITH /WITHOUT EXPLORATION CBD	16038
CM0738-I : OPEN CHOLECYSTOSTOMY	14580
CM0738-II : OPEN CHOLECYSTOSTOMY	14580
CM0739-I : GASTRECTOMY ANY TYPE - ANY CAUSE	29051
CM0739-II : GASTRECTOMY ANY TYPE - ANY CAUSE	29051
CM0739-III : GASTRECTOMY ANY TYPE - ANY CAUSE	29051
CM0740-I : GASTRECTOMY ANY TYPE - ANY CAUSE WITH LYMPHADENECTOMY	35612
CM0740-II : GASTRECTOMY ANY TYPE - ANY CAUSE WITH LYMPHADENECTOMY	35612
CM0740-III : GASTRECTOMY ANY TYPE - ANY CAUSE WITH LYMPHADENECTOMY	35612
CM0741-A : PENECTOMY- PARTIAL WITHOUT PERINEAL URETHEROSTOMY -CA	11372
CM0741-B : PENECTOMY- Total WITHOUT PERINEAL URETHEROSTOMY -CA	17751
CM0742A : PENECTOMY- PARTIAL WITH PERINEAL URETHEROSTOMY -CA	21542
CM0742B : PENECTOMY- TOTAL WITH PERINEAL URETHEROSTOMY -CA	29051
CM0743-I : ANTERIOR RESECTION	37070
CM0743-II : ANTERIOR RESECTION	37070
CM0743-III : ANTERIOR RESECTION	37070
CM0744-A-I : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH	17897
CM0744-A-II : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH	17897
CM0744-A-III : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH	17897
CM0744-B-I : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH /ILEOSTOMY	35757
CM0744-B-II : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH /ILEOSTOMY	35757
CM0744-B-III : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH /ILEOSTOMY	35757
CM0744-C-I : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH/ WITH STAPLED ANASTOMOSIS	54347
CM0744-C-II : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH/ WITH STAPLED ANASTOMOSIS	54347
CM0744-C-III : SEGMENTAL RESECTION/WEDGE RESECTION OF STOMACH/ WITH STAPLED ANASTOMOSIS	54347
CM0745-I : ABDOMINOPERINIAL RESECTION	28686
CM0745-II : ABDOMINOPERINIAL RESECTION	28686
CM0745-III : ABDOMINOPERINIAL RESECTION	28686
CM0746A-I : SPLENECTOMY WITHOUT DEVASCULARISATION -TRAUMATIC	25515
CM0746A-II : SPLENECTOMY WITHOUT DEVASCULARISATION -TRAUMATIC	25515
CM0749A-I : NECK DISSECTION ANY TYPE - WITH WIDE EXCISION (INCLUDING MALIGNANCY)	22125
CM0749A-III : NECK DISSECTION ANY TYPE - WITH WIDE EXCISION (INCLUDING MALIGNANCY)	22125
CM0749B-I : NECK DISSECTION ANY TYPE - WITHOUT WIDE EXCISION (INCLUDING MALIGNANCY)	14835
CM0749B-III : NECK DISSECTION ANY TYPE - WITHOUT WIDE EXCISION (INCLUDING MALIGNANCY)	14835
CM0750-A-I : NECK DISSECTION ANY TYPE - WITHOUT RECONSTRUCTION (INCLUDING MALIGNANCY)	18845
CM0750-A-III : NECK DISSECTION ANY TYPE - WITHOUT RECONSTRUCTION (INCLUDING MALIGNANCY)	18845
CM0750-B-I : NECK DISSECTION ANY TYPE - WITH RECONSTRUCTION (INCLUDING MALIGNANCY)	25406
CM0750-B-III : NECK DISSECTION ANY TYPE - WITH RECONSTRUCTION (INCLUDING MALIGNANCY)	25406
CM0751-I : HEMIMANDIBULECTOMY	18334
CM0751-II : HEMIMANDIBULECTOMY	18334
CM0751-III : HEMIMANDIBULECTOMY	18334
CM0751-IV : HEMIMANDIBULECTOMY	18334
CM0752-I : MARGINAL MANDIBULECTOMY	16366
CM0752-II : MARGINAL MANDIBULECTOMY	16366
CM0752-III : MARGINAL MANDIBULECTOMY	16366
CM0752-IV : MARGINAL MANDIBULECTOMY	16366
CM0753-I : SEGMENTAL MANDIBULECTOMY	16366
CM0753-II : SEGMENTAL MANDIBULECTOMY	16366
CM0753-III : SEGMENTAL MANDIBULECTOMY	16366
CM0753-IV : SEGMENTAL MANDIBULECTOMY	16366
CM0754 : LEIOMYOMA EXCISION	8748
CM0755 : MULTI ORGAN RESECTION FOR ANY GI CANCERS	49025
CM0756 : SURGERIES FOR ENTERO CUTANEOUS FISTULA	29160
CM0757 : INCISIONAL HERNIA REPAIR WITHOUT MESH	14580
CM0758 : INCISIONAL HERNIA REPAIR WITH MESH	18225
CM0759A-i : CRANIOSYNOSTOSIS - STRIP CRANIECTOMY	14580
CM0759A-ii : CRANIOSYNOSTOSIS - ORBITO FACIAL ADVANCEMENT	10935
CM0759A-iii : CRANIOSYNOSTOSIS - PLASTIC SURGICAL CORRECTION	10935
CM0760-I : LIVER ABSCESS - OPEN DRAINAGE	13122
CM0760-II : LIVER ABSCESS - OPEN DRAINAGE	13122
CM0761 : BRAIN - ANY BIOPSY	36428
CM0762 : SPINAL VASCULAR MALFORMATION (CONVENTIONAL/INTERVENTIONAL)	32477
CM0763A-I : RECTAL PROLAPSE - THEIRSCH WIRING	10935
CM0763A-II : RECTAL PROLAPSE - THEIRSCH WIRING	10935
CM0763B-I : RECTAL PROLAPSE - DEBULKING	18954
CM0763B-II : RECTAL PROLAPSE - DEBULKING	18954
CM0763C-I : RECTAL PROLAPSE - LAPAROSCOPIC RECTOPEXY	18954
CM0763C-II : RECTAL PROLAPSE - LAPAROSCOPIC RECTOPEXY	18954
CM0764B : SPLENECTOMY WITH DEVASCULARISATION -TRAUMATIC	27702
CM0764 : GLOSSECTOMY (TOTAL/HEMI/PARTIAL) FOR CANCER	14216
CM0765 : GLOSSECTOMY (TOTAL/HEMI/PARTIAL) WITH RECONSTRUCTION- FOR CANCER	29051
CM0766 : MAXILLECTOMY ANY TYPE -FOR CA	18225
CM0767 : PAROTIDECTOMY ANY TYPE- FOR CA	14216
CM0768 : LARYNGECTOMY ANY TYPE -FOR CA	26426
CM0769-I : LARYNGO PHARYNGO OESOPHAGECTOMY	53946
CM0769-II : LARYNGO PHARYNGO OESOPHAGECTOMY	53946
CM0770 A-I : TOTAL COLECTOMY - OPEN/ LAPROSCOPIC -ANY CAUSE	30618
CM0770 A-II : TOTAL COLECTOMY - OPEN/ LAPROSCOPIC -ANY CAUSE	30618
CM0770 A-III : TOTAL COLECTOMY - OPEN/ LAPROSCOPIC -ANY CAUSE	30618
CM0770 B-I : SUB TOTAL COLECTOMY - OPEN/ LAPROSCOPIC -ANY CAUSE	24057
CM0770 B-II : SUB TOTAL COLECTOMY - OPEN/ LAPROSCOPIC -ANY CAUSE	24057
CM0770 B-III : SUB TOTAL COLECTOMY - OPEN/ LAPROSCOPIC -ANY CAUSE	24057
CM0771-I : WHIPPLES ANY TYPE	60143
CM0771-II : WHIPPLES ANY TYPE	60143
CM0771-III : WHIPPLES ANY TYPE	60143
CM0772A-I : OPEN CYSTECTOMY(/PARTIAL/ COMPLETE) WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	25515
CM0772A-II : OPEN CYSTECTOMY(/PARTIAL/ COMPLETE) WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	25515
CM0772A-III : OPEN CYSTECTOMY(/PARTIAL/ COMPLETE) WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	25515
CM0772B-I : OPEN CYSTECTOMY(RADICAL )WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	32805
CM0772B-II : OPEN CYSTECTOMY(RADICAL )WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	32805
CM0772B-III : OPEN CYSTECTOMY(RADICAL )WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	32805
CM0773 A-I : LAPAROSCOPIC CYSTECTOMY [PARTIAL / COMPLETE] WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	25515
CM0773 A-II : LAPAROSCOPIC CYSTECTOMY [PARTIAL / COMPLETE] WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	25515
CM0773 B-I : LAPAROSCOPIC CYSTECTOMY [RADICAL ]WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	32805
CM0773 B-II : LAPAROSCOPIC CYSTECTOMY [RADICAL ]WITH OR WITHOUT DRAINAGE PROCEDURES - ANY CAUSE	32805
CM0774 : LAPROSCOPIC ASSISTED VAGINAL HYSTERECTOMY	14616
CM0775-I : SALPINGO OOPHORECTOMY U/L OR B/L- FOR CA	18480
CM0775-II : SALPINGO OOPHORECTOMY U/L OR B/L- FOR CA	18480
CM0776-I : MASTECTOMY ANY TYPE	14580
CM0776-II : MASTECTOMY ANY TYPE	14580
CM0777-A-I : MASTECTOMY ANY TYPE WITH AXILLARY DISSECTION	18225
CM0777-A-II : MASTECTOMY ANY TYPE WITH AXILLARY DISSECTION	18225
CM0777-B-I : MASTECTOMY ANY TYPE WITH SENTINAL NODE EXPLORATION	18225
CM0777-B-II : MASTECTOMY ANY TYPE WITH SENTINAL NODE EXPLORATION	18225
CM0778-A-I : WIDE EXICISION/ LUMPECTOMY - TUMORS OF BREAST -BENIGN	3572
CM0778-A-II : WIDE EXICISION/ LUMPECTOMY - TUMORS OF BREAST -BENIGN	3572
CM0778-B-I : WIDE EXICISION/ LUMPECTOMY - TUMORS OF BREAST (MALIGNANT)	4739
CM0778-B-II : WIDE EXICISION/ LUMPECTOMY - TUMORS OF BREAST (MALIGNANT)	4739
CM0779 : PNEUMONECTOMY- ANY CAUSE	38163
CM0780 : LUNG LOBECTOMY - ANY CAUSE	38163
CM0781 : DECORTICATION - ANY CAUSE	30873
CM0782 : VATS-LOBECTOMY	45453
CM0783 : VATS-PNEUMONECTOMY	45453
CM0784 : VATS-DECORTICATION	41808
CM0785-I : METASTATECTOMY SOLITARY OR MULTIPLE - ANY CAUSE	27228
CM0785-II : METASTATECTOMY SOLITARY OR MULTIPLE - ANY CAUSE	27228
CM0786-A-I : OPERATIONS OF ADRENAL GLAND - U/L( ANY CAUSE)	18189
CM0786-A-II : OPERATIONS OF ADRENAL GLAND - U/L( ANY CAUSE)	18189
CM0786-B-I : OPERATIONS OF ADRENAL GLAND - B/L ( ANY CAUSE)	32914
CM0786-B-II : OPERATIONS OF ADRENAL GLAND - B/L ( ANY CAUSE)	32914
CM0787 : TEMPORAL BONE - EXCISION / RESECTION - ANY TYPE	25515
CM0789-I : STERNOTOMY + MEDIASTINAL DISSECTION - CA / SOL	30290
CM0789-II : STERNOTOMY + MEDIASTINAL DISSECTION - CA / SOL	30290
CM0795-I : PARATHYROIDECTOMY - ANY TYPE	18225
CM0796-I : RESECTION AND ANASTOMOSIS /SEGMENTAL RESECTION - SMALL INTESTINE- ANY CAUSE	29160
CM0796-II : RESECTION AND ANASTOMOSIS /SEGMENTAL RESECTION - SMALL INTESTINE- ANY CAUSE	29160
CM0796-III : RESECTION AND ANASTOMOSIS /SEGMENTAL RESECTION - SMALL INTESTINE- ANY CAUSE	29160
CM0797-I : RESECTION AND ANASTOMOSIS /SEGMENTAL RESECTION - LARGE INTESTINE- ANY CAUSE	32805
CM0797-II : RESECTION AND ANASTOMOSIS /SEGMENTAL RESECTION - LARGE INTESTINE- ANY CAUSE	32805
CM0797-III : RESECTION AND ANASTOMOSIS /SEGMENTAL RESECTION - LARGE INTESTINE- ANY CAUSE	32805
CM0798-I : GASTROSTOMY/FEEDING GASTROSTOMY/PERCUTANEOUS ENDOSCOPIC GASTROSTOMY	14580
CM0798-II : GASTROSTOMY/FEEDING GASTROSTOMY/PERCUTANEOUS ENDOSCOPIC GASTROSTOMY	14580
CM0798-III : GASTROSTOMY/FEEDING GASTROSTOMY/PERCUTANEOUS ENDOSCOPIC GASTROSTOMY	14580
CM0799-I : OESOPHAGOSTOMY	18225
CM0799-II : OESOPHAGOSTOMY	18225
CM0800-I : JEJUNOSTOMY / FEEDING JEJUNOSTOMY	14580
CM0800-II : JEJUNOSTOMY / FEEDING JEJUNOSTOMY	14580
CM0801-I : GASTROJEJUNOSTOMY	18225
CM0801-II : GASTROJEJUNOSTOMY	18225
CM0802-I : ILEOSTOMY	14580
CM0802-II : ILEOSTOMY	14580
CM0803 A-I : ILEOTRANSVERSE COLOSTOMY	18225
CM0803 A-II : ILEOTRANSVERSE COLOSTOMY	18225
CM0803 A-III : ILEOTRANSVERSE COLOSTOMY	18225
CM0803 B-I : COLOSTOMY	14580
CM0803 B-II : COLOSTOMY	14580
CM0803 B-III : COLOSTOMY	14580
CM0804-I : HARTMANNS PROCEDURE WITH COLOSTOMY- ANY CAUSE	32805
CM0804-II : HARTMANNS PROCEDURE WITH COLOSTOMY- ANY CAUSE	32805
CM0805-I : CLOSURE OF GASTROSTOMY/ILEOSTOMY/COLOSTOMY / JEJUNOSTOMY / GASTROJEJUNOSTOMY / ILEOTRANSVERSE COLOSTOMY / OESOPHAGOSTOMY	14580
CM0805-II : CLOSURE OF GASTROSTOMY/ILEOSTOMY/COLOSTOMY / JEJUNOSTOMY / GASTROJEJUNOSTOMY / ILEOTRANSVERSE COLOSTOMY / OESOPHAGOSTOMY	14580
CM0805-III : CLOSURE OF GASTROSTOMY/ILEOSTOMY/COLOSTOMY / JEJUNOSTOMY / GASTROJEJUNOSTOMY / ILEOTRANSVERSE COLOSTOMY / OESOPHAGOSTOMY	14580
CM0806-I : RESECTION OF RETRO PERITONEAL TUMORS	32477
CM0806-II : RESECTION OF RETRO PERITONEAL TUMORS	32477
CM0807 : BONE RESECTION / CURRETTAGE/ CEMENTING- ANY CAUSE	21870
CM0808A : URINARY DIVERSION PROCEDURES ( INCLUDING PERCUTANEOUS / ANTEGRADE/RETROGRADE URETERIC STENTING )	21870
CM0808B : URINARY DIVERSION PROCEDURES ( NEPHROSTOMY)	5832
CM0809 : SUPRA PUBIC CYSTOSTOMY	5832
CM0810-I : INTERCOSTAL DRAINAGE	2989
CM0810-II : INTERCOSTAL DRAINAGE	2989
CM0811 : CRYOTHERAPY FOR ALL LESIONS	16585
CM0814-I : VASCULAR MALFORMATIONS- (INCLUDING SCLEROTHERAPY/ REDUCTION SURGERY)	19136
CM0820-I : AMPUTATION OF ANY SITE / ANY CAUSE WITHOUT PROSTHESIS (except fingers, toes and small joints)	18225
CM0820-II : AMPUTATION OF ANY SITE / ANY CAUSE WITHOUT PROSTHESIS (except fingers, toes and small joints)	18225
CM0820-III : AMPUTATION OF ANY SITE / ANY CAUSE WITHOUT PROSTHESIS (fingers, toes and small joints)	7290
CM0821-I : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints)	100000
CM0821-II : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints)	100000
CM0821-III : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (fingers, toes and small joints)	50000
CM0822 A-I : SOFT TISSUE INJURY - LACERATION (SUTURING) /WOUND DEBRIDEMENT	437
CM0822 A-II : SOFT TISSUE INJURY - LACERATION (SUTURING) /WOUND DEBRIDEMENT	437
CM0822 B-I : SOFT TISSUE INJURY - DEEP WOUND [NERVE/TENDON REPAIR]	3645
CM0822 B-II : SOFT TISSUE INJURY - DEEP WOUND [NERVE/TENDON REPAIR]	3645
CM0824 : CERVICAL RIB EXCISION	22089
CM0825A : POLYTRAUMA/HEAD INJURY MINOR (only lacerations less than 10 cm)	1823
CM0825B : POLYTRAUMA/HEAD INJURY MINOR (deep / pitted wound exposing scalp/ bone requiring debridement and suturing)	5103
CM0826 : POLYTRAUMA/HEAD INJURY MAJOR (with fractures, intracranial bleeding)	18225
CM0827-I : SEVERE MYOCARDITIS/CONGENITAL HEART DISEASE PRESENTING WITH OR WITHOUT / INFECTION / FAILURE / CARDIOGENIC SHOCK / SEPTIC SHOCK / INFECTIVE ENDOCARDITIS/ CYANOTIC SPELL - NON VENTILATED	29160
CM0827-II : SEVERE MYOCARDITIS/CONGENITAL HEART DISEASE PRESENTING WITH OR WITHOUT / INFECTION / FAILURE / CARDIOGENIC SHOCK / SEPTIC SHOCK / INFECTIVE ENDOCARDITIS/ CYANOTIC SPELL - NON VENTILATED	29160
CM0828-I : SEVERE MYOCARDITIS/CONGENITAL HEART DISEASE PRESENTING WITH OR WITHOUT / INFECTION / FAILURE / CARDIOGENIC SHOCK / SEPTIC SHOCK / INFECTIVE ENDOCARDITIS/ CYANOTIC SPELL - VENTILATED	36450
CM0828-II : SEVERE MYOCARDITIS/CONGENITAL HEART DISEASE PRESENTING WITH OR WITHOUT / INFECTION / FAILURE / CARDIOGENIC SHOCK / SEPTIC SHOCK / INFECTIVE ENDOCARDITIS/ CYANOTIC SPELL - VENTILATED	36450
CM0829-I : STATUS EPILEPTICUS WITH MECHANICAL VENTILATION -(ADULT/PAEDIATRIC )	29160
CM0829-II : STATUS EPILEPTICUS WITH MECHANICAL VENTILATION -(ADULT/PAEDIATRIC )	29160
CM0830 : DIABETIC KETOACIDOSIS - TYPE I / TYPE II	21870
CM0831-I : CHRONIC RENAL FAILURE WITH HEMODIALYSIS/ERYTHROPOIETIN / IRON	12502
CM0831-II : CHRONIC RENAL FAILURE WITH HEMODIALYSIS/ERYTHROPOIETIN / IRON	12502
CM0832-I : ACUTE RENAL FAILURE WITHOUT HEMODIALYSIS/ERYTHROPOIETIN / IRON	7071
CM0832-II : ACUTE RENAL FAILURE WITHOUT HEMODIALYSIS/ERYTHROPOIETIN / IRON	7071
CM0833-I : ACUTE RENAL FAILURE WITH HEMODIALYSIS/ ERYTHROPOIETIN / IRON	8238
CM0833-II : ACUTE RENAL FAILURE WITH HEMODIALYSIS/ ERYTHROPOIETIN / IRON	8238
CM0834-I : ACUTE RENAL FAILURE / CRF WITH VENTILATOR CARE	19464
CM0834-II : ACUTE RENAL FAILURE / CRF WITH VENTILATOR CARE	19464
CM0835A-I : ACUTE RENAL FAILURE / CRF - CONTINUOUS RENAL REPLACEMENT THERAPY-SCUF & SLED	41553
CM0835A-II : ACUTE RENAL FAILURE / CRF - CONTINUOUS RENAL REPLACEMENT THERAPY-SCUF & SLED	41553
CM0835B-I : ACUTE RENAL FAILURE / CRF - CONTINUOUS RENAL REPLACEMENT THERAPY - CVVH/CVVHD	56133
CM0835B-II : ACUTE RENAL FAILURE / CRF - CONTINUOUS RENAL REPLACEMENT THERAPY - CVVH/CVVHD	56133
CM0836 : RENAL BIOPSY	10858
CM0837-I : PYOGENIC /TB /VIRAL/ FUNGAL -MENINGITIS/ MENINGOENCEPHALITIS - NON VENTILATED	21870
CM0837-II : PYOGENIC /TB /VIRAL/ FUNGAL -MENINGITIS/ MENINGOENCEPHALITIS - NON VENTILATED	21870
CM0838-I : PYOGENIC /TB /VIRAL/ FUNGAL -MENINGITIS/ MENINGOENCEPHALITIS - WITH VENTILATORY SUPPORT	36450
CM0838-II : PYOGENIC /TB /VIRAL/ FUNGAL -MENINGITIS/ MENINGOENCEPHALITIS - WITH VENTILATORY SUPPORT	36450
CM0839-I : NEURO TUBERCULOSIS/NEUROCYSTICERCOSIS/ TUBERCULOMA	8748
CM0839-II : NEURO TUBERCULOSIS/NEUROCYSTICERCOSIS/ TUBERCULOMA	8748
CM0840 A : IDIPOPATHIC THROMBOCYTOPENIC PURPURA	29160
CM0840 B : TTP	43740
CM0841 A : ANY COAGULATION DISORDERS	36450
CM0841 B : DIC	18225
CM0843A : MULTI SYSTEM ORGAN FAILURE- ARDS WITHOUT DIC(BLOOD PRODUCTS)	66087
CM0843B : MULTI SYSTEM ORGAN FAILURE- ARDS WITH DIC(BLOOD PRODUCTS)	90387
CM0844 : ENTERIC ENCEPHALOPATHY	14740
CM0845 : LEPTOSPIROSIS WITH HEPATIC INVOLVEMENT	14507
CM0846 : SUBMERSION INJURY WITH VENTILATORY SUPPORT	19683
CM0847 : ARDS WITH VENTILATORY SUPPORT	61272
CM0848-I : RESPIRATORY FAILURE OF ANY CAUSE REQUIRING HIGH FREQUENCY VENTILATION	40970
CM0848-II : RESPIRATORY FAILURE OF ANY CAUSE REQUIRING HIGH FREQUENCY VENTILATION	40970
CM0848-III : RESPIRATORY FAILURE OF ANY CAUSE REQUIRING HIGH FREQUENCY VENTILATION	40970
CM0851A-I : CHEST WALL RESECTION WITHOUT RECONSTRUCTION	29051
CM0851A-II : CHEST WALL RESECTION WITHOUT RECONSTRUCTION	29051
CM0851B-I : CHEST WALL RESECTION WITH RECONSTRUCTION	38163
CM0851B-II : CHEST WALL RESECTION WITH RECONSTRUCTION	38163
CM0854 A-I : ORCHIDECTOMY /HIGH ORCHIDECTOMY U/L	8748
CM0854 A-II : ORCHIDECTOMY /HIGH ORCHIDECTOMY U/L	8748
CM0854 A-III : ORCHIDECTOMY /HIGH ORCHIDECTOMY U/L	8748
CM0855 B-I : ORCHIDECTOMY /HIGH ORCHIDECTOMY B/L	10935
CM0855 B-II : ORCHIDECTOMY /HIGH ORCHIDECTOMY B/L	10935
CM0855 C : LAPAROSCOPIC VARICOCELE LIGATION (PAEDIATRIC)	18225
CM0856 : ANEURYSM CLIPPING	71041
CM0857 : SURGERY OF CORD TUMORS - INTRA MEDULLARY TUMORS	42843
CM0858 : SURGERY OF CORD TUMORS -INTRADURAL EXTRAMEDULLARY TUMOR	33366
CM0859 : SURGERY OF CORD TUMORS - EXTRADURAL TUMOR	33366
CM0860 : SPILT CORD MALFORMATIONS - ANY TYPE(INCLUDES SPINA BIFIDA MAJOR/MINOR)	18990
CM0861-I : POSTERIOR DISCECTOMY WITH OR WITHOUT BONE GRAFT/SPACER/IMPLANT/VERTEBROPLASTY ( FOR CERVICAL COMPRESSIVE MYELOPATHY/ AT ANY LEVELS)	31456
CM0861-II : POSTERIOR DISCECTOMY WITH OR WITHOUT BONE GRAFT/SPACER/IMPLANT/VERTEBROPLASTY ( FOR CERVICAL COMPRESSIVE MYELOPATHY/ AT ANY LEVELS)	31456
CM0862 : ANTERIOR DISCECTOMY (WITH OR WITHOUT BONE GRAFTING/SPACER/IMPLANT/VETEBROPLASTY ) ANY LEVEL	31456
CM0863 : ANTERIOR CERVICAL SPINE SURGERY WITH FUSION	29196
CM0864 : ANTERIOR LATERAL DECOMPRESSION/STABILSIATION	17532
CM0865-I : LAMINECTOMY AT ANY LEVEL - (INCLUDING LUMBAR LAMINECTOMY FOR LUMBAR CANAL STENOSIS)- MICROLUMBAR	25551
CM0865-II : LAMINECTOMY AT ANY LEVEL - (INCLUDING LUMBAR LAMINECTOMY FOR LUMBAR CANAL STENOSIS)- MICROLUMBAR	25551
CM0866-I : LAMINECTOMY AT ANY LEVEL - (INCLUDING LUMBAR LAMINECTOMY FOR LUMBAR CANAL STENOSIS)- CONVENTIONAL	18261
CM0866-II : LAMINECTOMY AT ANY LEVEL - (INCLUDING LUMBAR LAMINECTOMY FOR LUMBAR CANAL STENOSIS)- CONVENTIONAL	18261
CM0867 : SPINAL FUSION PROCEDURE	31019
CM0868 : TRANS SPHENOIDAL SURGERY (SELLAR/SUPRASELLAR/SKULL BASAL LESION)	58298
CM0869 : TRANS ORAL SURGERY	18385
CM0870 : C.V. JUNCTION FUSION	28978
CM0871 : SYRINGOMYELIA	44287
CM0872 : CORPECTOMY (ANTERIOR /ANTEROLATERAL) AT ALL SPINAL LEVELS	32841
CM0873 : SPINAL FIXATION RODS ,SCREWS,PLATES, ARTIFICIAL DISCS	43776
CM0877 : CAROTID ENDARTERECTOMY	41006
CM0878-I : PELVIC FLOOR RECONSTRUCTION WITH MESH	22417
CM0878-II : PELVIC FLOOR RECONSTRUCTION WITH MESH	22417
CM0879-I : LAPAROSCOPIC / LAPROTOMY - ECTOPIC RESECTION	15564
CM0879-II : LAPAROSCOPIC / LAPROTOMY - ECTOPIC RESECTION	15564
CM0880 : LAPAROSCOPIC ADHESOLYSIS	14616
CM0881 A-I : THALASSEMIA MAJOR /HAEMOGLOBINOPATHIES/ CHELATION THERAPY	87480
CM0881 B-I : SICKLE CELL ANAEMIA	3645
CM0882-I : INTERSTITAL LUNG DISEASE	21360
CM0882-II : INTERSTITAL LUNG DISEASE	21360
CM0883-I : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - BANDING	7436
CM0883-II : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - BANDING	7436
CM0884-I : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - SCLEROTHERAPY	5540
CM0884-II : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - SCLEROTHERAPY	5540
CM0885-I : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - DEVASCULARISATION	29160
CM0885-II : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - DEVASCULARISATION	29160
CM0886-I : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - GLUE INJECTION	5540
CM0886-II : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - GLUE INJECTION	5540
CM0887-I : END STAGE RENAL DISEASE	10315
CM0887-II : END STAGE RENAL DISEASE	10315
CM0888-I : GULLAIN BARRE SYNDROME	72900
CM0888-II : GULLAIN BARRE SYNDROME	72900
CM0889-I : OPTIC NEURITIS	7290
CM0889-II : OPTIC NEURITIS	7290
CM0891-I : MYASTHENIA GRAVIS	10935
CM0891-II : MYASTHENIA GRAVIS	10935
CM0892 : MANAGEMENT OF COMA	21928
CM0893 : CAVERNOUS SINUS THROMBOSIS	18225
CM0894 : RHINOCEREBRAL MUCORMYCOSIS	21870
CM0895 : HYPER OSMOLAR NON-KETOTIC COMA	21870
CM0896 : OPERATION FOR HYDATID CYST OF LIVER	25515
CM0897-I : HEPATO CELLULAR CARCINOMA (ADVANCED) RADIO FREQUENCY ABLATION	21688
CM0897-II : HEPATO CELLULAR CARCINOMA (ADVANCED) RADIO FREQUENCY ABLATION	21688
CM0898 : COLONIC PULL THOROUGH /COLOPLASTY/ ABDOMINAL RESECTION	36450
CM0899-I : OESOPHAGECTOMY ANY TYPE INCLUDING (TRANS HIATAL / TRANS THORACIC WITH GASTRIC PULL UP)	47385
CM0899-II : OESOPHAGECTOMY ANY TYPE INCLUDING (TRANS HIATAL / TRANS THORACIC WITH GASTRIC PULL UP)	47385
CM0900 : OESOPHAGO- GASTRECTOMY	58320
CM0901 : ACHALASIA CARDIA -SURGICAL CORRECTION	21870
CM0902-I : ACHALASIA CARDIA - LAP SURGICAL CORRECTION ( INCLUDING HELLERS MYOTOMY)	21870
CM0902-II : ACHALASIA CARDIA - LAP SURGICAL CORRECTION ( INCLUDING HELLERS MYOTOMY)	21870
CM0903 : ACHALASIA CARDIA -PNEUMATIC DILATATION	7618
CM0904 : LAP FUNDOPLICATIONS	32805
CM0905-I : CYST EXCISION WITH OR WITHOUT HEPATIC JEJUNOSTOMY/ BILIARY DRAINAGE	32805
CM0905-II : CYST EXCISION WITH OR WITHOUT HEPATIC JEJUNOSTOMY/ BILIARY DRAINAGE	32805
CM0907 : ENUCLEATION OF CYST	29160
CM0908A-I : OTHER BYPASS PANCREAS	29160
CM0908A-II : OTHER BYPASS PANCREAS	29160
CM0908B-I : TRIPLE BYPASS	29160
CM0908B-II : TRIPLE BYPASS	29160
CM0910 : PANCREATIC NECROSECTOMY OPEN	30618
CM0911 : PANCREATIC NECROSECTOMY LAP	30618
CM0913 : SCLEROSING CHOLANGITIS	7290
CM0914 : DIAPHRAGMATIC EVENTERATION	29160
CM0915 : THORACOTOMY/EXPLORATIVE THOROCOTOMY/ THORACO ABDOMINAL APPROACH	18225
CM0916 : AV FISTULA ( INCLUDING PRE TRANSPLANTATION )	6926
CM0917 : COMPLEX AV ACCESS WITH GRAFT FOR HEMODIALYSIS	20777
CM0918 A : URETEROSCOPY AND DJ STENTING U/L	4374
CM0918 B : URETEROSCOPY AND DJ STENTING B/L	6561
CM0919 : URETEROSCOPY AND DJ STENT REMOVAL	2187
CM0920 : TRANSURETHRAL RESECTION OF BLADDER TUMOR /RE-TURBT	21870
CM0921A : EPIGASTRIC HERNIA / ABDOMINAL /UMBILICAL / FEMORAL HERNIA-WITHOUT MESH - OPEN	10935
CM0921B : HIATUS HERNIA REPAIR ABDOMINAL - WITHOUT MESH - OPEN	25515
CM0921C : VENTRAL AND SCAR /SPIGELIAN/OBTURATOR/SCIATIC- WITHOUT MESH - OPEN	11664
CM0921D : EPIGASTRIC HERNIA/UMBILICAL HERNIA - WITH MESH - OPEN	14580
CM0921E : HIATUS HERNIA REPAIR ABDOMINAL - WITH MESH - OPEN	29160
CM0921F : VENTRAL AND SCAR / FEMORAL /SPIGELIAN/OBTURATOR/SCIATIC WITH MESH - OPEN	14580
CM0922A : EPIGASTRIC HERNIA / ABDOMINAL /UMBILICAL / FEMORAL HERNIA-WITHOUT MESH - LAP	10935
CM0922B : HIATUS HERNIA REPAIR ABDOMINAL - WITHOUT MESH - LAP	25515
CM0922C : VENTRAL AND SCAR /SPIGELIAN/OBTURATOR/SCIATIC- WITHOUT MESH - LAP	11664
CM0922D : EPIGASTRIC HERNIA/UMBILICAL HERNIA - WITH MESH - LAP	14580
CM0922E : HIATUS HERNIA REPAIR ABDOMINAL - WITH MESH - LAP	29160
CM0922F : VENTRAL AND SCAR / FEMORAL /SPIGELIAN/OBTURATOR/SCIATIC WITH MESH - LAP	14580
CM0924 : APPENDICULAR PERFORATION	10935
CM0925A : VAGOTOMY ANY TYPE WITHOUT DRAINAGE PROCEDURES	18225
CM0925B : VAGOTOMY ANY TYPE WITH DRAINAGE PROCEDURES	29160
CM0926 : OPERATION FOR BLEEDING PEPTIC ULCER	29160
CM0927 : PYLOROMYOTOMY	16038
CM0928 : OPERATIONS FOR RECURRENT INTESTINAL OBSTRUCTION (NOBLE PLICATION /OTHER)	25515
CM0929 : OPERATION FOR ACUTE INTESTINAL PERFORATION / PERFORATION PERITONITIS (INTESTINAL/GASTRIC/BILIARY)/ DUODENAL PERFORATION	21870
CM0930 : OPERATION FOR ACUTE INTESTINAL OBSTRUCTION (INCLUDING VOLVULUS / MALROTATION/INTUSUSCEPTION)	29160
CM0931-I : INVESTIGATION AND MANAGEMENT CHRONIC HEPATITIS B / C	158697
CM0931-II : INVESTIGATION AND MANAGEMENT CHRONIC HEPATITIS B / C	158697
CM0932-I : CIRRHOSIS OF LIVER WITH COMPLICATIONS	21928
CM0932-II : CIRRHOSIS OF LIVER WITH COMPLICATIONS	21928
CM0933-I : TRACHEAL RESECTION WITH RECONSTRUCTION	29065
CM0933-II : TRACHEAL RESECTION WITH RECONSTRUCTION	29065
CM0934-I : TRACHEAL RESECTION WITHOUT RECONSTRUCTION	18859
CM0934-II : TRACHEAL RESECTION WITHOUT RECONSTRUCTION	18859
CM0935 : STAY IN GENERAL WARD - OBSERVATION FOR TRAUMA - PER DAY	510
CM0936 B : STAY IN ICU - MILD WITHOUT VENTILATION (FOR TRAUMA)	729
CM0936 C : STAY IN ICU - MODERATE WITHOUT VENTILATION (FOR TRAUMA)	10935
CM0936 D : STAY IN ICU - MODERATE WITH VENTILATION (FOR TRAUMA)	18225
CM0936 E : STAY IN ICU - SEVERE WITHOUT VENTILATION (FOR TRAUMA / POST OP COMPLICATIONS - Sepsis / coma)	18225
CM0936 F : STAY IN ICU - SEVERE WITH VENTILATION (FOR TRAUMA / POST OP COMPLICATIONS - Sepsis / Coma)	36450
CM0937 A : PYELOLITHOTOMY - OPEN	18225
CM0937 B : PYELOLITHOTOMY - LAP	18225
CM0938 A : NEPHROLITHOTOMY - OPEN	18225
CM0938 B : NEPHROLITHOTOMY - LAP	18225
CM0939 : OPEN CYSTOLITHOTOMY	10206
CM0940 A : URETEROLITHOTOMY - OPEN	14580
CM0940 B : URETEROLITHOTOMY - LAP	14580
CM0941 A : VESICOLITHOTOMY - OPEN	10206
CM0941 B : VESICOLITHOTOMY - LAP	10206
CM0942 : POSTERIOR FOSSA ENDOSCOPIC SURGERY	58320
CM0943 : ENDOSCOPIC RESECTION OF ANTERIOR SKULL BASE LESIONS	36428
CM0944-I : LARYNGOTRACHEAL/ TRACHEAL STENOSIS - POST CRICO TRACHEAL / POST TRAUMATIC (INTUBATION ) - RESECTION ANASTAMOSIS	21702
CM0944-II : LARYNGOTRACHEAL/ TRACHEAL STENOSIS - POST CRICO TRACHEAL / POST TRAUMATIC (INTUBATION ) - RESECTION ANASTAMOSIS	21702
CM0945-I : LARYNGOTRACHEAL/ TRACHEAL STENOSIS - POST CRICO TRACHEAL /POST TRAUMATIC (INTUBATION ) - STENTING	25347
CM0945-II : LARYNGOTRACHEAL/ TRACHEAL STENOSIS - POST CRICO TRACHEAL /POST TRAUMATIC (INTUBATION ) - STENTING	25347
CM0947 : SPINAL DEFORMITY STABILISATION/CORRECTION PROCEDURES /VERTERBROPLASTY	55222
CM0948 : SPINAL EPIDURAL ABSCESS/HEMATOMA - LAMINECTOMY / EVACUATION	19501
CM0951 A : TRANSVERSE MYELITIS WITH CENTRAL DEMYELINATION	72900
CM0951 B : TRANSVERSE MYELITIS WITHOUT CENTRAL DEMYELINATION	14580
CM0952A-I-i-a : Imatinib	1525
CM0952A-I-i-b : Nilotinib	17800
CM0952A-I-ii-a : Induction	12840
CM0952A-I-ii-b : Imatinib	1525
CM0952A-I-ii-c : Nilotinib	17800
CM0952A-I-iii-a : Daunorubicin (90mg/m2)+ Cytarabine	12320
CM0952A-I-iii-b : Daunorubicin + Cytarabine + Cladribine	10365
CM0952A-I-iii-c : Daunorubicin + Cytarabine (High Dose)	16725
CM0952A-I-iii-d : Daunorubicin (90mg) + Cytarabine	12320
CM0952A-I-iii-e : Idarubicin + Cytarabine (High Dose)	29600
CM0952A-I-iii-f : Idarubicin + Cytarabine	23240
CM0952A-I-iii-g : mitoxantrone + Cytarabine	10820
CM0952A-I-iii-h : Imatinib	1525
CM0952A-I-iii-i : Nilotinib	17800
CM0952A-I-iii-ii : Other Regimen	10000
CM0952A-I-iii-iii : Other Regimen	10000
CM0952A-II-a : Daunorubicin + Cytarabine 1	12320
CM0952A-II-b : Idarubicin + Cytarabine	23240
CM0952A-II-c : Daunorubicin + Cytarabine 2	10365
CM0952A-II-d : Daunorubicin + Cytarabine (High Dose)	16725
CM0952A-II-e : Idarubicin + Cytarabine (High Dose)	29600
CM0952A-II-f : Daunorubicin (90mg) + Cytarabine	12320
CM0952A-II-g : idarubicin + Cytarabine	23240
CM0952A-II-h : mitoxantrone + Cytarabine	10280
CM0952A-II-i : Cytarabine	6800
CM0952A-II-j : Decitabine	25000
CM0952A-II-k : azacytidine	77500
CM0952A-II-l : Hydroxyurea	1600
CM0952A-II-m : Cytarabine - High Dose	9720
CM0952A-II-n : Cladribine + Cytarabine + Idarubicin + Gcsf	85150
CM0952A-II-o : Cladribine + Cytarabine + Mitoxantrone + Gcsf	40690
CM0952A-II-p : Fludarabine + Cytarabine + Idarubicin + Gcsf	66710
CM0952A-II-q : Etoposide +Cytarabine+Mitoxantrone	13260
CM0952A-II-r : Cytarabine SC	2800
CM0952A-II-s : azacytidine	77500
CM0952A-II-t : Decitabine	25500
CM0952A-II-u : Other Regimen	10000
CM0952A-III-a-i : Rituximab + chlorambucil Cycle 1	1084
CM0952A-III-a-ii : Rituximab + chlorambucil Cycle 3	25584
CM0952A-III-a-iii : Rituximab + chlorambucil Cycle 4-8	32984
CM0952A-III-a-iv : Maintanance - Rituximab	25500
CM0952A-III-b : Rituximab Day 1, 8, 15, and 22:	100500
CM0952A-III-c : Chlorambucil	2344
CM0952A-III-d-i : Bendamustine + Rituximab (Cycle -1)	36500
CM0952A-III-d-ii : Bendamustine + Rituximab (Cycles 2-6)	37900
CM0952A-III-d-iii : Bendamustine (70mg) (Cycle -1)	12500
CM0952A-III-d-iv : Bendamustine (90 mg) (Cycles 2-6)	6500
CM0952A-III-e : Fludarabine + cyclophosphamide + rituximab (FCR)	31898
CM0952A-III-f : Fludarabine + rituximab (FR)	67930
CM0952A-III-g : Alemtuzumab + rituximab	108950
CM0952A-III-h : Alemtuzumab without rituximab	11450
CM0952A-III-i : High-dose methylprednisolone + rituximab	103955
CM0952A-III-j : High-dose methylprednisolone	6455
CM0952A-III-k : Other Regimen	10000
CM0952A-IV-i-a-1 : Childrens Oncology Group (COG) AALL-0031 INDUCTION PHASE	13340
CM0952A-IV-i-a-2 : Childrens Oncology Group (COG) AALL-0031 CONSOLIDATION PHASE - BLOCK 1	17095
CM0952A-IV-i-a-3 : Childrens Oncology Group (COG) AALL-0031 CONSOLIDATION PHASE - BLOCK 2	19175
CM0952A-IV-i-a-4 : Childrens Oncology Group (COG) AALL-0031 REINDUCTION	25291
CM0952A-IV-i-a-5 : Childrens Oncology Group (COG) AALL-0031 INTENSIFICATION	41425
CM0952A-IV-i-a-6 : Childrens Oncology Group (COG) AALL-0031 MAINTENANCE Cycles 1-4 (8 weeks)	35621
CM0952A-IV-i-a-7 : Childrens Oncology Group (COG) AALL-0031 MAINTENANCE Cycles 5-12 (8 weeks)	12836
CM0952A-IV-i-b-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3)	59429
CM0952A-IV-i-b-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4)	62380
CM0952A-IV-i-b-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7)	11469
CM0952A-IV-i-b-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8)	13420
CM0952A-IV-i-b-5 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction II	15133
CM0952A-IV-i-b-6 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction III	5535
CM0952A-IV-i-b-7 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Maintenance	9923
CM0952A-IV-i-c-1 : Multiagent Chemotherapy + TKIs INDUCTION PHASE	15133
CM0952A-IV-i-c-2 : Multiagent Chemotherapy + TKIs CONSOLIDATION I	8460
CM0952A-IV-i-c-3 : Multiagent Chemotherapy + TKIs CONSOLIDATION II	3700
CM0952A-IV-i-c-4 : Multiagent Chemotherapy + TKIs MAINTENANCE	3410
CM0952A-IV-i-c-5 : Imatinib	1525
CM0952A-IV-i-c-6 : Nilotinib	17800
CM0952A-IV-i-d : Other Regimen	10000
CM0952A-IV-ii-a-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3)	59429
CM0952A-IV-ii-a-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4)	62380
CM0952A-IV-ii-a-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7)	11469
CM0952A-IV-ii-a-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8)	13420
CM0952A-IV-ii-a-5 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction II	15133
CM0952A-IV-ii-a-6 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Induction III	5535
CM0952A-IV-ii-a-7 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) Maintenance	9923
CM0952A-IV-ii-b-1 : Multiagent Chemotherapy + TKIs INDUCTION PHASE	15573
CM0952A-IV-ii-b-2 : Multiagent Chemotherapy + TKIs CONSOLIDATION I	12110
CM0952A-IV-ii-b-3 : Multiagent Chemotherapy + TKIs CONSOLIDATION II	3200
CM0952A-IV-ii-b-4 : Multiagent Chemotherapy + TKIs MAINTENANCE	6410
CM0952A-IV-ii-b-5 : Imatinib	1525
CM0952A-IV-ii-b-6 : Nilotinib	17800
CM0952A-IV-ii-c : Corticosteroids + TKIs	9035
CM0952A-IV-ii-d : Other Regimen	10000
CM0952A-IV-iii-a-1 : GRAALL-2003 INDUCTION	15678
CM0952A-IV-iii-a-2 : GRAALL-2003 SALVAGE	28760
CM0952A-IV-iii-a-3 : GRAALL-2003 CONSOLIDATION	30779
CM0952A-IV-iii-a-4 : GRAALL-2003 Late intensification between consolidation blocks 6 and 7 (for patients in complete remission [CR] after the first induction course)	15495
CM0952A-IV-iii-a-5 : GRAALL-2003 Late intensification between consolidation blocks 6 and 7 (for patients in CR after salvage course)	27210
CM0952A-IV-iii-a-6 : GRAALL-2003 Maintenance	56898
CM0952A-IV-iii-b : CNS Therapy-Treatment of patients with initial CNS involvement:	21155
CM0952A-IV-iii-v : CCG-1961	18310
CM0952A-IV-iii-vi : Other Regimen	10000
CM0952A-IV-iv-a-1 : CALGB 8811 (Larson Regimen) INDUCTION	18038
CM0952A-IV-iv-a-2 : CALGB 8811 (Larson Regimen) CONSOLIDATION	16685
CM0952A-IV-iv-b-1 : Hyper-CVAD with or without Rituximab CYCLE 1,3,5,7	60970
CM0952A-IV-iv-b-2 : Hyper-CVAD with or without Rituximab CYCLE 2,4,6,8	56820
CM0952A-IV-iii-c : Other Regimen	10000
CM0952-ii : Surgery for All Leukemias - Utilise Surgical Oncology Package if unavailable maximum payable	36450
CM0953A-I-a : ABVD	4480
CM0953A-I-b : Escalated BEACOPP	7119
CM0953A-I-c : ABVD + Rituximab (cyled every 4 weeks)	28480
CM0953A-I-d-i : ABVD + Rituximab (1 cycle - weekly rituximab 4 doses) followed by ABVD	102480
CM0953A-I-d-ii : ABVD	4480
CM0953A-I-e-i : CHOP + Rituximab	26818
CM0953A-I-e-ii : CHOP	2818
CM0953A-I-f-i : CVP +/- Rituximab	25768
CM0953A-I-f-ii : CVP	1768
CM0953A-I-g : Rituximab	25500
CM0953A-I-h : Other Regimen	10000
CM0953A-II-a : Bortezomib + dexamethasone	68038
CM0953A-II-b : Cyclophosphamide + doxorubicin + vincristine + prednisone + rituximab	26818
CM0953A-II-c : Rituximab	25500
CM0953A-II-d : Rituximab + cyclophosphamide + prednisone	25738
CM0953A-II-e : Rituximab + cyclophosphamide + dexamethasone	25520
CM0953A-II-f-i : Thalidomide with or without rituximab (Weeks 1 and 2)	2540
CM0953A-II-f-ii : Thalidomide with or without rituximab (Weeks 3-50)	6000
CM0953A-II-f-iii : Thalidomide with or without rituximab (Weeks 50-52)	6000
CM0953A-II-f-iv : Thalidomide with or without rituximab Weeks 2-5 and 13-16	24000
CM0953A-II-g-i : Bendamustine with or without rituximab	36500
CM0953A-II-g-ii : Bendamustine - rituximab	12500
CM0953A-II-h-i : Cladribine with or without rituximab	32250
CM0953A-II-h-ii : Cladribine - rituximab	8250
CM0953A-II-i : Bendamustine	12500
CM0953A-II-j : Chlorambucil	1126
CM0953A-II-k : Fludarabine	12030
CM0953A-II-l : Fludarabine + cyclophosphamide + rituximab (FCR)	32398
CM0953A-II-m : Alemtuzumab	2650
CM0953A-II-n : Other Regimen	10000
CM0953A-III-i-a -1 : CALGB 10002 Cycle 1:	8967
CM0953A-III-i-a-2 : CALGB 10002 Cycles 2 (beginning Day 8), 4, and 6:	66113
CM0953A-III-i-a-3 : CALGB 10002 Cycles 3, 5, and 7:	33108
CM0953A-III-i-a-4 : CALGB 10002 Cycles 4, and 6:	36413
CM0953A-III-i-b : CODOX-M (original or modified) (cyclophosphamide + doxorubicin + vincristine with intrathecal MTX + cytarabine, followed by systemic MTX and cytarabine) with or without Rituximab	46780
CM0953A-III-i-c-1 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 1 & 2)	32972
CM0953A-III-i-c-2 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 3-6)	32572
CM0953A-III-i-d-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3)	59429
CM0953A-III-i-d-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4)	61880
CM0953A-III-i-d-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7)	10969
CM0953A-III-i-d-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8)	12920
CM0953A-III-i-e-1 : CODOX-M alternated with IVAC (CODOX-M) CODOX-M (original or modified) (cyclophosphamide + doxorubicin + vincristine, plus intrathecal MTX + cytarabine, followed by systemic MTX) alternating with IVAC (ifosfamide + cytarabine + etoposide) and intrathecal MTX with or without Rituximab	46780
CM0953A-III-i-e-2 : CODOX-M alternated with IVAC (IVAC) CODOX-M (original or modified) (cyclophosphamide + doxorubicin + vincristine, plus intrathecal MTX + cytarabine, followed by systemic MTX) alternating with IVAC (ifosfamide + cytarabine + etoposide) and intrathecal MTX with or without Rituximab	42847
CM0953A-III-i-f : RICE (rituximab + ifosfamide + carboplatin + etoposide)	32994
CM0953A-III-i-g : RIVAC (rituximab + ifosfamide + cytarabine + etoposide)	43894
CM0953A-III-i-h : RGDP (rituximab + gemcitabine + dexamethasone + cisplatin)	32255
CM0953A-III-i-i : HDAC + Rituximab	27800
CM0953A-III-i-ii : Other Regimen	10000
CM0953A-III-ii-a-1 : Zidovudine + alpha-interferon (induction)	4580
CM0953A-III-ii-a-2 : Zidovudine + alpha-interferon (Maintenance Therapy)	2100
CM0953A-III-ii-b : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP)	2818
CM0953A-III-ii-c : CHOEP	8640
CM0953A-III-ii-d : Dose-adjusted EPOCH(etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin)	6892
CM0953A-III-ii-e : Other Regimen	10000
CM0953A-III-iii-a : CDE (cyclophosphamide + doxorubicin + etoposide) + rituximab	2500
CM0953A-III-iii-b-1 : CODOX-M alternated with IVAC (CODOX-M) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine)	46780
CM0953A-III-iii-b-2 : CODOX-M alternated with IVAC (IVAC) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine)	42847
CM0953A-III-iii-c-1 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 1&2)	32972
CM0953A-III-iii-c-2 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 3-6)	32572
CM0953A-III-iii-d-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3)	59429
CM0953A-III-iii-d-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4)	61880
CM0953A-III-iii-d-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7)	10969
CM0953A-III-iii-d-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8)	12920
CM0953A-III-iii-e-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) Rituximab	26818
CM0953A-III-iii-e-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP)	2818
CM0953A-III-iii-f : Other Regimen	10000
CM0953A-III-iv-a : CDE (cyclophosphamide + doxorubicin + etoposide) + rituximab	2500
CM0953A-III-iv-b-1 : CODOX-M alternated with IVAC (CODOX-M) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine)	46780
CM0953A-III-iv-b-2 : CODOX-M alternated with IVAC (IVAC) CODOX-M/IVAC (modified) (cyclophosphamide + vincristine + doxorubicin + high-dose methotrexate alternating with ifosfamide + etoposide + high-dose cytarabine)	42847
CM0953A-III-iv-c-1 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 1&2)	32972
CM0953A-III-iv-c-2 : Dose-adjusted EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin) + intrathecal MTX + rituximab (Cycles 3-6)	32572
CM0953A-III-iv-d-1 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 1 and 3)	59429
CM0953A-III-iv-d-2 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 2 and 4)	61880
CM0953A-III-iv-d-3 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 5 & 7)	10969
CM0953A-III-iv-d-4 : HyperCVAD (cyclophosphamide + vincristine + doxorubicin + dexamethasone alternating with high-dose methotrexate and cytarabine) (Cycles 6 & 8)	12920
CM0953A-III-iv-e-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) with or without Rituximab	26818
CM0953A-III-iv-e-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP)	2818
CM0953A-III-iv-f : Other Regimen	10000
CM0953A-III-v-a-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) with or without Rituximab	26818
CM0953A-III-v-a-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP)	2818
CM0953A-III-v-b : Rituximab	25500
CM0953A-III-v-c : Other Regimen	10000
CM0953A-III-vi-a-1 : Bendamustine with or without rituximab	36500
CM0953A-III-vi-a-2 : Bendamustine (-) rituximab	12500
CM0953A-III-vi-b-1 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) with or without Rituximab	26818
CM0953A-III-vi-b-2 : Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP)	2818
CM0953A-III-vi-c : Cyclophosphamide + Vincristine + Prednisone + Rituximab (RCVP)	25768
CM0953A-III-vi-d : Rituximab	25500
CM0953A-III-vi-e : Lenalidomide + Rituximab	4940
CM0953A-III-vi-f : Other Regimen	10000
CM0953A-III-vii-a : SMILE	27483
CM0953A-III-vii-b : DeVIC +RT	9163
CM0953A-III-vii-c : VIPID	6619
CM0953A-III-vii-d : Other Regimen	10000
CM0953-ii : Surgery for All Lymphomas - Utilise Surgical Oncology Package if unavailable maximum payable	36450
CM0954-i-a : Lenalidomide	2575
CM0954-ii-a-1 : rHu-Epo with or without G-CSF	26080
CM0954-ii-a-2 : rHu-Epo (-) G-CSF	25750
CM0954-ii-b-1 : Darbepoetin alfa with or without G-CSF	9330
CM0954-ii-b-2 : Darbepoetin alfa (-) G-CSF	9000
CM0954-iii-a-1 : Decitabine (15mg/m2)	15500
CM0954-iii-a-2 : Decitabine (20mg/m2)	16500
CM0954-iii-b : Lenalidomide	2575
CM0955-a : Lenalidomide (28 days) + Dexamethasone	6817
CM0955-b : Lenalidomide (21 days) + Dexamethasone	5004
CM0955-c : Lenalidomide	2575
CM0955-d : Bendamustine + Lenalidomide + Dexamethasone	13639
CM0955-e : Bendamustine	22000
CM0955-f : Cyclophosphamide + Lenalidomide + Dexamethasone	5136
CM0955-g : Dexamethasone + Cyclophosphamide + Etoposide + Cisplatin (DCEP)	5764
CM0955-h : Dexamethasone + Thalidomide + Cisplatin + Doxorubicin + Cyclophosphamide + Etoposide (DT-PACE)	7724
CM0955-i : High-dose Cyclophosphamide	5140
CM0955-j : VAD / VAMP	6104
CM0955-k : Melphalan	3900
CM0955-l : Melphalan + Prednisolone	1137
CM0955-m : Thalidomide + Dexamethasone	2376
CM0955-n : Melphalan / Prednisolone/Thalidomide(MPT)	2257
CM0958 : BUDD CHIARI SYNDROME	11372
CM0959 : CYSTIC FIBROSIS	26681
CM0960 : SEPTIC SHOCK (ICU MANAGEMENT)	31383
CM0962-I : NEPHROTIC SYNDROME	11733
CM0962-II : NEPHROTIC SYNDROME	11733
CM0963-I : NEPHROTIC SYNDROME WITH COMPLICATIONS	18950
CM0963-II : NEPHROTIC SYNDROME WITH COMPLICATIONS	18950
CM0964-I : ACUTE DISSEMINATED ENCEPHALOMYELITIS	36450
CM0964-II : ACUTE DISSEMINATED ENCEPHALOMYELITIS	36450
CM0965 : MULTIPLE SCLEROSIS (INCLUDING RELAPSE)	10935
CM0966A : PLEURAL BIOPSY OPEN	17350
CM0966B : PLEURAL BIOPSY VATS	22818
CM0967-I : TOXIC/DRUG INDUCED LIVER INJURY	19537
CM0967-II : TOXIC/DRUG INDUCED LIVER INJURY	19537
CM0968 : MALIGNANT ASCITES	4119
CM0970 : SLEEVE RESECTION CA EAR	14216
CM0971 : SLEEVE RESECTION CA LUNG	17642
CM0973 : ENDOSCOPIC PARATHYROIDECTOMY	21870
CM0974-II : IVC FILTER REMOVAL	22125
CM0975A : IJV CATHETER INSERTION WITHOUT DIALYSIS	7290
CM0975B : IJV CATHETER INSERTION - INCLUDING DIALYSIS	9477
CM0976A : CT / C-ARM GUIDED DISC OZONE NUCLEOLYSIS (CERVICAL / THORACIC / LUMBAR DISC)	11482
CM0976B : USG GUIDED DISC OZONE NUCLEOLYSIS (CERVICAL / THORACIC / LUMBAR DISC)	7108
CM0978 : C-ARM GUIDED INTRA ARTICULAR INJECTIONS (SHOULDER / ELBOW / WRIST / HIP / KNEE / ANKLE / JOINTS OF FOOT AND HAND	11482
CM0979-I : CHEMO EMBOLIZATION FOR LIVER TUMORS USING DRUG AND PVA OR DC BEADS	51577
CM0980-I : TRANS JUGULAR INTRAHEPATIC PORTO SYSTEMIC SHUNT (TIPSS)	95681
CM0982 : OP /ANY POISIONING - CONSERVATIVE MANAGEMENT OR WITHOUT VENTILATORY SUPPORT (ONLY WITH FIR )	13122
CM0983 : MAXILLECTOMY WITH ORBITAL EXENTERATION	25041
CM0984 : MAXILLECTOMY WITH SKULL BASE RESECTION	27520
CM0986A : POSTERIOR DECOMPRESSION WITHOUT STABILISATION AT ANY LEVEL (2 -3 levels)	18225
CM0986B : POSTERIOR DECOMPRESSION WITH STABILISATION AT ANY LEVEL (2 -3 levels)	32805
CM0987 : ACUTE SEVERE ASTHMA WITH VENTILATION	37325
CM0988 : CRITICAL CARE ICU MANAGEMENT ( RESPIRATORY DISTRESS/ METABOLIC COMA/MULTIORGAN DYSFUNCTION/SEPTIC SHOCK/OTHERS WITH VENTILATION	22050
CM0989A : CRITICAL CARE ICU MANAGEMENT -CRITICAL LIMB ISCHEMIA (heparinisation)	14580
CM0989B : CRITICAL CARE ICU MANAGEMENT -CRITICAL LIMB ISCHEMIA (SK)	18225
CM0989C : CRITICAL CARE ICU MANAGEMENT -CRITICAL LIMB ISCHEMIA (rTPA)	54675
FUP0001A : CORONARY BALLOON ANGIOPLASTY (PPCI) - First Qtr	1500
FUP0001B : CORONARY BALLOON ANGIOPLASTY (PPCI) - Next 3 Qtrs	1000
FUP0002A : PTCA WITH STENT - First Qtr	1500
FUP0002B : PTCA WITH STENT - Next 3 Qtrs	1000
FUP0004A : ASD DEVICE CLOSURE - First Qtr	1500
FUP0004B : ASD DEVICE CLOSURE - Next 3 Qtrs	1000
FUP0005A : VSD DEVICE CLOSURE - First Qtr	1500
FUP0005B : VSD DEVICE CLOSURE - Next 3 Qtrs	1000
FUP0006A : PDA STENTING - First Qtr	1500
FUP0006B : PDA STENTING - Next 3 Qtrs	1000
FUP0007A : DEVICE CLOSURE - First Qtr	1500
FUP0007B : DEVICE CLOSURE - Next 3 Qtrs	1000
FUP0008A : SINGLE COIL - First Qtr	1500
FUP0008B : SINGLE COIL - Next 3 Qtrs	1000
FUP0009A : MULTIPLE COILS - First Qtr	1500
FUP0009B : MULTIPLE COILS - Next 3 Qtrs	1000
FUP0010A : BALLOON VALVOTOMY(ALL VALVE) - First Qtr	1300
FUP0010B : BALLOON VALVOTOMY(ALL VALVE) - Next 3 Qtrs	750
FUP0011A : PERMANENT PACEMAKER IMPLANTATION (SINGLE / DUAL CHAMBER) - First Qtr	500
FUP0011B : PERMANENT PACEMAKER IMPLANTATION (SINGLE / DUAL CHAMBER) - Next 3 Qtrs	500
FUP0012A : TEMPORARY PACEMAKER IMPLANTATION - First Qtr	500
FUP0012B : TEMPORARY PACEMAKER IMPLANTATION - Next 3 Qtrs	500
FUP0013A : COARCTATION OF AORTA - WITH STENT - First Qtr	3000
FUP0013B : COARCTATION OF AORTA - WITH STENT - Next 3 Qtrs	1500
FUP0014A : COARCTATION OF AORTA - WITHOUT STENT - First Qtr	3000
FUP0014B : COARCTATION OF AORTA - WITHOUT STENT - Next 3 Qtrs	1500
FUP0016A : CORONARY BYPASS SURGERY - First Qtr	3000
FUP0016B : CORONARY BYPASS SURGERY - Next 3 Qtrs	1500
FUP0017A : CORONARY BYPASS SURGERY-POST ANGIOPLASTY - First Qtr	3000
FUP0017B : CORONARY BYPASS SURGERY-POST ANGIOPLASTY - Next 3 Qtrs	1500
FUP0018A : CABG WITH IABP PUMP - First Qtr	3000
FUP0018B : CABG WITH IABP PUMP - Next 3 Qtrs	1500
FUP0019A : CORONARY BYPASS SURGERY OFF PUMP WITH IABP - First Qtr	3000
FUP0019B : CORONARY BYPASS SURGERY OFF PUMP WITH IABP - Next 3 Qtrs	1500
FUP0020A : CABG OF PUMP WITHOUT IABP - First Qtr	3000
FUP0020B : CABG OF PUMP WITHOUT IABP - Next 3 Qtrs	1500
FUP0021A : CABG WITH ANEURYSMAL REPAIR - First Qtr	1300
FUP0021B : CABG WITH ANEURYSMAL REPAIR - Next 3 Qtrs	750
FUP0022A : CABG WITH VENTRICULAR RUPTURE REPAIR - First Qtr	1300
FUP0022B : CABG WITH VENTRICULAR RUPTURE REPAIR - Next 3 Qtrs	750
FUP0023A : CABG WITH VALVE REPLACEMENT WITH MECHANICAL VALVE - First Qtr	3000
FUP0023B : CABG WITH VALVE REPLACEMENT WITH MECHANICAL VALVE - Next 3 Qtrs	1500
FUP0024A : CABG WITH VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - First Qtr	3000
FUP0024B : CABG WITH VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - Next 3 Qtrs	1500
FUP0025A : SINGLE VALVE REPLACEMENT WITH MECHANICAL VALVE - First Qtr	3000
FUP0025B : SINGLE VALVE REPLACEMENT WITH MECHANICAL VALVE - Next 3 Qtrs	1500
FUP0026A : SINGLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - First Qtr	3000
FUP0026B : SINGLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - Next 3 Qtrs	1500
FUP0027A : DOUBLE VALVE REPLACEMENT WITH MECHANICAL VALVE - First Qtr	3000
FUP0027B : DOUBLE VALVE REPLACEMENT WITH MECHANICAL VALVE - Next 3 Qtrs	1500
FUP0028A : DOUBLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - First Qtr	3000
FUP0028B : DOUBLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - Next 3 Qtrs	1500
FUP0029A : TRIPLE VALVE REPLACEMENT WITH MECHANICAL VALVE - First Qtr	3000
FUP0029B : TRIPLE VALVE REPLACEMENT WITH MECHANICAL VALVE - Next 3 Qtrs	1500
FUP0030A : TRIPLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - First Qtr	3000
FUP0030B : TRIPLE VALVE REPLACEMENT WITH BIOPROSTHETIC VALVE - Next 3 Qtrs	1500
FUP0031A : COARCTATION-AORTA REPAIR WITH GRAFT - First Qtr	3000
FUP0031B : COARCTATION-AORTA REPAIR WITH GRAFT - Next 3 Qtrs	1500
FUP0032A : ANEURYSM RESECTION & GRAFTING - First Qtr	3000
FUP0032B : ANEURYSM RESECTION & GRAFTING - Next 3 Qtrs	1500
FUP0033A : INTRATHORACIC ANEURYSM -REQUIRING BYPASS (WITH GRAFT) - First Qtr	3000
FUP0033B : INTRATHORACIC ANEURYSM -REQUIRING BYPASS (WITH GRAFT) - Next 3 Qtrs	1500
FUP0034A : ANNULUS AORTIC ECTASIA WITH VALVED CONDUITS - First Qtr	1300
FUP0034B : ANNULUS AORTIC ECTASIA WITH VALVED CONDUITS - Next 3 Qtrs	750
FUP0035A : ARTERIAL SWITCH - First Qtr	1300
FUP0035B : ARTERIAL SWITCH - Next 3 Qtrs	750
FUP0036A : SENNINGS PROCEDURE - First Qtr	1300
FUP0036B : SENNINGS PROCEDURE - Next 3 Qtrs	750
FUP0037A : TOTAL CORRECTION OF TETRALOGY OF FALLOT - ANY TYPE - First Qtr	1300
FUP0037B : TOTAL CORRECTION OF TETRALOGY OF FALLOT - ANY TYPE - Next 3 Qtrs	750
FUP0038A : WITH SPECIAL CONDUITS - First Qtr	1300
FUP0038B : WITH SPECIAL CONDUITS - Next 3 Qtrs	750
FUP0039A : WITH PROSTHETIC RING - First Qtr	3000
FUP0039B : WITH PROSTHETIC RING - Next 3 Qtrs	1500
FUP0043A : PRIMARY ANGIOPLASTY FOR ACUTE MI +DRUG ELUTING STENT - First Qtr	1500
FUP0043B : PRIMARY ANGIOPLASTY FOR ACUTE MI +DRUG ELUTING STENT - Next 3 Qtrs	1000
FUP0045A : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS - First Qtr	600
FUP0045B : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS - Next 3 Qtrs	500
FUP0046A : OESOPHAGECTOMY WITH TWO FIELD LYMPADENECTOMY / THREE FIELD LYMPADENECTOMY - First Qtr	400
FUP0046B : OESOPHAGECTOMY WITH TWO FIELD LYMPADENECTOMY / THREE FIELD LYMPADENECTOMY - Next 3 Qtrs	400
FUP0047A : ALL - First Qtr	1000
FUP0047B : ALL - Next 3 Qtrs	750
FUP0048A : CML - First Qtr	1000
FUP0048B : CML - Next 3 Qtrs	750
FUP0049A : CLL - First Qtr	1000
FUP0049B : CLL - Next 3 Qtrs	750
FUP0050A : MYELODYSPLASTIC SYNDROME - First Qtr	1000
FUP0050B : MYELODYSPLASTIC SYNDROME - Next 3 Qtrs	750
FUP0051A : LYMPHOMA HODGKIN DISEASE - First Qtr	1000
FUP0051B : LYMPHOMA HODGKIN DISEASE - Next 3 Qtrs	750
FUP0052A : LYMPHOMA NON HODGKINS DISEASES - First Qtr	1000
FUP0052B : LYMPHOMA NON HODGKINS DISEASES - Next 3 Qtrs	750
FUP0053A : SPECIALIZED RADIATION THERAPY - 3DCRT PACKAGE ADJUVANT PACKAGE 28-33 FRACTIONS(INCLUDES AQUAPLAST MOULD, PLANNINGCT, COUNTOURING, RT PLANNING & EXECUTION) - First Qtr	2000
FUP0053B : SPECIALIZED RADIATION THERAPY - 3DCRT PACKAGE ADJUVANT PACKAGE 28-33 FRACTIONS(INCLUDES AQUAPLAST MOULD, PLANNINGCT, COUNTOURING, RT PLANNING & EXECUTION) - Next 3 Qtrs	1000
FUP0054A : SPECIALIZED RADIATION THERAPY 3D CRT- RADICAL PACKAGE 34-37 FRACTIONS - First Qtr	2000
FUP0054B : SPECIALIZED RADIATION THERAPY 3D CRT- RADICAL PACKAGE 34-37 FRACTIONS - Next 3 Qtrs	1000
FUP0055A : SPECIALIZED RADIATION THERAPY - IMRT ADJUVANT PACKAGE 28-33 FRACTIONS (INCLUDES AQUAPLAST MOULD,PLANNING CT FOR IMRT, CONTOURING, RT PLANNING, QA, EXECUTION) - First Qtr	2000
FUP0055B : SPECIALIZED RADIATION THERAPY - IMRT ADJUVANT PACKAGE 28-33 FRACTIONS (INCLUDES AQUAPLAST MOULD,PLANNING CT FOR IMRT, CONTOURING, RT PLANNING, QA, EXECUTION) - Next 3 Qtrs	1000
FUP0056A : SPECIALIZED RADIATION THERAPY - IMRT - RADICAL PACKAGE 34-40 FRACTIONS - First Qtr	2000
FUP0056B : SPECIALIZED RADIATION THERAPY - IMRT - RADICAL PACKAGE 34-40 FRACTIONS - Next 3 Qtrs	1000
FUP0057A : SPECIALIZED RADIATION THERAPY - IMRT WITH IGRT - First Qtr	2000
FUP0057B : SPECIALIZED RADIATION THERAPY - IMRT WITH IGRT - Next 3 Qtrs	1000
FUP0058A : SPECIALIZED RADIATION THERAPY - RAPID ARC THERAPY - First Qtr	2000
FUP0058B : SPECIALIZED RADIATION THERAPY - RAPID ARC THERAPY - Next 3 Qtrs	1000
FUP0059A : TOTAL BODY RADIATION - First Qtr	2000
FUP0059B : TOTAL BODY RADIATION - Next 3 Qtrs	1000
FUP0060A : UPTO-60% WITH SCALDS (CONSERVATIVE) - First Qtr	750
FUP0060B : UPTO-60% WITH SCALDS (CONSERVATIVE) - Next 3 Qtrs	500
FUP0061A : UP TO-60% MIXED BURNS (WITH SURGERIES) - First Qtr	750
FUP0061B : UP TO-60% MIXED BURNS (WITH SURGERIES) - Next 3 Qtrs	500
FUP0062A : ABOVE 60% MIXED BURNS (WITH SURGERIES) - First Qtr	750
FUP0062B : ABOVE 60% MIXED BURNS (WITH SURGERIES) - Next 3 Qtrs	500
FUP0063A : TOTAL ELBOW REPLACEMENT - First Qtr	500
FUP0063B : TOTAL ELBOW REPLACEMENT - Next 3 Qtrs	500
FUP0064A : SHOULDER REPLACEMENT - First Qtr	500
FUP0064B : SHOULDER REPLACEMENT - Next 3 Qtrs	500
FUP0065A : TOTAL HIP REPLACEMENT - First Qtr	500
FUP0065B : TOTAL HIP REPLACEMENT - Next 3 Qtrs	500
FUP0066A : REVISION HIP REPLACEMENT SURGERY (ONLY WITH SPECIFIC APPROVAL) - First Qtr	500
FUP0066B : REVISION HIP REPLACEMENT SURGERY (ONLY WITH SPECIFIC APPROVAL) - Next 3 Qtrs	500
FUP0067A : REVISION KNEE REPLACEMENT SURGERY ( ONLY WITH SPECIFIC APPROVAL) - First Qtr	500
FUP0067B : REVISION KNEE REPLACEMENT SURGERY ( ONLY WITH SPECIFIC APPROVAL) - Next 3 Qtrs	500
FUP0068A : TOTAL KNEE REPLACEMENT - First Qtr	500
FUP0068B : TOTAL KNEE REPLACEMENT - Next 3 Qtrs	500
FUP0069A : INBORN ERROR OF METABOLISM - First Qtr	3000
FUP0069B : INBORN ERROR OF METABOLISM - Next 3 Qtrs	1500
FUP0070A : PRIMARY IMMUNO DEFICIENCY DISORDERS - First Qtr	1500
FUP0070B : PRIMARY IMMUNO DEFICIENCY DISORDERS - Next 3 Qtrs	1000
FUP0071A : HYPOPLASTIC/APLASTIC ANEMIA (FANCONI ANEMIA) - First Qtr	900
FUP0071B : HYPOPLASTIC/APLASTIC ANEMIA (FANCONI ANEMIA) - Next 3 Qtrs	500
FUP0072A : PRETERM BABY RDS WITH OR WITHOUT SURFACTANT WITH MECHANICAL VENTILATION/CPAP - First Qtr	1250
FUP0072B : PRETERM BABY RDS WITH OR WITHOUT SURFACTANT WITH MECHANICAL VENTILATION/CPAP - Next 3 Qtrs	750
FUP0073A : TERM BABY-CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE/ WITH VENTILATION - First Qtr	1250
FUP0073B : TERM BABY-CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE/ WITH VENTILATION - Next 3 Qtrs	750
FUP0074A : TERM BABY - CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE/ WITHOUT VENTILATION - First Qtr	1250
FUP0074B : TERM BABY - CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE/ WITHOUT VENTILATION - Next 3 Qtrs	750
FUP0075A : ECMO-EXTRACORPOREAL MEMBRANE OXYGENATION - First Qtr	3000
FUP0075B : ECMO-EXTRACORPOREAL MEMBRANE OXYGENATION - Next 3 Qtrs	1500
FUP0076A : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - First Qtr	1800
FUP0076B : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - Next 3 Qtrs	1000
FUP0077A : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - First Qtr	1800
FUP0077B : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - Next 3 Qtrs	1000
FUP0078A : TUMORS (NEONATES/PAEDIATRIC) - First Qtr	500
FUP0078B : TUMORS (NEONATES/PAEDIATRIC) - Next 3 Qtrs	500
FUP0079A : CONGENITAL LUNG LESIONS (CLE, CCAM) - First Qtr	2000
FUP0079B : CONGENITAL LUNG LESIONS (CLE, CCAM) - Next 3 Qtrs	1000
FUP0080A : EXCISION OF BRAIN TUMORS - [PRIMARY /BENIGN ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDESSUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR/ SUPRATENTORIAL- FRONTAL/TEMPORAL /PARIETAL SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA) - First Qtr	2000
FUP0080B : EXCISION OF BRAIN TUMORS - [PRIMARY /BENIGN ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDESSUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR/ SUPRATENTORIAL- FRONTAL/TEMPORAL /PARIETAL SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA) - Next 3 Qtrs	1000
FUP0081A : EXCISION OF BRAIN TUMORS - [MALIGNANT ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDESSUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR/ SUPRATENTORIAL- FRONTAL/TEMPORAL /PARIETAL SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA) - First Qtr	2000
FUP0081B : EXCISION OF BRAIN TUMORS - [MALIGNANT ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDESSUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR/ SUPRATENTORIAL- FRONTAL/TEMPORAL /PARIETAL SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA) - Next 3 Qtrs	1000
FUP0082A : EXCISION OF BRAIN TUMORS - [SECONDARIES ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDESSUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR/ SUPRATENTORIAL- FRONTAL/TEMPORAL /PARIETAL SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA) - First Qtr	2000
FUP0082B : EXCISION OF BRAIN TUMORS - [SECONDARIES ) (BOTH INTRA AXIAL AND EXTRA AXIAL -INCLUDESSUBTENTORIAL- CP ANGLE BRAINSTEM/CEREBELLAR/ SUPRATENTORIAL- FRONTAL/TEMPORAL /PARIETAL SELLAR/SUPRASELLAR/CRANIOPHARYNGIOMA) - Next 3 Qtrs	1000
FUP0083A : ANEURYSM CLIPPING - First Qtr	2000
FUP0083B : ANEURYSM CLIPPING - Next 3 Qtrs	1000
FUP0084A : STEREOTACTIC PROCEDURES- SURGICAL PROCEDURE - First Qtr	2000
FUP0084B : STEREOTACTIC PROCEDURES- SURGICAL PROCEDURE - Next 3 Qtrs	1000
FUP0085A : TRANS SPHENOIDAL SURGERY (SELLAR/SUPRASELLAR/SKULL BASAL LESION) - First Qtr	2000
FUP0085B : TRANS SPHENOIDAL SURGERY (SELLAR/SUPRASELLAR/SKULL BASAL LESION) - Next 3 Qtrs	1000
FUP0086A : TRANS ORAL SURGERY - First Qtr	2000
FUP0086B : TRANS ORAL SURGERY - Next 3 Qtrs	1000
FUP0087A : PROSTHETIC VALVE THROMBOSIS- THROMBOLYSIS - First Qtr	1500
FUP0087B : PROSTHETIC VALVE THROMBOSIS- THROMBOLYSIS - Next 3 Qtrs	1000
FUP0088A : CORPECTOMY (ANTERIOR /ANTEROLATERAL) AT ALL SPINAL LEVELS - First Qtr	2000
FUP0088B : CORPECTOMY (ANTERIOR /ANTEROLATERAL) AT ALL SPINAL LEVELS - Next 3 Qtrs	1000
FUP0089A : SPINAL FIXATION RODS ,SCREWS,PLATES, ARTIFICIAL DISCS - First Qtr	2000
FUP0089B : SPINAL FIXATION RODS ,SCREWS,PLATES, ARTIFICIAL DISCS - Next 3 Qtrs	1000
FUP0090A : EMBOLISATION OF ANEURYSM/ ANEURYSM COILING BALLOON ASSISTED - First Qtr	2500
FUP0090B : EMBOLISATION OF ANEURYSM/ ANEURYSM COILING BALLOON ASSISTED - Next 3 Qtrs	1500
FUP0091A : DEEP BRAIN STIMULATION - First Qtr	3000
FUP0091B : DEEP BRAIN STIMULATION - Next 3 Qtrs	1500
FUP0092A : D V T - IVC FILTER - First Qtr	3500
FUP0092B : D V T - IVC FILTER - Next 3 Qtrs	1500
FUP0093A : AORTO-BIILIAC-BIFEOMRAL BYPASS WITH VEIN / SYNTHETIC GRAFT - First Qtr	3500
FUP0093B : AORTO-BIILIAC-BIFEOMRAL BYPASS WITH VEIN / SYNTHETIC GRAFT - Next 3 Qtrs	1500
FUP0094A : AXILLO BIFEMORAL BYPASS WITH SYNTHETIC GRAFT - First Qtr	3500
FUP0094B : AXILLO BIFEMORAL BYPASS WITH SYNTHETIC GRAFT - Next 3 Qtrs	1500
FUP0095A : CAROTID ARTERY BYPASS WITH SYNTHETIC GRAFT - First Qtr	3500
FUP0095B : CAROTID ARTERY BYPASS WITH SYNTHETIC GRAFT - Next 3 Qtrs	1500
FUP0096A : NECK VASCULAR INJURY - CAROTID VESSELS - First Qtr	3500
FUP0096B : NECK VASCULAR INJURY - CAROTID VESSELS - Next 3 Qtrs	1500
FUP0097A : ABDOMINAL VASCULAR INJURIES - AORTA, ILLAC ARTERIES, IVC, ILIAC VEINS - First Qtr	3500
FUP0097B : ABDOMINAL VASCULAR INJURIES - AORTA, ILLAC ARTERIES, IVC, ILIAC VEINS - Next 3 Qtrs	1500
FUP0098A : THORACIC VASCULAR INJURIES - First Qtr	3500
FUP0098B : THORACIC VASCULAR INJURIES - Next 3 Qtrs	1500
FUP0101A : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - First Qtr	1000
FUP0101B : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - Next 3 Qtrs	500
FUP0102A : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - First Qtr	2500
FUP0102B : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - Next 3 Qtrs	1000
FUP0103A : THALASSEMIA MAJOR/HAEMOGLOBINOPATHIES/ CHELATION THERAPY/SICKLE CELL ANAEMIA - First Qtr	2500
FUP0103B : THALASSEMIA MAJOR/HAEMOGLOBINOPATHIES/ CHELATION THERAPY/SICKLE CELL ANAEMIA - Next 3 Qtrs	2500
FUP0105A : ACUTE RESPIRATORY FAILURE (WITH VENTILATOR - FOR MINIMUM 5 DAYS ) - First Qtr	2500
FUP0105B : ACUTE RESPIRATORY FAILURE (WITH VENTILATOR - FOR MINIMUM 5 DAYS ) - Next 3 Qtrs	1000
FUP0106A : ACUTE PANCREATITIS - CONSERVATIVE MANAGEMENT / MILD / MODERATE / SEVERE MEDICAL / IMAGE GUIDED DRAINAGE OF PANCREATIC COLLECTIONS - First Qtr	2500
FUP0106B : ACUTE PANCREATITIS - CONSERVATIVE MANAGEMENT / MILD / MODERATE / SEVERE MEDICAL / IMAGE GUIDED DRAINAGE OF PANCREATIC COLLECTIONS - Next 3 Qtrs	1500
FUP0107A : ACUTE MI REQUIRING IABP PUMP - First Qtr	4000
FUP0107B : ACUTE MI REQUIRING IABP PUMP - Next 3 Qtrs	2000
FUP0108A : IMMUNOGLOBULIN THERAPY - HEREDITARY MOTOR SENSORY NEUROPATHIES/HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY/PLEXOPATHY (LUMBOSACRAL/ BRACHIAL)/PERIPHERAL NEUROPATHY (WITH NERVE BIOPSY) (HANSEN, NUTRITIONAL, TOXIC, INFECTIVE, IMMUNE)/CARPAL TUNNEL SYNDROME/ACUTE ENTRAPMENT/ COMPRESSIVE NEUROPATHY / GBS/DOG BITE CATEGORY III/OTHERS - First Qtr	4000
FUP0108B : IMMUNOGLOBULIN THERAPY - HEREDITARY MOTOR SENSORY NEUROPATHIES/HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY/PLEXOPATHY (LUMBOSACRAL/ BRACHIAL)/PERIPHERAL NEUROPATHY (WITH NERVE BIOPSY) (HANSEN, NUTRITIONAL, TOXIC, INFECTIVE, IMMUNE)/CARPAL TUNNEL SYNDROME/ACUTE ENTRAPMENT/ COMPRESSIVE NEUROPATHY / GBS/DOG BITE CATEGORY III/OTHERS - Next 3 Qtrs	2000
FUP0109A : GROWTH HORMONE FOR HYPOPITUTARISM - First Qtr	3500
FUP0109B : GROWTH HORMONE FOR HYPOPITUTARISM - Next 3 Qtrs	1500
FUP0110A : LIVER TRANSPLANTATION - First Qtr	45000
FUP0110B : LIVER TRANSPLANTATION - Next 3 Qtrs	35000
FUP0111A : RT. HEPATECTOMY/NON ANATOMICAL RESECTION OF LIVER - First Qtr	2200
FUP0111B : RT. HEPATECTOMY/NON ANATOMICAL RESECTION OF LIVER - Next 3 Qtrs	1200
FUP0112A : LT. HEPATECTOMY/NON ANATOMICAL RESECTION OF LIVER - First Qtr	2200
FUP0112B : LT. HEPATECTOMY/NON ANATOMICAL RESECTION OF LIVER - Next 3 Qtrs	1200
FUP0113A : PORTOCAVAL ANASTOMOSIS - First Qtr	4000
FUP0113B : PORTOCAVAL ANASTOMOSIS - Next 3 Qtrs	2000
FUP0114A : SLEEVE GASTRECTOMY FOR MORBID OBESITY - First Qtr	2500
FUP0114B : SLEEVE GASTRECTOMY FOR MORBID OBESITY - Next 3 Qtrs	1500
FUP0115A : ROUXEN Y GASTRIC BYPASS FOR MORBID OBESITY - First Qtr	2500
FUP0115B : ROUXEN Y GASTRIC BYPASS FOR MORBID OBESITY - Next 3 Qtrs	1500
FUP0116A : DEVASCULARISATION WITH OESOPHAGEAL TRANSECTION - First Qtr	5000
FUP0116B : DEVASCULARISATION WITH OESOPHAGEAL TRANSECTION - Next 3 Qtrs	1500
FUP0118A : THORACO ABDOMINAL ANEURYSM REPAIR WITH RENO / MESENTRIC REVASCULARISATION - First Qtr	2200
FUP0118B : THORACO ABDOMINAL ANEURYSM REPAIR WITH RENO / MESENTRIC REVASCULARISATION - Next 3 Qtrs	1000
FUP0119A : RENAL TRANSPLANTATION SURGERY INCLUDES --POST RENAL TRANSPLANT REJECTION A.STEROID RESISTANT B.STEROID SENSITIVE/ POST RENAL TRANSPLANT INFECTION - LIFE TREATENING TREATMENT FOR FUNGAL INFECTIONS ( LIPOSOMAL AMP -B OR EICHNOCANDINS) , - First Qtr	40000
FUP0119B : RENAL TRANSPLANTATION SURGERY INCLUDES --POST RENAL TRANSPLANT REJECTION A.STEROID RESISTANT B.STEROID SENSITIVE/ POST RENAL TRANSPLANT INFECTION - LIFE TREATENING TREATMENT FOR FUNGAL INFECTIONS ( LIPOSOMAL AMP -B OR EICHNOCANDINS) , - Next 3 Qtrs	33300
FUP0120A : INVESTIGATION AND MANAGEMENT CHRONIC HEPATITIS B / C - First Qtr	1500
FUP0120B : INVESTIGATION AND MANAGEMENT CHRONIC HEPATITIS B / C - Next 3 Qtrs	1500
FUP0121A : INFERIOR VENA CAVA STENTING SINGLE STENT - First Qtr	2000
FUP0121B : INFERIOR VENA CAVA STENTING SINGLE STENT - Next 3 Qtrs	1000
FUP0122A : ACUTE STROKE THROMBOLYSIS (R TPA ) - First Qtr	2000
FUP0122B : ACUTE STROKE THROMBOLYSIS (R TPA ) - Next 3 Qtrs	1000
FUP0123A : RENAL ARTERY EMBOLIZATION WITH MULTIPLE COILS AND MICRO CATHETER - First Qtr	2500
FUP0123B : RENAL ARTERY EMBOLIZATION WITH MULTIPLE COILS AND MICRO CATHETER - Next 3 Qtrs	1000
FUP0124A : CORTICAL VENOUS SINUS THROMBOLYSIS - First Qtr	2500
FUP0124B : CORTICAL VENOUS SINUS THROMBOLYSIS - Next 3 Qtrs	1000
FUP0125A : INFERIOR VENA CAVA FILTER PLACEMENT - First Qtr	3000
FUP0125B : INFERIOR VENA CAVA FILTER PLACEMENT - Next 3 Qtrs	1500
FUP0126A : SUBCLAVIAN, ILIAC, SUPERFICIAL FEMORAL ARTERY STENTING EACH WITH ONE STENT - First Qtr	2500
FUP0126B : SUBCLAVIAN, ILIAC, SUPERFICIAL FEMORAL ARTERY STENTING EACH WITH ONE STENT - Next 3 Qtrs	1200
FUP0127A : TIBIAL ANGIOPLASTY IN CRITICAL LIMB ISCHEMIA - First Qtr	2500
FUP0127B : TIBIAL ANGIOPLASTY IN CRITICAL LIMB ISCHEMIA - Next 3 Qtrs	1200
FUP0128A : MESENTERIC ARTERY ANGIOPLASTY & STENTING IN ACUTE & CHRONIC MESENTERIC ISCHEMIA - SINGLE STENT - First Qtr	2500
FUP0128B : MESENTERIC ARTERY ANGIOPLASTY & STENTING IN ACUTE & CHRONIC MESENTERIC ISCHEMIA - SINGLE STENT - Next 3 Qtrs	1200
FUP0129A : BILIARY DRAINAGE PROCEDURES/ERCP - EXTERNAL DRAINAGE AND STENT PLACEMENT - METALLIC BILIARY STENT / POST OP BILIARY STRICTURE/LEAK/CHOLANGITIS/BILIARY PANCREATITIS/CHOLEDOCHAL CYST/BILE DUCT STONES - First Qtr	2000
FUP0129B : BILIARY DRAINAGE PROCEDURES/ERCP - EXTERNAL DRAINAGE AND STENT PLACEMENT - METALLIC BILIARY STENT / POST OP BILIARY STRICTURE/LEAK/CHOLANGITIS/BILIARY PANCREATITIS/CHOLEDOCHAL CYST/BILE DUCT STONES - Next 3 Qtrs	1000
FUP0130A : INTRA-ARTERIAL THROMBOLYSIS FOR ACUTE ISCHEMIC LIMBS - First Qtr	2000
FUP0130B : INTRA-ARTERIAL THROMBOLYSIS FOR ACUTE ISCHEMIC LIMBS - Next 3 Qtrs	1000
FUP0131A : CENTRAL VENOUS STENTING FOR CENTRAL VENOUS OCCLUSION (BRACHIOCEPHALIC, SUBCLAVIAN VEIN AND SUP VENA CAVA) SINGLE METALLIC STENT - First Qtr	2500
FUP0131B : CENTRAL VENOUS STENTING FOR CENTRAL VENOUS OCCLUSION (BRACHIOCEPHALIC, SUBCLAVIAN VEIN AND SUP VENA CAVA) SINGLE METALLIC STENT - Next 3 Qtrs	1200
FUP0132A : ENDOVASCULAR INTERVENTION FOR SALVAGING HEMODIALYSIS AV FISTULA - First Qtr	2000
FUP0132B : ENDOVASCULAR INTERVENTION FOR SALVAGING HEMODIALYSIS AV FISTULA - Next 3 Qtrs	1000
FUP0133A : BALLOON RETROGRADE TRANSVENOUS OBLITERATION OF BLEEDING GASTRIC VARICES (BRTO) - First Qtr	3500
FUP0133B : BALLOON RETROGRADE TRANSVENOUS OBLITERATION OF BLEEDING GASTRIC VARICES (BRTO) - Next 3 Qtrs	1500
FUP0134A : PREOPERATIVE PORTAL VEIN EMBOLIZATION FOR LIVER TUMORS - First Qtr	2000
FUP0134B : PREOPERATIVE PORTAL VEIN EMBOLIZATION FOR LIVER TUMORS - Next 3 Qtrs	1000
FUP0135A : CHEMO EMBOLIZATION FOR LIVER TUMORS USING DRUG AND PVA OR DC BEADS - First Qtr	2000
FUP0135B : CHEMO EMBOLIZATION FOR LIVER TUMORS USING DRUG AND PVA OR DC BEADS - Next 3 Qtrs	1000
FUP0136A : TRANS JUGULAR INTRAHEPATIC PORTO SYSTEMIC SHUNT (TIPSS) - First Qtr	3500
FUP0136B : TRANS JUGULAR INTRAHEPATIC PORTO SYSTEMIC SHUNT (TIPSS) - Next 3 Qtrs	1500
FUP0137A : EMBOLIZATION OF PULMONARY AV MALFORMATION - First Qtr	2500
FUP0137B : EMBOLIZATION OF PULMONARY AV MALFORMATION - Next 3 Qtrs	1000
FUP0138A : PREOPERATIVE PROPHYLACTIC TUMOR EMBOLISATION - First Qtr	2000
FUP0138B : PREOPERATIVE PROPHYLACTIC TUMOR EMBOLISATION - Next 3 Qtrs	1000
FUP0139A : EMBOLIZATION OF AV MALFORMATION OF BRAIN PER SITTING WITH ONYX - First Qtr	6000
FUP0139B : EMBOLIZATION OF AV MALFORMATION OF BRAIN PER SITTING WITH ONYX - Next 3 Qtrs	1000
FUP0140A : CAROTID STENTING SINGLE STENT WITH EMBOLIC PROTECTION DEVICE - First Qtr	2000
FUP0140B : CAROTID STENTING SINGLE STENT WITH EMBOLIC PROTECTION DEVICE - Next 3 Qtrs	1000
FUP0141A : INTRACRANIAL VENOUS STENTING - First Qtr	6000
FUP0141B : INTRACRANIAL VENOUS STENTING - Next 3 Qtrs	1000
FUP0142A : INTRACRANIAL ARTERIAL STENTING - First Qtr	6000
FUP0142B : INTRACRANIAL ARTERIAL STENTING - Next 3 Qtrs	1000
FUP0143A : PERIPHERAL STENT GRAFT FOR PERIPHERAL ANEURYSMS AND AV FISTULA - First Qtr	2500
FUP0143B : PERIPHERAL STENT GRAFT FOR PERIPHERAL ANEURYSMS AND AV FISTULA - Next 3 Qtrs	1200
FUP0144A : EMBOLIZATION OF CARATICO-CAVERNOUS FISTULA - First Qtr	6000
FUP0144B : EMBOLIZATION OF CARATICO-CAVERNOUS FISTULA - Next 3 Qtrs	1000
FUP0145A : PLAIN SIMPLE COILING OF ANEURYSM - First Qtr	2500
FUP0145B : PLAIN SIMPLE COILING OF ANEURYSM - Next 3 Qtrs	1500
FUP0146A : ILIAC / IVC STENTING / HIGH END VASCULAR REVASCULARISATION PROCEDURE - First Qtr	2500
FUP0146B : ILIAC / IVC STENTING / HIGH END VASCULAR REVASCULARISATION PROCEDURE - Next 3 Qtrs	1200
FUP0147A : VENOUS / POLY TETRA FLUORO ETHYLENE PATCH ANGIOPLASTY - First Qtr	2500
FUP0147B : VENOUS / POLY TETRA FLUORO ETHYLENE PATCH ANGIOPLASTY - Next 3 Qtrs	1200
FUP0148A : HEPATIC VEIN ANGIOPLASTY AND STENTING - First Qtr	3000
FUP0148B : HEPATIC VEIN ANGIOPLASTY AND STENTING - Next 3 Qtrs	1500
FUP0149A : MINIMAL ACCESS SURGERY- VALVE REPLACEMENT - First Qtr	3500
FUP0149B : MINIMAL ACCESS SURGERY- VALVE REPLACEMENT - Next 3 Qtrs	2500
FUP0150A : MINIMAL ACCESS SURGERY- CABG - First Qtr	2000
FUP0150B : MINIMAL ACCESS SURGERY- CABG - Next 3 Qtrs	1000
FUP0151A : MULTI ORGAN RESECTION FOR ANY GI CANCERS - First Qtr	1500
FUP0151B : MULTI ORGAN RESECTION FOR ANY GI CANCERS - Next 3 Qtrs	1000
FUP0152A : VISCERAL ARTERY ANEURSYM REPAIR / RENAL ARTERY ANEURYSM REPAIR - First Qtr	2500
FUP0152B : VISCERAL ARTERY ANEURSYM REPAIR / RENAL ARTERY ANEURYSM REPAIR - Next 3 Qtrs	1500
FUP0153A : HYBRID / OPEN INCLUDING COVERED STENT PLACEMENT - UNILATERAL - First Qtr	2500
FUP0153B : HYBRID / OPEN INCLUDING COVERED STENT PLACEMENT - UNILATERAL - Next 3 Qtrs	1200
FUP0154A : HYBRID / OPEN INCLUDING COVERED STENT PLACEMENT - BILATERAL - First Qtr	2000
FUP0154B : HYBRID / OPEN INCLUDING COVERED STENT PLACEMENT - BILATERAL - Next 3 Qtrs	2000
CM0219 D : TERM BABY HYPERBILIRUBINEMIA - Phototherapy	7000
CM0222 D : PRETERM BABY HYPERBILIRUBINEMIA - Phototherapy	10000
CM0494A : ARRYTHMIAS (SUPRAVENTRICULLAR / VENTRICULAR) - INVASIVE MANAGEMENT (without 3D mapping)	49500
CM0100-N : BREAST CANCER - TAMOXIFEN	100
CM0100-O : BREAST CANCER - AROMATASE INHIBITORS	1000
CM0100-P : BREAST CANCER - Zoledronic Acid for skeletal metastasis	2700
CM0124-c : PROSTATE CANCER - Zoledronic Acid for skeletal metastasis	2700
CM0955-O : Multiple Myeloma - Zoledronic Acid	2700
CM0821-I A : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSTIBIAL - MOBILITY GRADE 1	25500
CM0821-I B : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSTIBIAL - MOBILITY GRADE 2	62500
CM0821-I C : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSTIBIAL - MOBILITY GRADE 3	177000
CM0821-I D : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSFEMORAL - MOBILITY GRADE 1	69000
CM0821-I E : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSFEMORAL - MOBILITY GRADE 2	176500
CM0821-I F : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSFEMORAL - MOBILITY GRADE 3	177000
CM0821-I G : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSRADIAL - MOBILITY GRADE 1	39000
CM0821-I H : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSRADIAL - MOBILITY GRADE 2	94500
CM0821-I I : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSRADIAL - MOBILITY GRADE 3	183000
CM0821-I J : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSHUMERAL - MOBILITY GRADE 1	74000
CM0821-I K : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSHUMERAL - MOBILITY GRADE 2	79000
CM0821-I L : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSHUMERAL - MOBILITY GRADE 3	197000
CM0821-II A : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSTIBIAL - MOBILITY GRADE 1	25500
CM0821-II B : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSTIBIAL - MOBILITY GRADE 2	62500
CM0821-II C : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSTIBIAL - MOBILITY GRADE 3	177000
CM0821-II D : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSFEMORAL - MOBILITY GRADE 1	69000
CM0821-II E : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSFEMORAL - MOBILITY GRADE 2	176500
CM0821-II F : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSFEMORAL - MOBILITY GRADE 3	177000
CM0821-II G : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSRADIAL - MOBILITY GRADE 1	39000
CM0821-II H : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSRADIAL - MOBILITY GRADE 2	94500
CM0821-II I : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSRADIAL - MOBILITY GRADE 3	183000
CM0821-II J : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSHUMERAL - MOBILITY GRADE 1	74000
CM0821-II K : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSHUMERAL - MOBILITY GRADE 2	79000
CM0821-II L : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (except fingers, toes and small joints) - TRANSHUMERAL - MOBILITY GRADE 3	197000
CM0100-a-III : BREAST CANCER - Paclitaxel (Preceeded by Dose Dense AC - 4 cycles) ; (Day 1: Paclitaxel 175mg/m2) Repeat cycle - every 21 days for 4 cycles	7000
CM0100-a-IV : BREAST CANCER - Paclitaxel (Preceeded by Dose Dense AC - 4 cycles) ; (Day 1: Paclitaxel 80mg/m2) Repeat cycle - weekly for 12 cycles	3500
CM0101-a-IV : BLADDER CANCER - Radiosensitizing - Cisplatinc + 5-FU ; Days 1, 2, 3, 15, 16, and 17: IV hydration at a rate of 500mL/hour; followed by 5-FU 400mg/m2 IV push; followed by cisplatin 15mg/m2 IV over 1 hour as induction and consolidation therapy	9800
CM0101-a-V : BLADDER CANCER -Radiosensitizing - Cisplatin + paclitaxel ; Days 1, 8, and 15: Paclitaxel 50mg/m2 ; Day 1-3, 8-10, 15-17: Cisplatin 15mg/m2; followed by twice-daily radiotherapy for 8 days	18400
CM0101-a-VI : BLADDER CANCER -Radiosensitizing - 5-FU + mitomycin32 ; Day 1 of radiotherapy: Mitomycin 12mg/m2 IV bolus, plus ; Week 1 (fractions 1-5) and Week 4 (fractions 16-20) of radiotherapy: 5-FU 500mg/m2 continuous IV infusion (10 days total)	15100
CM0101-c : BLADDER CANCER - Concurrent Cisplatin; Cisplatin 40mg/m2 IV once weekly for up to 5 cycles	1800
CM0103-v: ESOPHAGEAL CANCER - Concurrent Cisplatin; Cisplatin 40mg/m2 IV once weekly for up to 5 cycles	1800
CM0106-vi : Other bone tumors - Mesenchymal Chordosarcoma VIDE (vincristine + ifosfamide + doxorubicin + etoposide) ; Day 1: Vincristine 1.4mg/m2 (max 2mg), ; Days 1-3: Doxorubicin 20mg/m2 IV + ifosfamide 3mg/m2 IV + mesna 3g/m2 + etoposide 150mg/m2 IV. ; Repeat cycle every 3 weeks for up to 6 cycles.	9200
CM0114-i-b-1 : EWINGS SARCOMA - Induction Treatment - VAC/IE - VAC ; Day 1: Vincristine 2mg/m2 (max 2mg) IV, doxorubicin 75mg/m2 IV bolus, cyclophosphamide 1,200mg/m2 IV, mesna. ; Dactinomycin 1.25mg/m2 IV can be substituted for doxorubicin when a total doxorubicin dose of 375mg/m2 is reached.	4600
CM0114-i-b-2 : EWINGS SARCOMA - Induction Treatment - VAC/IE - IE ; IE cycles ; Days 1-5: Ifosfamide 1,800mg/m2 IV + mesna + etoposide 100mg/m2 IV. ; Repeat each cycle every 3 weeks for 17 cycles.	6000
CM0114-i-e : EWINGS SARCOMA - Induction Treatment - VACA ; Day 1: Vincristine 1.5mg/m2 IV + cyclophosphamide 1,200mg/m2 IV + mesna ; Days 1, 3, and 5: Dactinomycin 0.5mg/m2 IV ; Days 2 and 4: Doxorubicin 30mg/m2 IV. ; Repeat cycle every 21 days for 10 cycles.	4600
CM0117-e : VULVAL CANCER - Cisplatin + 5FU ; Days 1 and 29: Cisplatin 50mg/m2 IV ; Days 2-5, and 30-33: 5-FU 1,000mg/m2 IV	11100
CM0128-ii-c-1 : BRAIN CARCINOMA - Systemic Therapy for Anaplastic Gliomas - Concurrent Temozolomide (with RT) - followed by adjuvant temozolomide ; Daily oral temozolomide (75mg/m2/day, 7 days per week from the first to the last day of radiotherapy)	7200
CM0128-ii-c-2 : BRAIN CARCINOMA - Systemic Therapy for Anaplastic Gliomas - adjuvant temozolomide - preceeded by Concurrent Temozolomide (with RT) ; Temozolomide 150-200mg/m2/day for 5 days. ; Repeat cycle every 28 days for 6 cycles	2100
CM0130 I a : RENAL CELL CARCINOMARENAL CELL CARCINOMA - First-line Therapy for Patients with Predominantly Clear Cell Histology - Pazopanib ; Pazopanib 800mg orally once daily	19250
CM0130 I b : RENAL CELL CARCINOMARENAL CELL CARCINOMA - First-line Therapy for Patients with Predominantly Clear Cell Histology - Sunitinib ; Sunitinib 50mg orally daily for 4 weeks, followed by 2 weeks off.	29250
CM0130 I c : RENAL CELL CARCINOMARENAL CELL CARCINOMA - First-line Therapy for Patients with Predominantly Clear Cell Histology - Bevacizumab + IFN-alpha ; Bevacizumab 10mg/kg IV every 2 weeks + IFN-alpha.	66750
CM0130 I d : RENAL CELL CARCINOMARENAL CELL CARCINOMA - First-line Therapy for Patients with Predominantly Clear Cell Histology - Sorafenib ; Sorafenib 400mg orally twice daily	3650
CM0130 II a : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Subsequent Therapy for Patients with Predominantly Clear Cell Carcinoma - Everolimus ; Everolimus 10mg orally once daily	37250
CM0130 II b : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Subsequent Therapy for Patients with Predominantly Clear Cell Carcinoma - Pazopanib ; Pazopanib 800mg orally once daily	19250
CM0130 II c : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Subsequent Therapy for Patients with Predominantly Clear Cell Carcinoma - Sorafenib ; Sorafenib 400mg orally twice daily	3650
CM0130 II d : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Subsequent Therapy for Patients with Predominantly Clear Cell Carcinoma - Sunitinib ; Sunitinib 50mg orally daily for 4 weeks, followed by 2 weeks off.	29250
CM0130 II e : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Subsequent Therapy for Patients with Predominantly Clear Cell Carcinoma - Bevacizumab ; Bevacizumab 10mg/kg IV every 2 weeks.	66250
CM0130 III a : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Systemic Therapy for Patients with Non-Clear Cell Histology - Sunitinib ; Sunitinib 50mg orally daily for 4 weeks, followed by 2 weeks off.	29250
CM0130 III b : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Systemic Therapy for Patients with Non-Clear Cell Histology - Bevacizumab ; Bevacizumab 10mg/kg IV every 2 weeks.	66250
CM0130 III c : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Systemic Therapy for Patients with Non-Clear Cell Histology - Everolimus ; Everolimus 10mg orally once daily	37250
CM0130 III d : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Systemic Therapy for Patients with Non-Clear Cell Histology - Erlotinib ; Erlotinib 150mg orally once daily	3400
CM0130 III e : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Systemic Therapy for Patients with Non-Clear Cell Histology - Pazopanib ; Pazopanib 800mg orally once daily	19250
CM0130 III f : RENAL CELL CARCINOMARENAL CELL CARCINOMA - Systemic Therapy for Patients with Non-Clear Cell Histology - Sorafenib ; Sorafenib 400mg orally twice daily	3650
CM0130 IV: RENAL CELL CARCINOMARENAL CELL CARCINOMA - Other Regimen (May be chosen for any other internationally approved Curative regimen with submission of substantiating Documents)	10000
CM0131-i-g : UNKNOWN PRIMARY - Adenocarcinoma - mFOLFOX ; Day 1: Oxaliplatin 85mg/m2 IV over 2 hours + leucovorin 400mg/m2 IV over 2 hours + 5-FU 400mg/m2 IV bolus then ; Days 1 and 2: 5-FU 1200mg/m2 (total 2400mg/m2 over 46-48 hours) IV continuous infusion. ; Repeat cycle every 2 weeks for 24 cycles	8000
CM0131-i-h : UNKNOWN PRIMARY - Adenocarcinoma - CapeOX ; Day 1: Oxaliplatin 130mg/m2 IV over 2 hours ; Day 1-14: Capecitabine 850-1000mg/m2 orally twice daily. ; Repeat cycle every 3 weeks for 16 cycles.	6500
CM0131-i-i : UNKNOWN PRIMARY - Adenocarcinoma - Irinotecan + carboplatin ; Day 1: Carboplatin AUC 5mg per min/mL IV ; Days 1, 8, and 15: Irinotecan 60mg/m2 IV. ; Repeat cycle every 4 weeks for up to 6 cycles	7700
CM0131-ii-c : UNKNOWN PRIMARY - Squamous cell carcinoma -Paclitaxel + carboplatin ; Day 1: Carboplatin AUC 6mg per min/mL IV over 30 minutes + paclitaxel 200mg/m2 IV over 3 hours. ; Repeat cycle every 3 weeks for 8 cycles in responding patients and for 6 cycles maximum in patients with stable disease	7200
CM0131-ii-d : UNKNOWN PRIMARY - Squamous cell carcinoma -Cisplatin + gemcitabine ; Day 1: Cisplatin 100mg/m2 IV ; Day 1 and 8: Gemcitabine 1250mg/m2 IV. ; Repeat every 3 weeks for 4 cycles.	5250
CM0131-ii-e : UNKNOWN PRIMARY - Squamous cell carcinoma -mFOLFOX ; Day 1: Oxaliplatin 85mg/m2 IV over 2 hours + leucovorin 400mg/m2 IV over 2 hours + 5-FU 400mg/m2 IV bolus then ; Days 1 and 2: 5-FU 1200mg/m2 (total 2400mg/m2 over 46-48 hours) IV continuous infusion. ; Repeat cycle every 2 weeks for 24 cycles.	8000
CM0131-ii-f : UNKNOWN PRIMARY - Squamous cell carcinoma -Paclitaxel + cisplatin ; Day 1: Paclitaxel 175mg/m2 IV + cisplatin 60mg/m2 IV. ; Repeat cycle every 3 weeks.	6450
CM0131-ii-g : UNKNOWN PRIMARY - Squamous cell carcinoma -Docetaxel + carboplatin ; Day 1: Docetaxel 75mg/m2 IV over 30 minutes + carboplatin AUC 5mg per min/mL IV over 30 minutes. ; Repeat cycle every 3 weeks for 8 cycles	8700
CM0131-ii-h : UNKNOWN PRIMARY - Squamous cell carcinoma -Docetaxel + cisplatin ; Day 1: Docetaxel 60mg/m2 IV + cisplatin 80mg/m2 IV. ; Repeat cycle every 3 weeks for 2 cycles and an additional 4 cycles until disease progression is demonstrated	5040
CM0131-ii-i : UNKNOWN PRIMARY - Squamous cell carcinoma -Docetaxel + cisplatin ; Day 1: Docetaxel 75mg/m2 IV + cisplatin 75mg/m2 IV. ; Repeat cycle every 3 weeks for up to 6 cycles.	3820
CM0131-ii-j : UNKNOWN PRIMARY - Squamous cell carcinoma -Cisplatin + fluorouracil ; Days 1-5: Cisplatin 20mg/m2 IV ; Days 1-5: Fluorouracil 700mg/m2/day IV via continuous infusion over 24 hours. ; Repeat cycle every 4 weeks for 3 cycles.	7050
CM0694-II-d : ERCP and Stent (plastic)	18225
CM0694-II-e : ERCP and Stent (SEMS)	40095
CM0694-II-f : POST OP BILIARY STRICTURE	25515
CM0707-I-A : ACUTE MILD PANCREATITIS - CONSERVATIVE MANAGEMENT	21870
CM0707-I-B : ACUTE MODERATE PANCREATITIS - CONSERVATIVE MANAGEMENT	29160
CM0707-I-C : ACUTE SEVERE PANCREATITIS - CONSERVATIVE MANAGEMENT	40788
CM0630 B -II-c : MIXED CONNECTIVE TISSUE DISEASE - WITH GANGRENE ON IV PROSTACYCLIN	5103
CM0630 B -II-d : MIXED CONNECTIVE TISSUE DISEASE - PNEUMOCOCCAL VACCINATION	3645
CM0631A-II -a : VASCULITIS - PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE	2187
CM0631A-II -b : VASCULITIS - PULSE CYCLOPHOSPHAMIDE THERAPY	2187
CM0630 A-I-a-ii : MIXED CONNECTIVE TISSUE DISEASE- PULSE CYCLOPHOSPHAMIDE THERAPY	2187
CM0630 A-I-b-ii :MIXED CONNECTIVE TISSUE DISEASE-METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE	2187
CM0630 B -II-a : MYCOPHENOLATE MOFETIL INDUCTION	4374
CM0630 B -II-b : MYCOPHENOLATE MOFETIL MAINTENANCE	2187
CM0630 B -II-e : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ WITH GANGRENE ON IV PROSTACYCLIN/ PNEUMOCOCCAL VACCIN	21870
CM0631A-II-c : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY )(including Diagnostic evaluation - 1st time)	8748
CM0707-II-A : ACUTE MILD PANCREATITIS - CONSERVATIVE MANAGEMENT	21870
CM0707-II-B : ACUTE MODERATE PANCREATITIS - CONSERVATIVE MANAGEMENT	29160
CM0707-II-C : ACUTE SEVERE PANCREATITIS - CONSERVATIVE MANAGEMENT	40788
CM0881 A-I-a : THALASSEMIA MAJOR (upto)	5103
CM0931-I-B : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 1 MG 30 TABS	1800
CM0931-I-C : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 0.5MG 30 TABS	3500
CM0931-I-F : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS	2000
CM0931-I-H : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS + VELPATASVIR 100 28 TABS	6000
CM0931-II-B : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 1 MG 30 TABS	4500
CM0931-II-D : MANAGEMENT CHRONIC HEPATITIS B / C - TELBUVUDINE 600MG 30 TABS	16000
CM0931-II-F : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS	11000
CM0931-I-ii : INVESTIGATION OF CHRONIC HEPATITIS B / C (VIRAL LOAD)	10000
CM0931-II-I : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS + LEDIPASVIR 90 28 TABS	15000
CM0931-II-i i: INVESTIGATION OF CHRONIC HEPATITIS B / C (VIRAL LOAD)	10000
CM0931-I-J : MANAGEMENT CHRONIC HEPATITIS B / C INTERFERON WILL BE APPROVED BASED ON DOSAGE)	1000
CM0879-I-a :LAPAROSCOPIC - ECTOPIC RESECTION	15565
CM0629-II-a : OBSCURE BLEED - Conservative management including Capsule endoscopy	21870
CM0629-II-b : OBSCURE BLEED - Conservative	7290
CM0629-II-c : NON VARICEAL BLEED - CLIPPING	21870
CM0629-II-d : NON VARICEAL BLEED - ARGON PLASMA COAGULATION	33644
CM0629-II-e : NON VARICEAL BLEED - CONSERVATIVE	7290
CM0774 A : LAPROSCOPIC ASSISTED VAGINAL HYSTERECTOMY	14616
CM0820-I-A : Amputation of AK / BK	21870
CM0820-I-B : Amputation of AE / BE	18225
CM0820-I-C : Amputation of Fore-Foot	10935
CM0820-I-E : Amputation of Toes	5103
CM0820-I-F : Amputation of Fingers	7290
CM0820-I-G : Trans Meta-Tarsal Amputation	10935
CM0879-I-b :LAPROTOMY - ECTOPIC RESECTION	8748
CM0898 A : COLONIC PULL THROW	36450
CM0898 B : COLOPLASTY	21870
CM0898 C : ABDOMINAL RESECTION	29160
CM0905-IA : CYST EXCISION WITH HEPATIC JEJUNOSTOMY/ BILIARY DRAINAGE	32805
CM0905-IB : CYST EXCISION WITHOUT HEPATIC JEJUNOSTOMY/ BILIARY DRAINAGE	25515
CM0774 B : LAPROSCOPIC ASSISTED VAGINAL HYSTERECTOMY	14616
CM0931-I-A : MANAGEMENT CHRONIC HEPATITIS B / C - TENOFOVIR 300MG 30 TABS	10000
CM0931-I-D : MANAGEMENT CHRONIC HEPATITIS B / C - TELBUVUDINE 600MG 30 TABS	1800
CM0931-I-E : MANAGEMENT CHRONIC HEPATITIS B / C - LAMIVUDINE 100MG 28 TABS	3500
CM0931-I-G : MANAGEMENT CHRONIC HEPATITIS B / C - DACLATASVIR 60 MG 28 TABS	2000
CM0931-I-I : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS + LEDIPASVIR 90 28 TABS	6000
CM0931-II-A : MANAGEMENT CHRONIC HEPATITIS B / C - TENOFOVIR 300MG 30 TABS	10000
CM0931-II-C : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 0.5MG 30 TABS	4500
CM0931-II-E : MANAGEMENT CHRONIC HEPATITIS B / C - LAMIVUDINE 100MG 28 TABS	16000
CM0931-II-G : MANAGEMENT CHRONIC HEPATITIS B / C - DACLATASVIR 60 MG 28 TABS	128545
CM0931-II-H : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS + VELPATASVIR 100 28 TABS	11000
CM0931-II-J : MANAGEMENT CHRONIC HEPATITIS B / C INTERFERON WILL BE APPROVED BASED ON DOSAGE)	15000
CM0952A-I-iii-j : Chronic Myeloid Leukemia (CML) - Other Regimen	10000
CM0952A-II-z : Acute Myeloid Leukemia (AML) - Other Regimen	10000
CM0218 A- iii : TERM BABY WITH CULTURE POSITIVE SEPSIS (Multi drug resistant requiring Higher antibiotics - Imipenems, Vancomycin etc)	14580
CM0218 A-i : TERM BABY WITH CLINICAL SEPSIS	5103
CM0218 A-ii : TERM BABY WITH CULTURE POSITIVE SEPSIS	7290
CM0218 B-i : TERM BABY WITH CLINICAL SEPSIS WITH CPAP	14580
CM0218 B-ii : TERM BABY WITH CULTURE POSITIVE SEPSIS WITH CPAP	21870
CM0218 B-iii : TERM BABY WITH CULTURE POSITIVE SEPSIS WITH CPAP(Multi drug resistant requiring Higher antibiotics - Imipenems, Vancomycin etc)	29160
CM0218 C- i : TERM BABY WITH CLINICAL SEPSIS WITH MECHANICAL VENTILATION	21870
CM0218 C-ii : TERM BABY WITH CULTURE POSITIVE SEPSIS WITH MECHANICAL VENTILATION	29160
CM0218 C-iii : TERM BABY WITH CULTURE POSITIVE SEPSIS WITH MECHANICAL VENTILATION (Multi drug resistant requiring Higher antibiotics - Imipenems, Vancomycin etc)	43740
CM0220 D : TERM BABY PERSISTENT PULMONARY HYPERTENSION / MECONIUM ASPIRATION SYNDROME / PERINATAL ASPHYXIA / WITH MECHANICAL VENTILATION - Mechanical High-frequency oscillatory ventilation (HFOV)	47385
CM0221 A- iii : PRETERM BABY WITH CULTURE POSITIVE SEPSIS (Multi drug resistant requiring Higher antibiotics - Imipenems, Vancomycin etc)	21870
CM0221 A-i : PRETERM BABY WITH CLINICAL SEPSIS	7290
CM0221 A-ii : PRETERM BABY WITH CULTURE POSITIVE SEPSIS	14580
CM0221 B-iii : PRETERM BABY WITH CULTURE POSITIVE SEPSIS WITH CPAP(Multi drug resistant requiring Higher antibiotics - Imipenems, Vancomycin etc)	29160
CM0221 C- i : PRETERM BABY WITH CLINICAL SEPSIS WITH MECHANICAL VENTILATION	21870
CM0221 C-ii : PRETERM BABY WITH CULTURE POSITIVE SEPSIS WITH MECHANICAL VENTILATION	29160
CM0221 C-iii : PRETERM BABY WITH CULTURE POSITIVE SEPSIS WITH MECHANICAL VENTILATION (Multi drug resistant requiring Higher antibiotics - Imipenems, Vancomycin etc)	43740
CM0221B-i : PRETERM BABY WITH CLINICAL SEPSIS WITH CPAP	14580
CM0221B-ii : PRETERM BABY WITH CULTURE POSITIVE SEPSIS WITH CPAP	21870
CM0227 D : PRETERM BABY RDS WITH SURFACTANT WITH MECHANICAL VENTILATION	47385
CM0228 A : TERM BABY-CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE- WITH VENTILATION (High Frequency Oscillatory Ventilation)	36450
CM0230 A : TERM BABY-CONGENITAL HEART DISEASE / CONGESTIVE CARDIAC FAILURE- WITH VENTILATION (High Frequency Oscillatory Ventilation)	43740
CM0722-I-A : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MAXILLA	7309
CM0722-I-B : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MANDIBLE	7309
CM0722-I-C : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MANDIBLE, MAXILLA- INTERDENTAL WIRING	3645
CM0436A : THERAPEUTIC PENETRATING KERATOPLASTY	7290
CM0436B : OPTICAL PENETRATING KERATOPLAS	9951
CM0444A : VITRECTOMY - MEMBRANE PEELING- ENDOLASER	10935
CM0444B : VITRECTOMY - SILICON OIL	7290
CM0183a : Neck/ Shaft Of Femur ORIF	16221
CM0183b : IM Nailing	10935
CM0183c : Shaft of Other Long Bones (Humerus)	12393
CM0183d : Tibia	10935
CM0183e : Radius, Fibula, Ulna (ORIF)	10935
CM0183f : Clavicle ( CRIF) (Displaced)	5832
CM0183g : Clavicel (ORIF) (Displaced)	8748
CM0183h : Both Bones of Forearm, Both Bones of Leg (Fixation of both bones)	16221
CM0183i : Bimalleolar Fracture	10935
CM0183j : Closed Reduction and Proximal Femoral nailing / Screw Fixation	10935
CM0183k : Closed Reduction and Pinning / Tens Nail	8748
CM0183l : Closed Reduction and Internal Fixation with K wire	4374
CM0183m : Tension Band wiring	8748
CM0184a : Neck/ Shaft Of Femur ORIF	16221
CM0184b : IM Nailing	10935
CM0184c : Shaft of Other Long Bones (Humerus)	12393
CM0184d : Tibia	10935
CM0184e : Radius, Fibula, Ulna (ORIF)	10935
CM0184f : Clavicle ( CRIF) (Displaced)	5832
CM0184g : Clavicel (ORIF) (Displaced)	8748
CM0184h : Both Bones of Forearm, Both Bones of Leg (Fixation of both bones)	16221
CM0184i : Bimalleolar Fracture	10935
CM0184j : Closed Reduction and Proximal Femoral nailing / Screw Fixation	10935
CM0184k : Closed Reduction and Pinning / Tens Nail	8748
CM0184l : Closed Reduction and Internal Fixation with K wire	4374
CM0184m : Tension Band wiring	8748
CM0186A-i : IMPLANT EXIT- K-WIRES - Single	1094
CM0186A-ii : IMPLANT EXIT- K-WIRES - Multiple	1823
CM0186A-iii : IMPLANT EXIT- SCREWS - single (Open)	2916
CM0186A-iv : IMPLANT EXIT- SCREWS - Multiple (Open)	5468
CM0186A-v : IMPLANT EXIT- SCREWS - single (Closed)	1458
CM0186A-vi : IMPLANT EXIT- SCREWS - Multiple (Closed)	2187
CM0186A-vii : IMPLANT EXIT- OTHER MINOR IMPLANTS (TENS, TBW, etc) - Solitary	3645
CM0186A-viii : IMPLANT EXIT- OTHER MINOR IMPLANTS (Pins / TENS, TBW, etc) - Multiple	5650
CM0186B-i : IMPLANT EXIT- PLATES (Open)	9113
CM0186B-ii : IMPLANT EXIT- Femoral Screws / IM Nails / Rush Nail (Open)	7290
CM0186B-iii : IMPLANT EXIT- SPINE IMPLANTS - upto 2 levels(complete exit) (eg- L2-L3, L3-L4)	12758
CM0186B-iv : IMPLANT EXIT- SPINE IMPLANTS - upto 2 levels(partial exit) (eg- L2-L3, L3-L4)	10935
CM0186B-v : IMPLANT EXIT- SPINE IMPLANTS - > 2 levels(complete exit) (eg- L2-L3, L3-L4, L4-L5)	14945
CM0186B-vi : IMPLANT EXIT- SPINE IMPLANTS - > 2 levels(partial exit) (eg- L2-L3, L3-L4, L4-L5)	12758
CM0186B-vii : IMPLANT EXIT- Bipolar, etc	10935
CM0186B-viii : IMPLANT EXIT - Other Major implants	9113
CM0187a : ARTHRODESIS OF JOINTS - HIP	19683
CM0187b : ARTHRODESIS OF JOINTS - SHOULDER / KNEE	14580
CM0187c : ARTHRODESIS OF JOINTS - ELBOW/ ANKLE / WRIST	10935
CM0187d : ARTHRODESIS OF JOINTS - ANKLE - Triple Arthrodesis	11664
CM0187e : ARTHRODESIS OF JOINTS - HAND / FOOT	7290
CM0192-A : ILIZAROV RING FIXATOR APPLICATION-FEMUR - DEFORMITY CORRECTION / LIMB LENGTHENING	18225
CM0192-B : ILIZAROV RING FIXATOR APPLICATION- TIBIA - DEFORMITY CORRECTION / LIMB LENGTHENING	13122
CM0193-A : SURGERY FOR NEGLECTED CTEV/RECURRENT CTEV/RESISTANT CTEV BY JESS FIXATION	32623
CM0195-A : KNEE LIGAMENT RECONSTRUCTION-ACL RECONSTRUCTION/PCL RECONSTRUCTION	21870
CM0195-B : KNEE LIGAMENT RECONSTRUCTION-MPFL RECONSTRUCTION	18225
CM0204- b : ACETABULAR FRACTURES	21506
CM0204-a : CORRECTION SACRO ILLIAC JOINT	14580
CM0625-II A : AMPUTATIONS - FORE QUARTER	29160
CM0625-II B : AMPUTATIONS - HIND QUARTER / Internal Hemipelvectomy	29160
CM0625-II C : AMPUTATIONS - HIND QUARTER / External Hemipelvectomy	29160
CM0722-II-A : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MAXILLA	7309
CM0722-II-B : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MANDIBLE	7309
CM0722-II-C : RECONSTRUCTIVE SURGERY FOLLWING FACIO MAXILLARY TRAUMA, FRACTURE MANDIBLE, MAXILLA- INTERDENTAL WIRING	3645
CM0807-a - I : Cementing (only as Addon)	3645
CM0807-a : BONE RESECTION	18225
CM0807-b - I : Cementing (only as Add on)	3645
CM0807-b : BONE Curettage	10935
CM0820-II-A : Amputation of AK / BK	21870
CM0820-II-B : Amputation of AE / BE	18225
CM0820-II-C : Amputation of Fore-Foot	10935
CM0820-II-E : Amputation of Toes	5103
CM0820-II-F : Amputation of Fingers	7290
CM0820-II-G : Trans Meta-Tarsal Amputation	10935
CM0820-III-a : Amputation of great toe	5103
CM0820-III-b : Amputation toe- single	3645
CM0820-III-c : Amputation toe- Multiple	5103
CM0820-III-d : Amputation of Finger - single	5103
CM0820-III-e : Amputation of Finger - Multiple	7290
CM0820-III-f : Transmetatarsal Amputation	7290
CM0861-II-A : POSTERIOR DISCECTOMY WITH SPACER/IMPLANT/VERTEBROPLASTY (open)	31347
CM0861-II-B : POSTERIOR DISCECTOMY WITH BONE GRAFT	24057
CM0861-II-C : POSTERIOR DISCECTOMY WITHOUT BONE GRAFT/SPACER/IMPLANT/VERTEBROPLASTY	18225
CM0233- A : SEVERE BRONCHIOLITIS/SEVERE BRONCHO PNEUMONIA / SEVERE ASPIRATION PNEUMONIA (Non ICU)	5468
CM0233- B : SEVERE BRONCHIOLITIS/SEVERE BRONCHO PNEUMONIA / SEVERE ASPIRATION PNEUMONIA (ICU - with Photograph)	10935
CM0247A : ADVERSE EVENTS FOLLOWING IMMUNISATION REQUIRING VENTILATOR SUPPORT	29160
CM0250-A : BILIARY ATRESIA	25515
CM0250-B : CHOLEDOCHAL CYST	25515
CM0255A : CONGENITAL HYDRONEPHROSIS (IF ANTENATALLY DETECTED & AGE	14580
CM0255B : CONGENITAL HYDRONEPHROSIS (IFAGE >1YR AND NO EVIDENCE AS PER ANTENATAL USG)	21870
CM0256- B : EXSTROPHY BLADDER - STAGE 2	21870
CM0256-A : EXSTROPHY BLADDER - STAGE 1	29160
CM0260A : HAMARTOMA EXCISION<5CM	10935
CM0260B : HAMARTOMA EXCISION >5CM	14580
CM0273A : CONGENITAL UROGENITAL ANOMALY STAGED CORRECTION Stage 1	32805
CM0273B : CONGENITAL UROGENITAL ANOMALY STAGED CORRECTION Stage 2	32805
CM0276A : Lobectectomy	38164
CM0276B :Cyst excision	72900
CM0277A : SURGICAL CORRECTION FOR ANY CONGENITAL ANOMALY (Complex - Single stage)	36450
CM0277B : SURGICAL CORRECTION FOR ANY CONGENITAL ANOMALY (simple - Single stage)	21870
CM0277C : SURGICAL CORRECTION FOR ANY CONGENITAL ANOMALY - Two Stage - per stage - upto	18225
CM0277D : SURGICAL CORRECTION FOR ANY CONGENITAL ANOMALY - Three Stage - per stage - upto	12393
CM0280-A : RECTAL POLYP - POLYPECTOMY- OPEN	21870
CM0280-B : RECTAL POLYP - POLYPECTOMY- LAP	25515
CM0212-A : HYPOPLASTIC ANEMIA	2260
CM0212-B : APLASTIC ANEMIA	2260
CM0212-C : FANCONI ANEMIA	2260
CM0213-A : NECROTISING ENTEROCOLITIS - NON VENTILATED	14580
CM0821-IV : AMPUTATION OF ANY SITE / ANY CAUSE WITH CUSTOM MADE PROSTHESIS (fingers, toes and small joints)	36450
CM0630 B -I-c : MIXED CONNECTIVE TISSUE DISEASE - WITH GANGRENE ON IV PROSTACYCLIN	5103
CM0630 B -I-d : MIXED CONNECTIVE TISSUE DISEASE - PNEUMOCOCCAL VACCINATION	3645
CM0631A-I -a : VASCULITIS - PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE	2187
CM0631A-I -b : VASCULITIS - PULSE CYCLOPHOSPHAMIDE THERAPY	2187
CM0631A-I -c : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY ) (including Diagnostic evaluation - 1st time)	8748
CM0630 A-I-a-i : MIXED CONNECTIVE TISSUE DISEASE- PULSE CYCLOPHOSPHAMIDE THERAPY	2187
CM0630 A-I-b-i :MIXED CONNECTIVE TISSUE DISEASE-METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE	2187
CM0630 A-I-i : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY (including Diagnostic evaluation - 1st time)	11664
CM0630 B -I-a : MYCOPHENOLATE MOFETIL INDUCTION	4374
CM0630 B -I-b : MYCOPHENOLATE MOFETIL MAINTENANCE	2187
CM0630 B -I-e : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ WITH GANGRENE ON IV PROSTACYCLIN/ PNEUMOCOCCAL VACCINA	21870
CM0861-I-A : POSTERIOR DISCECTOMY WITH SPACER/IMPLANT/VERTEBROPLASTY (open)	31347
CM0861-I-B : POSTERIOR DISCECTOMY WITH BONE GRAFT	24057
CM0861-I-C : POSTERIOR DISCECTOMY WITHOUT BONE GRAFT/SPACER/IMPLANT/VERTEBROPLASTY	18225
CM0862A : ANTERIOR DISCECTOMY WITHOUT IMPLANTS	21870
CM0862B : ANTERIOR DISCECTOMY WITH IMPLANTS	31457
CM0947 A : SPINAL DEFORMITY STABILISATION/CORRECTION PROCEDURES ( MORE THAN 4 LEVELS)	54675
CM0947 B : SPINAL DEFORMITY STABILISATION/CORRECTION PROCEDURES LESS THAN 4 LEVELS)	36450
CM0947C : SPINAL DEFORMITY STABILISATION/CORRECTION PROCEDURES WITH VERTERBROPLASTY	32805
CM0629-I-a : OBSCURE BLEED - Conservative management including Capsule endoscopy	21870
CM0629-I-b : OBSCURE BLEED - Conservative	7290
CM0629-I-c : NON VARICEAL BLEED - CLIPPING	21870
CM0629-I-d : NON VARICEAL BLEED - ARGON PLASMA COAGULATION	33644
CM0629-I-e : NON VARICEAL BLEED - CONSERVATIVE	7290
CM0694-I-a : BILIARY DRAINAGE PROCEDURES - T- Tube	14580
CM0694-I-b : BILIARY DRAINAGE PROCEDURES - Choledocojejunostomy	25515
CM0694-I-c : BILIARY DRAINAGE PROCEDURES - Hepaticojejunostomy	32805
CM0694-I-d : ERCP and Stent (plastic)	18225
CM0694-I-e : ERCP and Stent (SEMS)	40095
CM0694-I-f : POST OP BILIARY STRICTURE	25515
CM0905-IBI : CYST EXCISION WITHOUT HEPATIC JEJUNOSTOMY/ BILIARY DRAINAGE	25515
CM0905-IIA : CYST EXCISION WITH HEPATIC JEJUNOSTOMY/ BILIARY DRAINAGE	32805
CM0775-I-a : SALPINGO OOPHORECTOMY B/L- FOR CA	18481
CM0775-I-b : SALPINGO OOPHORECTOMY U/L FOR CA	13122
CM0625-I A : AMPUTATIONS - FORE QUARTER	29160
CM0625-I B : AMPUTATIONS - HIND QUARTER / Internal Hemipelvectomy	29160
CM0625-I C : AMPUTATIONS - HIND QUARTER / External Hemipelvectomy	29160
CM0765A : GLOSSECTOMY (HEMI/PARTIAL) WITH RECONSTRUCTION- FOR CANCER	21870
CM0765B : GLOSSECTOMY (TOTAL) WITH RECONSTRUCTION- FOR CANCER	29051
CM0338-A : EXCISION OF ARTERIO VENOUS MALFORMATION - SMALL (Limbs) < 3 sq CM Surface Area	10935
CM0338-B : EXCISION OF ARTERIO VENOUS MALFORMATION - SMALL (Limbs) 3 to 6 CM	14580
CM0338-C : EXCISION OF ARTERIO VENOUS MALFORMATION - SMALL (Others) < 3 CM	18225
CM0338-D : EXCISION OF ARTERIO VENOUS MALFORMATION - SMALL (Others) 3 to 6 CM	21870
CM0338-E : EXCISION OF ARTERIO VENOUS MALFORMATION - SMALL (Brain) < 6 CM	28978
CM0339-A : EXCISION OF ARTERIO VENOUS MALFORMATION - LARGE (Brain) > 6 CM	53946
CM0339-B : EXCISION OF ARTERIO VENOUS MALFORMATION - LARGE (Limbs) > 6 CM	18225
CM0339-C : EXCISION OF ARTERIO VENOUS MALFORMATION - LARGE (Others) > 6 CM	29160
CM0343-A : MEDIUM SIZE ARTERIAL ANEURYSMS (eg. Radial, cephalic, brachial, etc) - Repair	25515
CM0343-B : MEDIUM SIZE ARTERIAL ANEURYSMS (eg. Carotid, Jugular, Femoral, etc) - Repair	33899
CM0344-A : MEDIUM SIZE ARTERIAL ANEURYSMS WITH SYNTHETIC GRAFT (eg. Radial, cephalic, brachial, etc)	43740
CM0344-B : MEDIUM SIZE ARTERIAL ANEURYSMS WITH SYNTHETIC GRAFT(eg. Carotid, Jugular, Femoral, etc)	53582
CM0347A-i : AORTO - ILLIAC BYPASS WITH VEIN	36450
CM0347A-ii : AORTO - FEMORAL BYPASS WITH VEIN	43740
CM0347B-i : AORTO - BILLIAC BYPASS WITH VEIN	51030
CM0347B-ii : AORTO - BIFEMORAL BYPASS WITH VEIN	57774
CM0347C-i : AORTO - ILLIAC BYPASS WITH SYNTHETIC GRAFT	51030
CM0347C-ii : AORTO - FEMORAL BYPASS WITH SYNTHETIC GRAFT	58320
CM0347D-i : AORTO - BILLIAC BYPASS WITH VEIN WITH SYNTHETIC GRAFT	59414
CM0347D-ii : AORTO - BIFEMORAL BYPASS WITH VEIN WITH SYNTHETIC GRAFT	67615
CM0367-A : VASCULAR INJURY IN UPPER LIMBS - AXILLARY REPAIR WITH VEIN GRAFT	24786
CM0367-B : VASCULAR INJURY IN UPPER LIMBS - BRACHIAL - REPAIR WITH VEIN GRAFT	18225
CM0367-C : VASCULAR INJURY IN UPPER LIMBS - RADIAL AND ULNAR - REPAIR WITH VEIN GRAFT	14580
CM0368A : MAJOR VASCULAR INJURY -REPAIR (Femoral)	30436
CM0368B : MAJOR VASCULAR INJURY -REPAIR (Tibial)	25515
CM0369A : MINOR VASCULAR INJURY REPAIR -LOWER LIMBS (Fibular, Popliteal)	13305
CM0369B : MINOR VASCULAR INJURY REPAIR -LOWER LIMBS (Foot)	8748
CM0369C : MINOR VASCULAR INJURY REPAIR -LOWER LIMBS (Digits)	5832
CM0373A : ABDOMINAL VASCULAR INJURIES - AORTA, ILLAC ARTERIES, IVC, ILIAC VEINS - Vein Graft	51030
CM0373B : ABDOMINAL VASCULAR INJURIES - AORTA, ILLAC ARTERIES, IVC, ILIAC VEINS - Synthetic Graft	66157
CM0375A : VARICOSE VEINS RFA FOR U/L	12758
CM0377C : THROMBOLYSIS FOR DEEP VEIN THROMBOSIS (Systemic) - STK	7290
CM0377D : THROMBOLYSIS FOR DEEP VEIN THROMBOSIS (Systemic) - RTPA	21870
CM0384A : PSEUDOANEURYSM LIGATION - Small vessels (eg. Radial, cephalic, brachial, etc)	10935
CM0384B : PSEUDOANEURYSM LIGATION - Medium vessels (eg. Carotid, Jugular, Femoral, etc)	21870
CM0384C : PSEUDOANEURYSM LIGATION - Large vessels (eg. Aorta, Iliac, IVC, etc)	25333
CM0384D : PSEUDOANEURYSM LIGATION -Post AV Fistula	8100
CM0395A : GRAFT THROMBECTOMY BYPASS	15492
CM0395B : AV ACCESS SURGERY (not for Dialysis)	10935
CM0674-II-a : TIBIAL ANGIOPLASTY IN CRITICAL LIMB ISCHEMIA - Balloon plasty	42465
CM0674-II-b : TIBIAL ANGIOPLASTY IN CRITICAL LIMB ISCHEMIA - Stenting	67980
CM0692-II-A : ACUTE STROKE THROMBOLYSIS (R TPA ) (Cathter Directed)	54858
CM0814-I-a : VASCULAR MALFORMATIONS- Sclerotherapy	9477
CM0814-I-b : VASCULAR MALFORMATIONS- Sclerotherapy and Excision	19137
CM1038 : Drainage of Subdiaphramatic Abscess	7290
CM1046 : Excision Benign Tumor -Small intestine	10935
CM1067 : IlieoSigmoidostomy	12393
CM1076 : Repair of Common Bile Duct	10935
CM1083 : Pharyngectomy& Reconstruction - Total	14580
CM1084 : Tracheoplasty (Throat)	10935
CM1088 : Estlander Operation (lip)	5103
CM1093 : Operation for carcinoma lip- cheek advancement	8748
CM1096 : Resection Enucleation of Adenoma (lung)	7290
CM1099 : Thoracoplasty	14580
CM1100 : Thoracoscopic Segmental Resection	18225
CM1101 : Thoracoscopic Sympathectomy	10935
CM1148 : Dacryocystectomy with implants	7290
CM1150 : Intraocular Foreign Body Removal from Posterior Segment	14580
CM1161 : Anterior Chamber Reconstruction +Perforating corneo - Scleral Injury + IOL	8384
CM1191 : Abdominal Perineal neo construction Cx + Uteria + Vagina	14580
CM1198 : Brust abdomen repair	10206
CM1212 : Intrauterine transfusions	7290
CM1220 : Fixator with Joint Arthrolysis	14580
CM1223 : Pelvic Osteotomy with fixation with plaster	21870
CM1231 : Endopyelotomy (retrograde with laser/bugbee)	18225
CM1232 : Endopyelotomy (antegrade with laser/bugbee)	20412
CM1233 : Ureterocalycostomy Open	18225
CM1234 : Ureterocalycostomy Laparoscopic	21870
CM1235 : Uretero-ureterostomy Open	18225
CM1236 : Uretero-ureterostomy Laparoscopic	25515
CM1252 : Holmium Laser Prostatectomy	29160
CM1276 : Duroplasty - Endogenous	9113
CM1277 : Duroplasty - Exogenous	29342
CM1279 : Micro discectomy - Cervical	29160
CM1283 : Cranial Nerve Anastomosis	23328
CM1286 : Additonal clip for Aneurysm Clipping	10935
CM1288 : Superficial Temporal Artery (STA): middle cerebral artery (MCA) or (other EC - IC) Bypass procedure	43740
CM1296 : Balloon Atrial Septostomy	18000
CM1297 : PTSMA	25000
CM1298 : Pulmonary artery stenting	40000
CM1299 : Pulmonary artery stenting (double)	65000
CM1300 : Right ventricular outflow tract (RVOT) stenting	40000
CM1301 : Percutaneous Transluminal Tricuspid Commissurotormy (PTTC)	25000
CM1302 : Atrioventricular septal defect/ Atrioventricular (AV) Canal Defect	90000
CM1303 : Aortopulmonary Window (AP Window)	81000
CM1304 : Surgery for Hypertrophic Obstructive Cardiomyopathy (HOCM)	81000
CM1305 : Double Switch Operation	108000
CM1306 : Root Replacement (Aortic Aneurysm/ Aortic Dissection) / Bental Procedure	130500
CM1307 : Aortic Arch Replacement	144000
CM1308 : Central Shunt	45000
CM1309 : Pulmonary AV Fistula surgery	40500
CM1310 : Thyomectomy	31500
CM1311 : Encysted Empyema/Pleural Effusion - Tubercular	9000
CM1312 : Pulmonary Sequestration Resection	36000
CM1313 : Operations for Congenital Arteriovenous Fistula	13500
CM1316 : Fecal Fistula Closure	18225
CM1317 : GI Tumor Excision	21870
CM1318 : Hirschsprungs Disease - Retal Biopsy-Punch	7290
CM1319 : Hirschsprungs Disease - Retal Biopsy -Open	7290
CM1320 : Intussusception - Non -Operative Reduction in infants	14580
CM1321 : Congenital Lobar Emphysema	18225
CM1322 : Exomphalos/gastroschisis	18225
CM1323 : Microvascular reconstruction	32805
CM1325 : Axillary dissection	10935
CM1326 : Enucleation of pancreatic neoplasm	18225
CM1419 A : Acute lymphoblastic leukemia: Supportive care/ rehabilitation - Blood & Blood Product transfusions / granulocyte colony-stimulating factor (G-CSF) / Granulocyte-macrophage colony-stimulating factor (GM-CSF) / TPN	20000
CM1420 A : Acute myeloid leukemia: Supportive care/ rehabilitation - Blood & Blood Product transfusions / granulocyte colony-stimulating factor (G-CSF) / Granulocyte-macrophage	30000
CM1421 A : Hodgkin Lymphoma (Favorable group): Supportive care/ rehabilitation - Blood & Blood Product transfusions / granulocyte colony-stimulating factor (G-CSF) / Granulocyte-macrophage colony-stimulating factor (GM-CSF) / TPN	15000
CM1422 A : Hodgkin Lymphoma (unfavorable group): Supportive care/ rehabilitation - Blood & Blood Product transfusions / granulocyte colony-stimulating factor (G-CSF) / Granulocyte-macrophage colony-stimulating factor (GM-CSF) / TPN	25000
CM1423 A : Non-Hodgkin Lymphoma: Supportive care/ rehabilitation - Blood & Blood Product transfusions / granulocyte colony-stimulating factor (G-CSF) / Granulocyte-macrophage colony-stimulating factor (GM-CSF) / TPN	50000
CM1429 A : Chronic Myeloid Leukemia : supportive care/ rehabilitation - Blood & Blood Product transfusions / granulocyte colony-stimulating factor (G-CSF) / Granulocyte-macrophage colony-stimulating factor (GM-CSF) / TPN	20000
CM1430 A : Terminally Ill - Pain management (Opioid therapy / Neural Blocks / epidural or Intrathecal infusions / Antero-lateral spinal cordotomy (tractotomy) by RFA) / TPN - Per month	3000
CM0692-II-B-i : ACUTE STROKE THROMBOLYSIS (R TPA ) (IV - Thrombolysis - 50 mg)	30300
CM0692-II-B-ii : ACUTE STROKE THROMBOLYSIS (R TPA ) (IV - Thrombolysis - 70mg)	48300
CM0692-III : ACUTE STROKE THROMBOLYSIS (R TPA )	54857
CM0692-III-B-i : ACUTE STROKE THROMBOLYSIS (R TPA ) (IV - Thrombolysis - 50 mg)	30300
CM0692-III-B-ii : ACUTE STROKE THROMBOLYSIS (R TPA ) (IV - Thrombolysis - 70mg)	48300
CM0522-A : ACUTE RESPIRATORY FAILURE (WITHOUT VENTILATOR) COVID POSITIVE 1 TO 5 DAYS	45000
CM0522-B : ACUTE RESPIRATORY FAILURE (WITHOUT VENTILATOR) COVID POSITIVE 6 TO 10 DAYS	45000
CM0522-C : ACUTE RESPIRATORY FAILURE (WITHOUT VENTILATOR) COVID POSITIVE - RECOVERY PHASE - POST VENTILATOR PHASE	45000
CM0523-A : ACUTE RESPIRATORY FAILURE (WITH VENTILATOR - FOR MINIMUM 5 DAYS) COVID POSITIVE 1 TO 7 DAYS	88200
CM0523-B : ACUTE RESPIRATORY FAILURE (WITH VENTILATOR - FOR MINIMUM 5 DAYS) COVID POSITIVE 8 TO 14 DAYS	88200
CM0960-1-A : SEPTIC SHOCK (ICU MANAGEMENT - NON VENTILATED) COVID POSITIVE 1 TO 5 DAYS	49500
CM0960-1-B : SEPTIC SHOCK (ICU MANAGEMENT - NON VENTILATED ) COVID POSITIVE 6 TO 10 DAYS	49500
CM0960-1-C : SEPTIC SHOCK (ICU MANAGEMENT - NON VENTILATED) COVID - RECOVERY PHASE	49500
CM0960-2-A : SEPTIC SHOCK (ICU MANAGEMENT - VENTILATORY SUPPORT) COVID POSITIVE 1 TO 7DAYS	94500
CM0960-2-B : SEPTIC SHOCK (ICU MANAGEMENT - VENTILATORY SUPPORT) COVID POSITIVE 8 TO 14 DAYS	94500
CM0988-A : CRITICAL CARE ICU MANAGEMENT (RESPIRATORY DISTRESS/METABOLIC COMA/MULTIORGAN DYSFUNCTION/SEPTIC SHOCK/OTHERS WITH VENTILATION COVID POSITIVE 1 TO 7 DAYS	94500
CM0988-B : CRITICAL CARE ICU MANAGEMENT (RESPIRATORY DISTRESS/METABOLIC COMA/MULTIORGAN DYSFUNCTION/SEPTIC SHOCK/OTHERS WITH VENTILATION COVID POSITIVE 8 TO 14 DAYS	94500
CM01600-I-A : COVID POSITIVE - MILDLY SYMPTOMATIC/NON CRITICAL MANAGEMENT 1 TO 5 DAYS	25000
CM01600-I-B : COVID POSITIVE - MILDLY SYMPTOMATIC/NON CRITICAL MANAGEMENT 6 TO 10 DAYS	25000
CM01600-II-A : COVID POSITIVE - MILDLY SYMPTOMATIC/NON CRITICAL MANAGEMENT 1 TO 5 DAYS	25000
CM01600-II-B : COVID POSITIVE - MILDLY SYMPTOMATIC/NON CRITICAL MANAGEMENT 6 TO 10 DAYS	25000

Say hello to us , Toll-Free

Write to us

Reach us At